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Synopsis 
 
It is almost 10 years since the famous athlete Marion Jones won 5 medals at the Sydney 
Olympics 2000, a success now known to have been highly contributed to by performance-
enhancing drugs. She was not the first athlete to win so many medals at one Olympic 
game, but probably she was the first top athlete to plead guilty whilst never having been 
caught by anti doping authorities. In December 2007 the International Olympic Committee 
stripped her of the medals won in Sydney, and she was banned from the Beijing Olympics 
in 2008 in any capacity. Interestingly, 10 years after this case the screening for anabolic 
agents and stimulants in sports still relies on classical gas chromatographic – mass 
spectrometry (GC-MS) analysis, the “transparency” of which was the major cause of this 
failure to catch Jones.       
 
Gas chromatographic analysis has been continuously improving since its introduction in 
1950s. The two milestones in this technological progress were the introduction of capillary 
columns for the separation part and mass spectrometry for the detection part of the 
analysis. Capillary GC-MS was soon established as a golden standard in many areas of 
analysis, dominating the analytical methodologies up to today. Improvement has not 
stopped, but continues apace. Probably the next milestone, along with the improvement in 
MS technology, is the introduction of multidimensional separations, i.e. heart-cut GC and 
more recently its comprehensive two-dimensional GC counterpart. This thesis represents 
an original work in which the applicability of comprehensive two-dimensional gas 
chromatography (GC×GC) in performance enhancing and illicit drug analysis has been 
investigated.  
 
The thesis covers a diverse range of analytes (endogenous sterols, anabolic agents, ecstasy, 
heroin, cocaine), matrices (urine, illicit preparations), sample preparation techniques (solid 
phase micro extraction, solid phase extraction, derivatization), separation and detection 
approaches (one dimensional GC, two-dimensional GC, quadrupole MS, fast time-of-flight 
 xxiii 
MS, accurate mass TOFMS, flame photometric detection). The scope of the thesis justifies 
the extensive comprehensive introductory part given in Chapter 1, where a major focus is 
devoted chronologically on developments in profiling and analysis methods usually 
applied in forensic and anti-doping laboratories.      
 
Chapter 2 provides details on the reagents and samples used in the study as well as the 
sample preparation steps applied prior to analysis. While some general instrumental 
approaches are given in this chapter, the details on the specific experimental set up for 
each study are included in the subsequent chapters.    
 
The emerging need for better separation has arisen from the limitation of conventional one 
dimensional (one column) GC separation, which was unable to solve the perpetual 
problem where coelution causes imprecise or erroneous analytical results. This becomes 
especially true in cases where detection and unambiguous identification of ever smaller 
amounts of analytes in the presence of a complex matrix becomes mandatory due to lower 
required detection limits. As the ratio between the analyte and the matrix changes in 
favour of the latter, the use and relevance of highly selective detectors has diminished. An 
alternative and logical approach to solve the problem is to improve separation instead of 
resorting to altering detector selectivity. This subject has been discussed in Chapter 3, 
where special focus has been given to a literature review on application of 
multidimensional separations in performance enhancing and illicit drug analysis, 
supported by several examples arising from the work in this thesis. A clear in-depth 
classification of multidimensional GC techniques, based on multidimensionality arising 
from separation and multidimensionality arising from detection, has been given for the 
first time.  
 
The endogenous sterols profile has become an important part of every top athlete’s 
“biological passport” and increased importance has been given to this baseline 
measurement in the last several years. The applicability of GC×GC-TOFMS in this area has 
been discussed in Chapter 4. The synergic effect of the highly selective TOFMS detector 
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and improved separation of GC×GC has been shown as particularly advantageous over 
classical GC in terms of net information content and component identification. A new 
metric named the minimum acceptable match (MAM) has been proposed for the first time 
as an additional criterion when defining the limit of detection (LOD). The new LOD 
definition incorporates not only a reproducible signal magnitude (a simple single number) 
but also a “named” signal whose identity is based on full mass spectral similarity to a 
specific reference component.      
 
Key World Anti-Doping Agency (WADA) anabolic agents, the most difficult to analyse by 
using GC, have been chosen as model components of exogenous doping substances. The 
application of GC×GC in this area has been discussed in Chapter 5. One of the most 
important parameters in separation of anabolic agents in urine samples has been shown to 
be the column set. Better separation followed by improved identification of anabolic 
agents has been obtained by using a thicker film on the 2D column. The poor similarity of 
GC×GC-TOFMS experimental spectra against commercial MS databases has been ascribed 
to the bias of TOFMS detector towards higher masses. Therefore it was necessary to create 
an in-house TOFMS based library of anabolic agents and sterols which has greatly 
improved spectra match similarity, and further improved the limit of detection when the 
MAM criterion was applied. Other benefits of the proposed methods are detection and 
identification of non-target components and retaining the full mass spectra of the matrix. 
This could be very beneficial to doping control authorities since it enables retrospective 
search for new “designer” drugs through data files only, without need for sample re-
analysis.    
 
The World Anti-Doping Agency has set up rigorous criteria for minimum required 
performance limit (MRPL) of the method applied in doping control and for identification 
of anabolic agents in urine. Chapter 6 focuses on unique evaluation of the GC×GC format, 
for results obtained in Chapter 5 against the strict WADA criteria in doping control. 
Retention time tolerance, relative abundance tolerance window, presence of abundant 
isotopes (Cl, Br), presence of diagnostic ions, linearity and signal-to-noise ratio of data in 
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GC×GC format are shown here to largely comply with WADA criteria. The TOFMS bias 
toward higher masses has been found to have both advantages and disadvantages 
compared to the traditional GC-qMS analysis. The lack of at least three diagnostic ions 
with abundance higher than 5% in TOFMS spectra has been compensated by the high 
spectral similarity against the in-house library. Many more advantages of GC×GC over GC 
have been discussed in details. 
 
Illicit drug profiling is another area where the applicability of GC×GC should have 
obvious advantages. The pitfalls of classical GC separations in this area, reported in 
several occasions in the literature, have been overcome by improvement in the separation 
phase of the process rather than by making the detection system more “blind” (i.e. more 
highly specific to just one or a few single compounds). The applicability of GC×GC-
TOFMS in ecstasy profiling has been discussed in Chapter 7, and heroin and cocaine 
profiling in Chapter 8.  
 
SPME sampling of volatiles in ecstasy tablets and subsequent separation on a non-polar – 
polar column set has shown the most versatile impurity profile patterns for sample 
differentiation. Sixteen components have been selected for profiling purposes amongst the 
great number of components which have been detected and identified. All 24 ecstasy 
samples were correctly classified according to their post-tabletting characteristics and 
intelligence information. The advantages of GC×GC over GC have been discussed. 
      
In contrast to the endogenous and exogenous sterols work where low MS similarity was 
obtained in the absence of a dedicated in-house library, in this work high TOFMS spectral 
similarity has been obtained against commercial (e.g. NIST05) MS databases for the 
volatiles in the illicit drugs. This has been attributed to the lower molecular mass of the 
components analysed, since the sample preparation procedure was based on SPME 
(headspace) extraction. It has been shown that GC×GC has many advantages over classical 
GC. Many more components have been detected, which in turn means that there are 
opportunities for new relationships between their presence and their origin in the sample 
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to be established, and indeed are required before their potential use as markers for the 
synthesis route or origin differentiation is proposed.  
 
An alternative approach to close the gap between comprehensive, information-rich and 
tedious methods, and fast, simple and less powerful profiling methods, has been proposed 
in heroin and cocaine profiling, discussed in Chapter 8. A fast, simple and information-
rich method based on SPME extraction of volatiles and semi-volatiles in drug samples, 
followed by GC×GC separation, has been shown as a good base for development of new 
profiling approaches. 21 heroin samples have been classified in 9 groups, and 18 cocaine 
samples in 8 groups according to their volatile profiles. Links between the presence and 
the origin of the new components revealed in the GC×GC profiles need to be established, 
which in turn will define their importance in the profiling process. The advantages and 
disadvantages compared to traditional drug profiling methods have been discussed in 
detail. 
 
The thesis concludes with Chapter 9, where the most important findings, outcomes and 
specific conclusions of each study are summarised. The perspectives of the research 
undertaken are discussed in this chapter and recommendations for further study are 
proposed. 
  
 
 
 
 
 
 
 
Chapter 1 
 
1 INTRODUCTION 
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1.1 GLOBAL DRUG PROBLEM 
 
Currently illicit drug use has been estimated to be less than 5% of the world adult 
population aged 15-64 [1]. In other words, one in every twenty people used illicit drug at 
least once in the past 12 months. The number of problem drug users or people severely 
drug dependant is estimated to be one tenth of that number or 26 millions in total, 
comprising about 0.6% of the world’s adult population. 
 
According to the United Nations World Drug Report (WDR) for 2008 [1], this is an 
impressive achievement when considered in the historical perspective of a century of drug 
control. The result is even fascinating when compared to the consumption of tobacco or 
alcohol, the two most addictive legal psychoactive drugs that are used by at least one 
quarter of the world’s adult population, and cause millions of deaths every year. In the 
absence of the drug control system, illicit drug use may well have reached such levels, 
with devastating consequences for public health.  
 
On the other hand, WDR provides evidence of a surge in illicit drug supply in 2007. The 
world’s opium production almost doubled between 2005 and 2007, with Afghanistan 
alone accounting for 82% of the total area harvested. Coca cultivation has also increased in 
the Andean countries. Amphetamine-Type Stimulants (ATS) is the only drug type for 
which production and consumption remained steady in the last few years. However, the 
prevalence rate of ATS abusers (0.6%) is higher than the cocaine (0.4%) and double the 
heroin (0.3%) prevalence rate. 24.7 million people aged 15-64 consumed ATS at least once 
in 2006, of which 9 million were ecstasy abusers. Interestingly, Australia has the highest 
prevalence rate of ecstasy abusers in the world (4.4%).          
 
Drug abuse is one of the major problems of the modern world. Illicit drugs are harmful to 
individuals due to: (a) their side effects and physical harm; (b) potential for addiction or 
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the tendency of the drug to induce dependence; and (c) the effect of drug use on family 
and society [2]. Based on these three main factors the drugs are classified as more or less 
harmful, where heroin and cocaine are graded as the most harmful, and ecstasy and 
anabolic agents as less harmful. Nevertheless of their harm, the total burden of drug 
misuse only in Britain, in terms of health, social, and crime-related costs, has been 
estimated to be between £10 billion and £16 billion per year [3].  
 
Illegal drug production and trafficking is a “lucrative” underground business. The United 
Nations has estimated that organized crime earns $1.83 trillion a year from heroin related 
activities alone [4]. Drug empires are international, corrupting, and operating with 
impunity, often outside the reach of law enforcement agencies [5]. An excellent 
compilation of data on drugs, especially on heroin and amphetamines in Australia, is the 
PhD thesis of Bruce Myor [5].  
 
 
1.2 GLOBAL FIGHT AGAINST DRUG PRODUCTION AND TRAFFIKING 
 
The global drug problem requires a global response. Efforts to establish linkage between 
samples seized nationally or internationally, or to find out the geographic origin of drugs 
is never-ending. As the drug problem spreads around the world and filled every pore of 
the people’s life, more detailed analysis are performed in order to increase the net 
background information content of drugs. The needs for intelligence and data exchange 
between countries have never been greater, resulting in several harmonised methods [6-
10]. The Commission on Narcotic Drugs (CND) at the UN passed a resolution that was 
particularly relevant to drug profiling [6]. Resolution 47/5, ‘Illicit drug profiling in 
international law enforcement: maximizing outcome and improving cooperation’, 
expressed the following statements (selected by the author): 
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• … recognizing also the value of illicit drug characterization and profiling in 
supporting law enforcement intelligence gathering and operational work and the 
international fight against illicit drugs … 
 
• Noting the need for the effective exchange of drug profiling information between 
States to optimize the intelligence capacity of drug profiling programmes and 
facilitate the identification of illicit drug sources, trafficking patterns and 
distribution networks … 
 
• (the CND) Affirms the need to develop and, subsequently, to harmonize the illicit 
drug profiling activities of the international drug law enforcement community; 
 
The CND requested action by the United Nations Office on Drugs and Crime (UNODC) to 
encourage member states to: 
 
• seek to enhance their capacity to undertake profile analysis of seized illicit drugs, 
including heroin and other narcotics in the opiate group, cocaine and 
amphetamine-type stimulants; 
 
• participate in the international exchange of profile analysis information and 
samples of seized illicit drugs for profile analysis purposes. 
 
The RMIT Australian Centre for Research on Separation Science (ACROSS) group has 
commenced a program to contribute to the profiling of both illicit and sports drugs by 
using comprehensive two-dimensional gas chromatography (GC×GC).       
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1.3 DRUG PROFILING 
 
Drug profiling, like any other form of profiling, is basically an intelligence-gathering 
process. We profile people, religious attitude, politicians, food, wine etc. As we gather 
more information about the subject being “profiled”, the more we learn about the subject 
and we can use the information for our benefit [7].     
 
1.3.1 Drug characterization and impurity profiling 
 
Illicit drugs are rarely pure substances. Among the main (active) component, they contain 
many other substances, thus representing a complex mixture. According to the UNODC 
[8] illicit drugs may contain one or more of the three different types of key components: 
natural components, by-products and cutting agents. 
 
Natural components naturally occur in the plants (coca leaf, opium) from which plant-
based drugs (cocaine, heroin) are produced. As a result of their chemical similarities to the 
main component (solubility, polarity), they are co-extracted with the main compound 
through the production process and remain in the final product. Even though it is hard to 
establish a strict classification, generally components which are present in more than 1% 
relative abundance to the main component are considered as major and those present in 
less that 1% as minor.    
 
By-products are formed during drug manufacture (synthesis) and they are method 
dependant. Because of the crude production and purification processes they are also co-
extracted into the final product and remain as key markers for the particular route of 
synthesis. They usually belong to the minor components group.   
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Cutting agents are intentionally added substances to the drugs in order to increase the 
weight, and therefore the profit, or to enhance some effect of drugs, i.e. volatility of drugs 
for smoking, to relieve the pain when injected etc. Psychologically active substances or 
adulterants are used for latter purposes (caffeine, procaine, paracetamol, aspirin) and 
psychologically inactive substances or diluents are used for the former purpose (sugars, 
talc, starch).  
 
The variety of components found in the drugs and their variability in the amount allow 
more comprehensive analysis to be done, resulting in chemical profiles, also known as 
“signatures” or “impurity profiles” of the drug. Profiling typically involves several 
analyses that are designed to produce a detailed picture (profile) of a drug sample, usually 
in the form of chromatographic data. These data are further processed by means of 
statistical and chemometric evaluation in order to classify material from different seizures 
into groups of related samples and/or to identify the origin of samples, if appropriate 
samples with known origin are available for comparison. Impurity profiling studies 
together with the drug characterization, where physical features of drugs as well as 
chemical composition are determined, can be valuable scientific tools to support law 
enforcement operations.  
 
While “characterization” in organic chemistry is often utilized to describe the process of 
exact structure determination, in drug characterization it means describing the main 
features of the drug samples, both physical and chemical. Physical characteristics of 
samples, like colour, texture, logo and other toolmarks on tablet exhibits, packages (wraps) 
of drug blocks, are equally important as chemical characteristics, i.e. major and minor 
components composition, trace metals and occluded solvents, organic impurities, stable 
isotope abundance etc.       
 
Impurity profiling is used to describe the process of gathering a large number of data 
(both in number of samples and in unique data per sample) from variety of instrumental 
analyses (usually in form of chromatograms), visual or statistical evaluation of the results, 
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and finally an interpretation of the results in terms of sample relations and/or 
origin/production route determination. The results of impurity profiling are called drug 
“signatures” or impurity profiles. The importance of “signatures” originated from the 
region-specific routes of drug production and the concept of batch variation [9].  
 
1.3.2 Batch concept 
 
Discrete and separate “batches” of the final product are usually processed at any time in 
clandestine drug production. Because production conditions can not be reproduced 
exactly each time variations in batch to batch composition will occur, i.e. different batches 
from the same clandestine laboratory or operator will have different and unique signature 
(inter-batch variation). In addition, the illicit drugs are usually non-homogenous and small 
variations in composition within the same batch are to be expected (intra-batch variation). 
Normally, it is expected inter-batch variations to be significantly greater than intra-batch 
variations. If sufficient data are gathered by applying different analytical methods and 
proper discrimination criteria are established based on these variations, then successful 
common batch origin classification of samples is possible. Samples with a similarity 
greater than the established statistical intra-batch variation are considered as linked and in 
contrast, samples with a lower similarity are considered as non-linked. In practice, it is 
much more difficult to establish a link between samples than to exclude the linkage. The 
data “density” acquired and its uniqueness, as well as the frequency of the particular 
pattern of profile defines the strength of the linkage. Sample similarity based on larger and 
more unique data sets is stronger, as well as similarity between samples with unusual 
profile, i.e. of low frequency compared to the previously encountered patterns. However, 
several factors may complicate the establishment of specific links between drug samples. 
Post-production sample decomposition due to the sun/heat expose, hydrolysis, dilution 
with some aggressive cutting agents (ascorbic acid), may cause significant differences in 
the profiles of linked samples. Highly purified or highly diluted samples might limit the 
gathering of large amounts of data to support strong sample similarity links.  
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1.3.3 Geographic origin concept 
 
It is well known that some plant-derived drugs have a unique compositional pattern 
which depends on the geographical region where the plant is grown. In addition, 
clandestine production methods in any one region are believed to be similar or the same. 
As a consequence, samples from that region may contain similar impurities in similar 
proportions, and despite the batch-to-batch variation in the composition, can be classified 
together. A representative signature or impurity profile can be assigned to the region by 
running authentic samples or samples originating from known geographic regions.  
 
1.3.4 Drug profiling and law enforcement 
 
Generally, impurity profiling applications fall into one of two overlapping categories: 
tactical and strategic. The establishment of a drug distribution network and/or trafficking 
links based on sample similarity is an example of tactical application. The results are 
usually presented at the court as evidence, complementary to the intelligent investigation. 
Geographic origin determination for naturally based drugs, and production route 
determination for synthetic drugs, based on the sample characterization are examples of 
strategic application and the results are part of the intelligent information used in the fight 
against drug production on regional and global scale. Well experienced chemists who are 
very familiar with all the target components and close cooperation / data exchange with 
law enforcement personal are the two most important prerequisites for successful 
application of sample characterisation and impurity profiling.     
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1.3.5 Data handling and interpretation of results 
 
Large amounts of data in the form of numbers and chromatograms are usually generated 
in such a comprehensive approach. If visual inspection and comparison of chromatograms 
were the only way of data evaluation in the early years of impurity profiling applications, 
commercial and dedicated in-house computer programmes are used for data handling and 
statistical processing in modern objective methods. Sample composition expressed in 
absolute values offers long-term reproducibility, possibility of quality control and data 
exchange between laboratories [10]. However, the magnitude of the analytical variance, 
especially for less abundant components, and the lack of reference materials of such a 
great number of diverse impurities, make this approach less practical. Component ratio 
method is preferred in impurity profiling since it overcomes the limitations of the former 
method. Basically it takes into account the ratio of impurities to the main component or to 
an appropriate internal standard.  
 
The results of impurity profiling, i.e. the sample similarity or geographic origin 
determination, have to be interpreted carefully, taking all relevant considerations into 
account. Good understanding of the purpose of impurity profiling and drug 
production/distribution pattern, and close cooperation with law enforcement personal are 
equally important as knowledge and skill in relevant chemistry methodologies. A well 
experienced chemist can recognize the uniqueness of some impurities and can give them 
more weight in the discrimination process, thus making the evidence (linkage) stronger.  
 
 
1.4 ILLEGAL PRODUCTION OF HEROIN 
 
Heroin is a semi synthetic drug obtained from morphine by acetylation with acetic 
anhydride. Morphine is the main alkaloid of the papaveraceae family, and Papaver 
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Somniferum (more commonly referred to as opium) being the most exploited in this 
manner.   
 
1.4.1 History of opium 
 
Cultivation of opium poppies for food, anesthesia, and ritual purposes dates back to at 
least the Neolithic Age. The Sumerian, Assyrian, Egyptian, Greek, Roman, Persian and 
Arab Empires each made widespread use of opium, which was the most potent form of 
pain relief then available. By the sixteenth century, residents of Persia and India began 
eating and drinking opium mixtures as a purely recreational euphoric. Portuguese and 
Dutch merchants traded ever-increasing cargoes of Indian opium to China, which forced 
China’s Emperor to ban opium, addressing the rising opium addiction problem. The law 
failed to slow the opium smuggling by British and Americans merchants and the Emperor 
was forced to rescind the opium ban after British fought two successful Opium Wars (1839 
and 1856) against China. At the turn of the 18th century, 13.5 million addicts were 
estimated in China’s population of 400 million, consuming 39000 tons of smoking opium 
[11]. 
  
Several conventions, treaties and acts (Shanghai Opium Commission, 1909; Harrison 
Narcotic Act, 1914; Geneva Convention, 1925; League’s Limitation Convention, 1931) were 
enforced in the beginning of the 20th century in order to reduce the legal production of 
opium and heroin for recreational use. However, the reduction in legal opium cultivation 
and heroin production had a negligible effect on global heroin production and 
consumption. Instead, opium cultivation and heroin production were driven underground 
and made even more profitable.  
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1.4.2 Opium poppy cultivation and opium production 
 
About three months after planting, each stem produces a brightly coloured flower hiding a 
seedpod, which synthesises a milky white sap (opium) soon after the petals have fallen 
away [5]. The maximum content of morphine in the poppy is reached when the capsules 
(seedpod) are still in the green stage. At this stage a series of shallow incisions through the 
capsules are made which allow latex to “bleed” onto the surface. Most commonly, the 
latex is collected the next day, when it is partially dry on the capsule surface, by scraping 
with a special hand tool. The fresh dried latex is like a gum with light to dark brown 
colour, turning dark to black material by ageing, known as opium. The yield varies from 
10 kg/ha in Myanmar (South East Asia, SEA) to as much as 50 kg/ha in Afghanistan (South 
West Asia, SWA) [1]. The differences in the yield are mainly due to the growing conditions 
and the differences in the opium poppy varieties. More than 30 alkaloids are found in this 
product, together with resins, triterpenoid alcohols, sterols, fatty acids, polysaccharides 
etc.  
 
According to the WDR for 2008 [1] opium poppy cultivation continues to increase in 2007, 
with Afghanistan accounting for 82% (193,000 ha) of the world’s area under cultivation. 
Other regions contributing to the global opium cultivation are South East Asia (Lao PDR, 
Myanmar, Thailand, Viet Nam), South West Asia (Pakistan), Latin America (Colombia) 
and Mexico. The estimated annual opium production for 2007 is 8870 metric tons, with 
Afghanistan alone accounting for 92% of the world’s production [1]. 
 
The alkaloid content of opium latex will vary from region to region, from field to field, or 
even from plant to plant. It is quite clear that the composition is affected the most by the 
climatic and agronomic conditions. However, nearly always the bulk of the alkaloidal 
fraction is comprised of 5 main alkaloids in different proportions: morphine (1), codeine 
(2), thebaine (3), noscapine (4) and papaverine (5). The first three are classified as 
phenanthrene alkaloids and the other two as isoquinoline alkaloids. Their structures are 
given in Figure 1.1.          
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Figure 1.1 Structures of main opium alkaloids: 1. morphine, 2. codeine, 3. thebaine, 4. 
papaverine, 5. narcotine (noscapine). 
 
According to a study in which 1414 raw opium samples were quantified [12], morphine is 
the most abundant, followed by noscapine. Even though opium has a long history, the 
first isolation of the main alkaloid was in 1803 by the German pharmacist Friedrich 
Sertürner, who named it morphium after Morpheus, the Greek god of dreams. The details 
of the alkaloidal composition of opium are given in Table 1.1.    
 
Table 1.1 Alkaloidal composition of opium [12]. 
Alkaloid Min (%) Max (%) Aver. (%) 
Morphine 3.1 19.2 11.4 
Codeine 0.7   6.6   3.5 
Thebaine 0.2 10.6   3.1 
Papaverine    <0.1   9.0   3.2 
Noscapine 1.4 15.8   8.1 
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1.4.3 Extraction of morphine 
 
There are numerous methods for extraction of morphine from raw opium. However, the 
most exploited in illegal production is “the lime method” [12]. Opium pieces are dissolved 
in hot water, stirred and filtered. The filtrate is reduced to half by boiling and poured into 
a solution of boiling calcium hydroxide. The precipitate formed in this step is filtered, re-
extracted and residues are discarded. The combined filtrates are reduced to half by boiling 
and filtered again till clear solution is obtained. After that, the solution is boiled and 
ammonium chloride is added. When the solution cools morphine base will precipitate, 
and the raw base is collected by cloth filtration. If there is a demand for a pure heroin, or 
morphine is the final step in production, the base is further purified by dissolving in a 
minimum volume of warm hydrochloric acid. As the solution cools, morphine 
hydrochloride precipitates, whereupon it is collected by filtration. Further purification 
involves boiling with a charcoal and filtration.    
 
The lime method is not the only one used for the extraction of morphine from opium in 
clandestine laboratories. However, its simplicity, and most importantly in illegal 
production, the use of only a few simple and widely available materials (lime, ammonium 
chloride, drums, cloths) makes it widely spread.  
 
1.4.4 Synthesis of heroin 
 
The first reported synthesis of heroin was in 1874 and the first commercial production in 
1898 by the “Bayer” company, who named this new drug as heroin [12]. Shortly after its 
appearance on the market the drug popularity grows as a cough suppressant reducing 
morphine and codeine use, and was widely used for tuberculosis and other respiratory 
disease treatments. A few years after the 1925 International Convention on Narcotics, 
international control begun to limit the supply of heroin, and the illegal production of 
heroin began.  
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Almost with no exceptions, clandestine heroin synthesis is a one step acetylation process 
involving boiling of morphine with acetic anhydride. The process is completed in several 
hours (usually overnight) and the product is removed by treating the cooled reaction 
mixture with sodium carbonate and collecting the precipitate (heroin base) by filtration. 
There are at least two regions in the world, New Zealand [13] and Poland and some 
regions in Russia [14], where the clandestine process differs from the traditional. However, 
both processes are thought to be exclusively used to produce small scale quantities for 
individual consumption.  
 
The heroin base can be a final product distributed on the black market, as in the case of 
southwest Asia (SWA), or can be further processed into heroin hydrochloride. This 
process involves dissolution of heroin base in a minimum volume of organic solvent, i.e. 
diethyl ether, and precipitation by adding concentrated hydrochloric acid. The precipitate 
is removed by filtration and further processed by decolourisation and pre-crystallization if 
highly purified heroin hydrochloride is required. A block of SWA heroin base with 
stamped logo, seized during an international smuggling operation through the 
Macedonian/Serbian border, is shown in Figure 1.2.   
 
 
Figure 1.2 Heroin block (~0.5 kg) with a stamp on its surface, seized in 2006 in 
Macedonia 
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1.4.5 Impurities in heroin 
 
As previously stated, there are three main ways which contribute to the total impurities in 
heroin samples:  
 
1. co-extracted natural products originating from the opium, which do not change 
their chemical nature during the production process; 
2. by-products or components generated during the acetylation process, which 
include the components capable of undergoing acetylation or components 
decomposed by the rigorous acetylation environment; 
3. cutting agents and their impurities added after the completion of the production 
process, usually during the distribution chain.  
 
Opium minor components and their acetylation and degradation by-products encountered 
in heroin samples have been extensively studied in a series of works done at the Special 
Testing and Research Laboratory (STRL) at Drug Enforcement Agency (DEA) [19-25]. 
Many components were synthesized and characterized by using gas chromatography 
(GC), high performance liquid chromatography (HPLC), preparative and semi-preparative 
HPLC, high resolution mass spectrometry (HRMS), nuclear magnetic resonance (NMR), 
infra red spectroscopy (IR), and the data generated by the analyses were extensively used 
in many further works in this field.    
 
Natural products can be divided in three main groups according to their chemical 
structures. These include morphine-related (morphine, codeine and thebaine), 
benzylisoquinoline (papaverine) and phthalideisoquinoline alkaloids (narcotine, narceine), 
as well as their acetylation products and by-products.  
 
 
 
Introduction 
 16 
1.4.5.1 Morphine-related compounds 
Morphine (1, Figure 1.1) is a major constituent in opium (see Table 1.1). Acetylation of 
morphine by using warm acetic anhydride generates diacetylmorphine or heroin (6) via 
two stable intermediates. Dybowski and Gough [15] have shown that acetylation of 
hydroxyls in morphine predominantly involves the hydroxyl at position 3, giving 3-
monoacetylmorphine (7), followed by the acetylation of hydroxyl at position 6 (Figure 1.3). 
Hydrolysis of acetyl group at position 3 in heroin (phenolic hydroxyl) gives 6-
monoacetylmorphine (8), one of the most important morphine-related by-products. 
Further hydrolysis, obviously, will give morphine. These compounds are present in heroin 
samples at varying amount, 8 being the most abundant after the main drug. 
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Figure 1.3 The major acetylated products in heroin samples: 6. diacetylmorphine (DAM, 
heroin), 7. 3-monoacetylmorphine (3-MAM), 8. 6-monoacetylmorphine (6-MAM), 9. 
acetylcodeine.  
 
 
Codeine (2) is structurally very similar to morphine, thus it is very often co-extracted with 
morphine. Similarly to morphine, codeine undergoes acetylation giving 6-acetyl codeine 
3 
6 
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(9), and its relative concentration is often used as a marker for geographic origin 
determination. N-oxide forms of morphine (10) and codeine (11), as well as their 
acetylated products (12, 13), can be found as impurities in raw processed heroin samples 
(Figure 1.4).  
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Figure 1.4 N-oxide forms of morphine and codeine, and their respective acetylation 
products: 10. normorphine, 11. norcodeine, 12. N,3,6-triacetylnormorphine, 13. N,O-
diacetylnorcodeine  
 
Thebaine (3) is a highly toxic alkaloid found in opium, but rarely found in processed 
heroin samples due to its degradation in the acetylation step. Allen et al. [16] have 
described at least nine degradation products of thebaine when boiled in acetic anhydride; 
acetyl thebaol being the main degradation product. Some of the products encountered in 
heroin and used in impurity profiling procedures (14-18) are given in Figure 1.5.    
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Figure 1.5 Thebaine degradation products: 14. thebanol, 15. acetylthebanol, 16. 3,6-
dimethoxy-4,5-epoxyphenanthrene, 17. thebaine degradation product 1, 18. thebaine 
degradation product 2. 
 
Neopine (19), oripavine (20) and their acetylated products (21, 22) are minor morphine-
related alkaloids which can be found in heroin samples at varying amounts, depending 
upon the climate and soil conditions. Apomorphine (23) and morphothebaine (24), as 
respective degradation products of morphine and thebaine, are also found. Their 
structures are given in Figure 1.6.      
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Figure 1.6 Minor opium alkaloids: 19. neopine, 20. oripavine, 21. acetylneopine, 22. 
acetyloripavine, 23. apomorphine, 24. morphothebaine. 
 
1.4.5.2 Benzoquinoline-derived impurities 
 
Papaverine (4) is one of the principal opium alkaloid, derived from the benzylisoquinoline 
structure. Laudanosine (25), reticuline (26), codamine (27) and laudanine (28) are minor 
alkaloids from this group (Figure 1.7), which undergo degradation in boiling acetic 
anhydride giving at least 18 degradation products [17]. They are found as precursors for 
papaverine and others alkaloids in papaver somniferum. Other impurities from this group 
are norlaudanosine (29) and its acetylated product N-acetylnorlaudanosine (30).   
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Figure 1.7 Benzoquinoline-derived impurities found in heroin: 25. laudanosine, 26. 
reticuline, 27. codamine, 28. laudanine, 29. norlaudanosine, 30. N-acetylnorlaudanosine  
 
1.4.5.3 Phthalideisoquinoline-derived impurities 
Narcotine (5) is the second most abundant alkaloid in opium, after morphine. This 
wrongly named non-narcotic alkaloid (lately renamed as noscapine) does not undergo 
acetylation but forms many degradation products when boiled with acetic anhydride 
(Figure 1.8). N-acetylnornarcotine (31), N-acetylanhydronornarceine (32), 1-acetoxy-N-
acetyl-1,9-dihydroanhydronornarceine (33) and (E)-3-[2-(2-(N-methylacetamido)ethyl)-4,5-
methylendioxy-6-methoxyphenyl]acrylic acid (34) have been detected in heroin samples 
[18].   
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Figure 1.8 Phthalideisoquinoline-derived impurities found in heroin samples: 31. N-
acetylnornarcotine, 32. N-acetylanhydronornarceine, 33. narcotine degradation product 
1, 34. narcotine degradation product 2. 
 
1.4.5.4 Other alkaloid impurities 
Many other minor alkaloids, often at very low concentrations, can be found in heroin 
samples (Figure 1.9): protopine (35), cryptopine (36), aporeine (37), rheadine (38), 
hydrocotarnine (39) etc. [5].    
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Figure 1.9 Other minor alkaloids found in opium: 35. protopine, 36. cryptopine, 37. 
aporeine, 38. rheadine, 39. hydrocotarnine 
 
1.4.5.5 Cutting agents 
A large number of other substances have been seen in heroin samples, especially at 
“street” level. There are two main reasons for this: a) to increase the mass of the drug and 
to make an extra profit and b) to pronounce some effects or properties of the drug. 
Diluents are used for the former, mostly sugars, talc, starch, and adulterants for the latter, 
most exploited being paracetamol, caffeine, procaine, phenobarbitone etc. For example, 
procaine is used in heroin as a local anaesthetic to relieve the pain at the injection point 
and caffeine is used to facilitate the volatility of heroin base when smoked. Cutting agents 
are usually not origin-related or process-related compounds but some low frequently 
agents can be seen as valuable information in sample comparison, distribution chain 
establishment or even geographic origin determination.      
 
The most exploited impurities in heroin profiling are major components, minor organic 
impurities, stable isotope-ratio abundances, metal contaminants and solvents occluded in 
the drug crystal. Gas chromatography coupled to flame-ionisation (GC-FID) and mass 
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spectrometry (GC-MS) detection, high performance liquid chromatography (HPLC), 
isotope ratio mass spectrometry (IRMS) and atomic absorption spectroscopy (AAS) are 
widely used for gathering analytical data. However, the literature review on heroin 
profiling in the thesis is mainly focused on GC methods, because of its pre-eminence in 
this area. The high separation power and versatility of the detectors used are the two main 
reasons for this.             
 
1.4.6 Gas chromatographic methods for heroin impurity profiling 
 
It has been a quarter of a century since Neuman and Gloger [19] developed a capillary gas 
chromatography method for heroin impurity profiling. The work was one of the first on 
use of high resolution GC on trace organic components in heroin samples. The method is 
based on an extraction of neutral and acidic impurities with toluene from an acidic heroin 
solution. About 70 peaks were detected in a highly complex chromatogram obtained in the 
case of a near/middle East Asia heroin sample, showing distinct advantage over methods 
previously used for forensic comparison of illicit heroin samples based on packed 
columns. Furthermore, it was found that the profile of a heroin sample from Turkey was 
totally different from that from Malaysia, and small but significant differences appear 
when compared to that from Lebanon. In conclusion, the method clearly demonstrated its 
practical value in forensic case work.  
 
The same method [19], slightly modified, was used also for opium and crude morphine 
profiling with even more components (150) detected in chromatograms [20]. The author 
concluded that greater similarities are obtained between opium and morphine profiles 
than between heroin and opium/morphine profiles. It is expected if we have in mind that 
the processing of morphine from opium involves only extraction and precipitation steps, 
but processing heroin from opium/morphine involves acetylation, which changes the 
impurity pattern drastically.      
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Barnfield et al. [21] have developed a method for routine profiling of heroin samples based 
on the analysis of the main components. The similarity between samples is obtained by 
comparing the relative ratio of each of the analysed components in samples to that of 
diacetylmorphine. The data obtained have been used as the basis for providing the courts 
with information about the possible links between heroin samples. The method has been 
shown to fulfil the criteria given by the authors concerning the simplicity, robustness and 
separation efficiency of the procedure as well as the homogeneity of the sample. Neumann 
[22] has commented on the huge solvent peak in the chromatograms arising from this 
work [21], which have a negative effect on the determination of the first several eluting 
components.     
 
In contrast to earlier heroin profiling works which were based on visual comparison of 
chromatograms [23], multidimensional statistical methods like principal component 
analysis (PCA) and hierarchical cluster analysis (HCA) have been applied later. A HCA 
approach has been used to classify selected heroin samples seized in Germany in 1991 into 
four impurity profiles [24]. Furthermore, impurity profile analysis results were used as a 
valuable second method besides the results from the main components analysis for sample 
comparison.   
 
A theoretical consideration of comparative analysis and its importance in forensic drug 
profiling has been discussed by Perillo et al. [25] and Huizer [10]. While trace level 
chemical analysis of a heroin sample, which produces a signature characteristic of its 
origin, is a very important step, the ballistic comparison must not be negligible. All 
manufacturing techniques (compressing powder into tablets or blocks, imprinting logo 
designs) can leave unique and reproducible toolmarks on the final product, amenable to 
ballistic (toolmark) comparison with other exhibits or authentic samples from a reference 
collection [25]. Ballistics thereby represents a complementary but completely independent 
source of strategic and/or tactical intelligence.  
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Analysis of the major components has been used to predict the batch membership of 
heroin samples [26, 27], or to predict the country of origin [28, 29]. A brief review on 
comparative analysis of heroin and cocaine samples was published by Chiarotti [30], 
summarising the analytical methods used in the field. However, no comments on data 
analysis were given, beside the variety of techniques covered (TLC, HPLC, GC, CE, GC-
IRMS, AAS). A desire for a single robust method able to resolve any possible significant 
marker compounds, and a standardized general procedure suitable for use on an 
international level has been expressed.  
 
Soon after this review was published, a harmonized study for retrospective heroin 
impurity profile comparison was published [31], as a collaboration study initiated by three 
well equipped forensic laboratories. The majority of the GC conditions and the sample 
extraction procedure, based on the previously published methods [18, 19], were 
optimized, 16 variables (compounds) were selected and the criteria of similarity were 
defined. The quotient method (Q-method) [32], a software program developed at the 
National Laboratory of Forensic Science (SKL), Linkoping, Sweden, was used for statistical 
treatment of data. Briefly, it calculates for each selected peak in the chromatogram the 
ratio between that peak in sample A and that peak in sample B, and the similarity between 
the two samples is expressed as the number of peaks giving similar ratios (within a 
predefined window). It has been shown that, despite the intensive research and quality 
control checks between the three well equipped and experienced forensic laboratories, the 
variation of the inter-laboratory results are much larger than the variation of the intra-
laboratory results. The main source of the irreproducibility is shown to be the GC or 
precisely the limitations of GC (which have been reached) for this specific application using 
the selected 16 variables.                
 
As instrumental development progresses the choice of method for heroin samples 
comparison and profiling becomes wider. Besacier et al. [33] have extended the two step 
procedure (major/minor components analysis and impurity profiling) with a third step – 
stable isotope ratio of major components. They have described a case where impurity 
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profiling was not as efficient as the isotope ratio method. However, the three step 
procedure proved to be suitable for complete comparative chemical analysis of drug 
samples. Myors et al. [34] have used a GC-MS procedure for heroin samples profiling, 
based on 25 discriminating factors (selected organic impurities). HCA was used to 
investigate the similarities between samples, explaining 85-100% of the variations.  
 
Trends in heroin profiling throughout 1990s, a decade proclaimed by the United Nations 
as the ‘Decade for Eradicating Drug Abuse’, were reviewed by Dams et al. [35]. The 
authors stated that due to its speed and high resolution, capillary GC was the most often 
applied technique during the covered period. Capillary electrophoresis (CE) and 
hyphenated LC-MS have been viewed as promising techniques in drug profiling in the 
next period, offering solution of some problems encountered with the previously used 
techniques. In contrast to the previous review [30], a great part of Dams’ work was 
devoted to data treatment and interpretation, since the authors concluded that the most 
significant trend during the 1990s was the way that large amount of quantitative data are 
handled. While in the early 1990s the comparison between samples was performed by 
visual inspection of physical properties and chromatograms, statistical programmes for 
extensive data handling, i.e. chemometrics, were introduced later. Both unsupervised 
(HCA, PCA) and supervised (linear discriminant analysis, k-nearest neighbours) methods 
were used in heroin profiling, allowing the formation of accurate and more objective 
profiles and fingerprints. However, more sophisticated statistical methods are proposed to 
be explored in the future. 
 
Various statistical approaches in heroin profiling have been implemented in a series of 
research conducted at the Institute de Police Scientifique, University of Lausanne 
(Switzerland). Cosine function [43, 44] and artificial neural network (ANN) [36] have been 
used on results from the major components analysis in heroin, while the graph theory [37] 
was used in profiling of cutting agents in heroin samples. The authors stated that the 
major components method offers advantages over the minor components method in terms 
of simplicity, sample consumption and speed, and 98% of the results from the former one 
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were confirmed by the latter one. Because of this, the Laboratoire de Police Scientifique de 
Lyon (France) switched the routine profiling procedure from minor components to major 
components method [38]. However, the fact that the number of variables when using 
major components method is limited can not be ignored.  
 
The application of machine learning algorithms (spectral clustering and kernel-PCA) on 
heroin and cocaine gas chromatography data have been recently published [39]. The 
results have shown that the classical methods miss the inherent structure of data, which is 
highlighted by methods such as spectral clustering and its variants. Once again, the data 
was based on major components analysis, taking into consideration only 7 variables 
(meconin, acetylcodeine, acetylthebaol, monoacetylmorphine, diacetylmorphine, 
papaverine and narcotine).  
 
The most comprehensive heroin profiling procedure applied on a large heroin seizure was 
reported by Collins et al. [40]. The authors have used many analytical techniques (HPLC, 
CE, GC-MS, GCcIRMS, GC-EAIRMS) for major and volatiles (solvents) component 
analysis, organic impurity profiles and stable isotope-ratio abundance. While alkaloid 
ratios (major components) and volatile components profiles were consistent with heroin 
from Southeast Asia (SEA), the acid/neutral impurity profile was significantly different. 
Such a detailed analysis revealed a new heroin origin and/or production route which was 
classified as unknown at the time of the case report.       
1.4.6.1 Prerequisites in heroin comparison and profiling 
Several problems associated with heroin profiling are cited in the literature, and 
researchers should be aware of them.  
 
Transacetylation, or the transfer of an acetyl group of one compound to another, can occur 
in the heroin molecule when injected in mixture with some hydroxyl-containing 
components capable of acetylation. Mixtures of heroin and codeine can give trace levels of 
6-MAM and acetylcodeine as a result of transacetylation [15]. Similarly, mixture of heroin 
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and acetaminophen (paracetamol) will give 6-MAM and acetylaminophen [41]. 
Transacetylation of heroin has not been observed by using HPLC and so was attributed to 
occur in the injection port of the GC. The problem can be avoided by lowering the injector 
temperature and by using non-alcoholic solvents.    
 
Klemenc has reported a case [42] where major components analysis were performed on 22 
blocks of seized heroin weighing 11 kg in total. While 20 samples contained unusual high 
concentration of noscapine, heroin was absent from the remaining two, even though they 
resembled the common SWA heroin samples. Detailed analysis revealed 88% of noscapine 
and 6% of papaverine, with no measurable amount of heroin, acetyl codeine, 6-
monoacetylmorphine and morphine. The research based on 22 case samples has shown 
that noscapine can be used as an adulterant in heroin samples, increasing the 
noscapine/whole morphine (WM) ratio up to 3.5. In this way the major components 
criteria for classification of samples could be wrong, or even the organic impurity profiles 
can be inconsistent due to the unusual variability of the noscapine and its related by-
products. Similar case samples were encountered in the author’s previous laboratory - 
Forensic Science Laboratory at the Ministry of Internal Affairs, Skopje, Macedonia, during 
1999-2001 (B. Mitrevski, unpublished results). The report suggested that the significance of 
the noscapine should be evaluated with care in cases of comparative sample analysis or in 
predicting the sample origin.  
 
Similarly, a case where three illicit drug seizure thought to be “brown heroin” completely 
lacked diacetylmorphine, but contained 6-acetylmorphine, acetyl codeine, morphine, 
codeine, paracetamol and mannitol hexaacetate (MHA), has been reported [43]. After 
series of experiments it has been shown the MHA was a genuine heroin ingredient, 
resulting from the addition of mannitol before the acetylation step of heroin production. 
The lack of heroin in the samples was explained by its incomplete acetylation due to the 
presence of the mannitol as a big consumer (contains 6 hydroxyls) of the acetylating agent 
(acetic anhydride). The case has shown the alkaloid proportions sometimes can lead to a 
wrong conclusion and inconsistence to the previously established criteria. However, the 
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presence of an unusual adulterant can be used as a very useful indicator in heroin 
profiling enabling the connection of batches that underwent the same production 
sequence to the same production source. 
 
All current methodologies for heroin profiling are based on acetic anhydride acetylation of 
morphine and opium-related alkaloids, although there are at least two other reported 
acetylation reagent (acetyl chloride and ethylidene diacetate). Odell et al. [44] have 
developed a method for detection and discrimination of heroin samples produced by 
trifluoroacetic anhydride (TFAA) acetylation, suggesting 6-monoacetylmorphine/whole 
morphine (WM) ratio window as a new criteria. TFAA acetylation is an extremely clean, 
efficient and fast route which yields high quality heroin without heat and large reagent 
excess. From a drug enforcement perspective the use of this method in clandestine heroin 
production is significant, not only because of the high yield, but also because neither 
TFAA nor acetic acid is restricted precursors. 
 
All current heroin signature programs are based on determination of the origin of heroin 
between the major world producers (SEA, SWA, South America, Mexico), with limited 
success for determination of samples from between sub-regions. Odell et al. [45] have 
developed a profiling signature of heroin produced from Tasmanian opium which 
accounts for 25% of the world’s legal supply of opium straw. The signature is based on the 
presence of the unique marker compound in opium – oripavine and its several acetylated 
products and by-products. While most of them were detected in selected heroin samples 
seized in Australia and suggesting they originate from Tasmanian opium, none of these 
compounds has been detected in heroin samples from SWA, SEA and South America (SA). 
The authors’ opinion is that the unique marker impurities signature has advantage over 
traditional heroin signature programmes (HSP) which rely on the differences in 
production processes that result in quantitative variation in the ratio of commonly 
encountered major and minor compounds. 
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1.4.6.2 Profiling of volatile compounds (solvents occluded) in heroin samples 
The production procedure of almost all drugs involves some dissolution and precipitation 
steps. Trace amount of solvents used as a medium can be trapped into the crystal structure 
of the drugs during the crystallization step, giving valuable information about the drug 
production history. Since the clandestine production does not comply with any quality 
control / quality assurance protocol (QA/QC), residual solvent are often left behind in 
crudely dried drugs. Some solvents found in illicit drugs are due to degradation processes. 
Acetic acid, which is the product of hydrolysis of heroin, gives its characteristic “acidic” 
odour. The variety and the number of solvents encountered in the drugs can reveal the 
production route, the number and the type of purification steps applied, or the storing 
conditions. Volatile components profiles of the samples can be used as a valuable 
additional tool in sample comparison or in drug origin determination. 
 
Chiarotti and Fucci [46] completed one of the first works on volatile components analysis 
in heroin samples. Static head space (HS) technique was used for sampling, three different 
type of packed column were used for separation, and FID for detection of components. 
One to five volatiles were found in all analysed samples with acetic acid, acetone and 
diethyl ether being the most frequent. The authors stated that the sample ageing does not 
impair the detection of volatiles by this non-destructive sampling methodology.  
 
GC-MS with HS [47], solid phase adsorption [48] and solid phase microextraction (SPME) 
[49] sampling techniques was used for identification and confirmation of volatiles in 
heroin and cocaine samples. Much more volatile components are detected in heroin 
samples when compared to the previous work [46], probably thanks to the capillary 
column used. However, the variety and the number of occluded solvents were in favour of 
cocaine samples, probably because generally it has larger crystal size than heroin which 
may account for its ability to retain larger amount of occluded solvents [47]. The volatile 
components heroin profile must be seen as a complement to other profiles (major 
components, organic impurities, trace metal contaminants) in sample comparison since the 
limited number of variables (solvents) in the profile can lead to wrong conclusions [48].  
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The heroin and cocaine sample odour, represented by its volatile components 
composition, have been used in detector dog training programs [49]. SPME sampling 
technique was used to develop a “pseudo heroin” and “pseudo cocaine” formulation for 
initial scent association training. It enables screening of stock materials in order to 
minimize the risk of dogs being trained on a wrong scent and fail to alert when they 
encounter real drug samples. 
 
1.4.7 Profiling of trace metal contaminations in heroin samples 
 
The variety of trace metals and their different ratio in heroin samples are used as a 
complementary method in heroin profiling. Some of trace metals are accumulated in 
plants from soil [50], some are added during the trafficking chain (Ca), and some can 
originate from the metal utensils used in production processes (Fe, Zn, Cu). The 
importance of this approach has arisen from the similarity of the impurity profiles 
obtained from heroin samples originated from SEA, which are usually very pure and 
contain organic contaminants in almost constant proportions  [51]. Atomic absorption 
(AAS) [52], inductively coupled plasma atomic emission (ICP-AES) [50, 53] and ICP-MS 
[51, 54] have been applied for atomisation and detection. 
 
Myors et al. [51] have successfully used a number of statistical methods (HCA, PCA, k-
means cluster) to differentiate SEA from non-SEA heroin samples using the results from 
analysis of 73 elements. However, they have found it difficult to discriminate the sub-
groups within the SEA samples. Broad similarity has also been obtained between 44 SWA 
originated heroin samples, based on data from 10 elements [55]. Tactical intelligence 
(sample-to-sample comparison) is more likely to profit from the results of this profile than 
strategic, since more reliable data from analysis of authentic samples is required in order 
to correlate trace metal composition to the geographic origin. Another obstacle is 
Introduction 
 32 
difficulties in the rationale for presence/absence of trace elements in samples from 
different geographic regions. 
 
1.4.8 Isotope-ratio mass spectrometry in heroin profiling 
 
The stable isotope content of a plant, or its constituents, is characterized by its 
photosynthetic cycle and the metabolic pathways of the fixation of carbon, nitrogen, 
oxygen, hydrogen, which in turn depends on the environmental conditions (humidity, 
soil, temperature, isotope ratio of the ambient CO2) in which the plant has grown [56]. 
Therefore, stable isotope abundance of carbon, nitrogen and oxygen in heroin samples will 
differ according to the geographic origin of its natural precursor – opium. The isotope-
ratio mass spectrometry (IRMS) technique is capable of measuring these small differences 
in the isotope ratio, which in turn can be attributed to the geographical origin of heroin 
samples, or its natural precursor. Since partial sample degradation or multiple sample 
dilutions do not alter the isotope-ratio, the results can be used as a valuable contribution to 
the overall drug origin determination procedure, combining the results of the major 
components analysis, organic impurity profiling, volatile components and trace metal 
composition. 
 
Isotope ratios are usually expressed as δ values (in permille, ‰) versus a standard:  
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δ13C and δ2H ratios are calculated correspondingly. Pure gaseous air (for δ15N), hydrogen 
(for δ2H) or carbon dioxide (for δ13C), previously calibrated against standard reference 
materials (SRM), are pulsed (20-30 s) in the MS before and after the analysed component.  
 
Desage et al. [57] have applied IRMS for the first time in heroin profiling, determining the 
δ13C isotope ratio of samples from different origins. While samples from Turkey were 
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significantly distinguished from all other analysed samples, the samples from Pakistan, 
Niger and Thailand were quite close to each other and could not be distinguished based 
solely on the δ13C ratio of the whole heroin molecule. Further discrimination is proposed 
by measuring the individual δ13C ratio: from the morphine moiety and the acetyl 
substituent after heroin hydrolysis. This has been done by Besacier et al. [56]. They have 
shown that the δ13C ratio in the heroin molecule can be greatly contributed by the two 
acetyl groups. The obtained differences between δ13C enrichment of heroin molecules and 
morphine molecules after hydrolysis were in the range from +0.17 ‰ to -4.99 ‰ and are 
solely contributed by the acetyl moiety from the reagent used to derivatise the molecule. 
After this correction, no significant differences in δ13C are obtained between samples from 
the same geographic origin. However, some samples from various origins showed very 
close δ13C and it was difficult to distinguish them. The authors stated that either the 
samples’ origin is inaccurate or the δ13C is not informative enough. For example, at least 
0.6 ‰ difference in δ13C ratio is necessary to differentiate two values in the enrichment 
range of 3 ‰. 
 
Ehleringer et al. [58] have extended the research, including also the δ15N ratio along with 
the δ13C ratio. 76 heroin samples from the four major growing regions (SEA, SWA, SA and 
Mexico), supplied by Drug Enforcement Administration (DEA) of USA with a high 
certainty of their authenticity, were used in the study. The results have shown that heroin 
samples from all four geographic regions are statistically distinguished, except the limited 
overlap of δ13C and δ15N values of samples from Mexico and SA. Similarly to the previous 
work [56], δ13C and δ15N ratio values of corresponding morphine molecules (obtained after 
hydrolysis of heroin) have shown clearer separation of samples from different origin, with 
no overlapping. In this way, the δ13C ratio variation of the four carbons from the two 
acetyls, which in term can show great difference in δ13C, is eliminated, leaving the 
variation solely on the pure plant-origin compound – morphine. It has been concluded 
that samples from different geographic origin can be correctly distinguished on the bases 
of stable isotope-ratio data of the heroin molecule, and even more completely through the 
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morphine molecule. IRMS has been applied in heroin profiling on a limited number of 
samples by Idoine et al. [59] and Galimov et al. [60].  
 
Casale et al. [61] have reported a case in which heroin samples from a big seizure were not 
classified in any of the four major geographic regions based on organic impurity profiles 
[40], even though the major components and occluded solvents profiles resembled the 
SEA origin. IRMS was applied to confirm the authenticity of the samples from the possible 
newly encountered heroin production region or production process, according to their 
distinct and unique δ13C and δ15N ratios.  
 
Site specific natural isotope-ratio fractionation measured by deuterium nuclear magnetic 
resonance (SNIF-NMR) was used in geographic determination of heroin samples [62], 
offering separate δ2H enrichment for every labelled site in the molecule. Even though the 
method is capable to measure the “synthetic” deuterium sites independently (i.e. the two 
acetyl groups in heroin), the high sample consumption of about 1 g of purified heroin (due 
to the relatively inactive and low abundant deuterium nuclei) and the peak overlapping in 
the low resolved deuterium NMR spectra, make this technique difficult to apply in the 
case of heroin. The use of higher field magnets on smaller naturally occurring molecules, 
where availability is not limited, was expected to increase the sensitivity and improve the 
peak resolution.  
 
1.4.9 Other methods used in heroin profiling 
 
Capillary gas chromatography is not the only technique used in heroin analysis/profiling 
of main constituents, minor impurity composition or cutting agents. However, its high 
separation power and sensitivity has not left much room for other techniques. Thin layer 
chromatography (TLC) has been mainly used in adulterant identification and comparison 
purposes based on main alkaloidal composition [35]. Other spectroscopic techniques such 
as FTIR [72, 73] or Raman spectroscopy [74, 75] have been used as non-destructive 
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methods but exclusively for the main active compound (diacetylmorphine). Two 
techniques which are worth mentioning are HPLC and CE.    
 
1.4.9.1 HPLC methods in heroin profiling 
Liquid chromatography coupled to various detectors has also been used in heroin 
analysis/profiling. It overcomes some problems associated with GC separation as 
absorption, decomposition, transesterification [41], inability to elute higher boiling point 
components etc. However, the lower separation power due to the lower peak capacity 
limits the applicability of liquid chromatography techniques in separation of highly 
complex heroin impurity matrixes. On the other hand, preparative and semi-preparative 
LC are widely used in isolation and characterisation of many impurities present in heroin 
samples.  
 
Lurie and Allen [63] have developed a HPLC method for separation, isolation and 
detection of acidic and neutral acetylated products arising from the rearrangement of 
opium alkaloids when reacted with acetic anhydride. Ultraviolet (UV), flame ionisation 
(FID) and electron capture (ECD) detectors in series have produced highly sensitive and 
selective detection of studied compounds. Similarly, a HPLC-UV method for simultaneous 
analysis of heroin, basic impurities and the most common adulterants in heroin samples 
has been developed [64]. Improved peak capacity over classical HPLC was obtained by 
applying a 1.7 µm particle size column at elevated pressure [65]. It has been shown that 
the peak capacity and sensitivity can be even greater than that of capillary electrophoresis 
(CE) by 2 and 15 fold, respectively. 
 
Further improvement in application of LC in heroin profiling was contributed by coupling 
MS to the separation system. Single MS [66] was applied for fast separation (5 min run 
time) and quantification of major alkaloid components. The lack of the method sensitivity 
was compensated by its high throughput, and since the major components are usually 
found at higher concentration the method has been shown to suit heroin profiling. 
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Tandem mass spectrometry coupled to ultra performance liquid chromatography (UPLC-
MS/MS) [67] has also been applied in heroin profiling. Many unreported solutes, amongst 
the basic impurities, were detected in heroin samples from SWA. UPLC-MS/MS has 
shown significant increase in selectivity and sensitivity versus photo diode array (PDA) 
detection. However, several problems encountered in the separation steps, such as 
hydrolysis of heroin at basic pH, double peaks obtained when using acidic injection 
solvent and decreased sensitivity when aprotic solvent (acetonitrile) was used, were still 
reported.  
1.4.9.2 CE in heroin profiling 
Capillary electrophoresis (CE) like HPLC has been primarily used for separation and 
quantification of major components and adulterants in heroin samples [81-83], rather than 
used for impurity profiling. It shows greater peak capacity than HPLC, generally shorter 
run time and economy of use [68].  
 
Lurie et al. [69] have developed a sensitive determination of acidic and neutral impurities 
in heroin samples based on PDA and laser-induced fluorescence detection. The sensitivity 
for phenanthrene-related impurities, which show high native fluorescence under 248 nm 
wavelength excitation, was up to 500 times (acetylthebaol) higher with laser induced 
fluorescence (LIF) detection when compared to UV detection. However, its application in 
organic impurities profiling is limited due to the lower peak capacity compared to 
capillary GC methods. 
 
 
1.5 ILLICIT COCAINE PRODUCTION 
 
Cocaine is a plant-derived illicit drug and one of the most frequently abused. Coca leaf 
chewing has a long history (over one thousand years) among South American indigenous 
peoples. It has been used in the past as an ingredient in wines, medicines, soft drinks 
Introduction 
 37 
(Coca Cola) and cigarettes [70]. Today it represents one of the biggest global problems, 
with an estimated 16 million people aged 15-64 who had consumed it in 2006/07 [1].       
 
1.5.1 Coca leaves 
 
Whole cocaine which is available in the clandestine market derives from the leaves of the 
genus Erythroxilum, a plant indigenous to the Andean region of South America. The plant 
resembles a blackthorn bush, and grows to a height of 2–3 m. The branches are straight, 
and the leaves, which have a green tint, are thin, opaque, oval, and taper at the extremities. 
A marked characteristic of the leaf are the two longitudinal curved lines, one line on each 
side of the midrib.  
 
The leaf of the plant has a long history as a stimulant, local anesthetic, appetite and fatigue 
suppressant, cure for many illnesses, and it was chewed for centuries by some indigenous 
communities. Ancient Peruvian mummies have been found with the remains of coca 
leaves and in 2005 cocaine and benzoylecgonine were detected in nails and hair of 
mummies dating almost 1000 BC [71]. The plant is grown historically as a source of 
homeopathic medicine but the cultivation for production of illicit cocaine has become a 
major global problem in the last century.  
 
There are four recognized varieties of two species that contain significant level of cocaine 
[72]: Erythroxilum coca var. coca (ECVC), Erythroxilum coca var. ipadu (ECVI), Erythroxilum 
novogranatense var. novogranatense (ENVN) and Erythroxilum novogranatense var. truxillense 
(ENVT). ECVC (Bolivian coca) has been considered historically as the source of most of the 
world’s supply of cocaine. It is found on the eastern slopes of the Andes in areas of humid 
montane forests. ECVI (Amazonian coca) was considered to be cultivated only sparingly 
in the western part of the Amazon Basin. ENVN (Colombian coca) existed as a plantation 
crop in Colombia and as an ornamental plant throughout the tropics. ENVT, mostly 
confined to the desert areas of northern Peru, was cultivated for ‘coca-chewing’ and in the 
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19th and early 20th centuries, for flavouring of an internationally popular, cola-based soft 
drink. 
 
According to the WDR for 2008 [1] the total area under coca cultivation in 2007 was 181600 
ha, the highest level since 2001. Fifty-five per cent of coca bush was cultivated in 
Colombia, followed by Peru (30%) and Bolivia (15%).  
 
1.5.2 Cocaine extraction 
 
Although the stimulant and hunger-suppressant properties of coca had been known for 
many centuries, the isolation of the coca alkaloid was not achieved until 1855, when 
cocaine (40, Figure 1.10) was first isolated by the German chemist Friedrich Gaedcke [70]. 
 
The sun-dried coca leaves (100-150 kg) are mixed with an alkaline substance, usually lime, 
and the resulting pulp is crushed. Kerosene is added and the mixture is stirred, allowing 
alkaloids extraction into the organic phase. After separation and filtering, kerosene is 
mixed with acidified water (usually H2SO4) extracting alkaloids into aqueous layer. The 
two immiscible solvents are separated, aqueous phase being made alkaline to force 
alkaloid precipitation while the kerosene is usually recycled for the next batch. The 
precipitate is filtered and dried as a final product (coca paste, ~1 kg) of the “pasta lab” [73]. 
Coca paste can be processed to cocaine base by further purification which is achieved by 
dissolution in diluted H2SO4 and adding KMnO4 solution. The olefinic moiety of 
cinnamoylcocaines, as the main impurities in coca paste, is being attacked by KMnO4 
giving a water soluble products which are removed after precipitation of cocaine base by 
adding lime or ammonia. The purity of this product is usually 70-90% [74]. If further 
purification is required, coca base is converted to cocaine hydrochloride (cocaine HCl) by 
dissolution in diethyl ether in which concentrated HCl in acetone is added. The white 
precipitate (cocaine HCl) is filtered and dried. The purity of this product can be as high as 
99% [75]. In 2007, global potential production of cocaine reached 994 metric tons [1].  
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1.5.3 Impurities in cocaine 
 
Many components are co-extracted with cocaine during the production process to the final 
product. They originate from the two main sources: naturally occurring components in 
coca leaves and processing by-products.  
 
Naturally occurring minor alkaloids are often found in the final product, even in the 
highly refined cocaine. Their similarity in structures and properties to the major 
components result in co-extraction and “survival” during the production process. Since 
their variety and relative concentration depend on climate conditions, geographic region, 
taxonomy, processing steps applied etc. they represent a valuable source of data for 
sample comparison and drug profiling. Tropacocaine (41), cis-cinnamoylcocaine (42), 
trans-cinnamoylcocaine (43) and truxillines (44, 45, Figure 1.10) are the most common 
found in illicit cocaine samples. Hydroxycocaines (46) and trimethoxycocaines (47-50) 
isomers are present at lower levels in coca leaves and cocaine samples. While 
cuscohygrine (51) and hygrine (52) are present at higher levels in coca leaves their 
solubility in water and volatility make them less encountered in the refined cocaine 
samples. A summary of coca leaves composition is given in Table 1.2 and their structures 
are given in Figure 1.10.  
 
In addition to the naturally occurring minor alkaloids, processing by-products are another 
group of components found in the final product. They can be formed in a variety of 
chemical or physical processes. One of the most common is the hydrolysis of the major 
alkaloid – cocaine.  
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Figure 1.10 Major and minor alkaloidal components originating from coca leaves: 40. 
Cocaine, 41. tropacocaine, 42. cis-cinnamoylcocaine, 43. trans-cinnamoylcocaine, 44. α-
truxilline, 45. β-truxilline, 46. 6-hydroxycocaine, 47. trimethoxycocaine, 48. 
trimethoxytropacocaine, 49. trimethoxy-cis-cinnamoylcocaine, 50. trimethoxy-trans-
cinnamoylcocaine, 51. cyscohygrine, 52. hygrine. (Continued on page 41) 
 
 
Introduction 
 41 
Continued… 
N
H3C
O
O
H OCH3
OCH3
OCH3
  
N
H3C
O
HO
H
COOCH3
H
H
H3CO OCH3
H3CO
 
48        49 
N
H3C
O
O
H
COOCH3
H
H
H
OCH3
OCH3
OCH3     
N
CH3
N
O
CH3
   
N
CH3
O  
                       50                                    51                           52 
(Figure 1.10) 
 
The hydrolysis of cocaine (and tropane alkaloids in general) usually occurs at ester 
linkages, thus producing benzoylecgonine (53), ecgonine methyl ester (54), ecgonine (55) 
and benzoic acid (56) [75]. Minor alkaloids can also undergo hydrolysis at ester sites, 
giving rise to the complexity of the impurity profiles of cocaine samples: cinnamic acid 
(57) is formed from cinnamoylcocaines, and truxinic/truxillic acids (58, 59) are formed 
from truxillines (Figure 1.11).  
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Figure 1.11 Cocaine and truxillines hydrolysis products: 53. benzoylecgonine, 54. 
ecgonine methyl ester, 55. ecgonine, 56. benzoic acid, 57. cinnamic acid, 58. truxinic acid, 
59. truxillic acid.  
 
Another type of impurities, so called “N-nor” series (Figure 1.12), are components 
oxidized by the peroxides which are usually present in diethyl ether. N-norcocaine (60), N-
formylnorcocaine (61) and N-benzoylnorecgonine methyl ester (62) are formed during the 
demethylation process of the respective components.  
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Figure 1.12 Nor-series of impurities found in cocaine samples: 60. N-norcocaine, 61. N-
formylnorcocaine, 62. N-benzoylnorecgonine methyl ester. 
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The use of strong bases can cause epimerization and rearrangement which results in 
formation of traces of some pseudo-epimers [76] and N-nor esters [74]. The excess use of 
KMnO4 in the purification step can oxidize cocaine to yield trace levels of N-
formylnorcocaine (61) [73, 74]. The quantitative level of these by-products can vary by 
several orders of magnitude in cocaine samples. Except for cocaine hydrolysis products, 
which are usually detected at levels over 1%, the rest are present at levels well below 1%. 
Major alkaloids in coca leaves, and cocaine impurities, are given in Table 1.2. 
 
Recently, two new groups of cocaine impurities have been identified in cocaine samples: 
six tropane ethyl esters (63-66, Figure 1.13) have been detected in samples purified by 
using ethanol instead of KMnO4 [77], and four incompletely oxidized cinnamoylcocaines 
(67-70, Figure 1.14) in samples oxidized by KMnO4 from neutral instead of acidic medium 
[78]. Cocaethylene (63) has been detected in high amount (up to 20%) in smuggled cocaine 
samples dissolved in ethanol (wine or liquor) [79]. A cocaine sample smuggled in a bottle 
of wine and seized at the airport in Skopje (Macedonia) is shown in Figure 1.15.  
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Figure 1.13 Ethyl esters of cocaine alkaloids encountered in cocaine samples: 63. 
cocaethylene, 64. 3’,4’,5’-trimethoxybenzoylecgonine ethyl ester, 65. cis-
cinnamoylcocaine ethyl ester, 66. trans-cinnamoylcocaine ethyl ester.  
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Figure 1.14 Recently encountered incompletely oxidised cinnamoylcocaines by-
products: 67. (2S,3R)-dihydroxy-3-phenylpropionylecgonine methyl ester, 68. (2R,3S)-
dihydroxy-3-phenylpropionylecgonine methyl ester, 69. (2R,3R)-dihydroxy-3-
phenylpropionylecgonine methyl ester, 70. (2S,3S)-dihydroxy-3-phenylpropionyl-
ecgonine methyl ester   
 
 
 
Figure 1.15 Cocaine smuggled in a wine bottle and seized at Macedonian borders.  
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Solvents used in dissolution/precipitation steps can be trapped in the cocaine crystals, 
representing another valuable dataset for sample comparison, geographic origin and 
process determination. The most common encountered are acetone and methyl ethyl 
ketone, followed by diethyl ether, benzene, toluene etc. Their usual concentration is from 
zero to several hundreds ppm [80].  
 
Table 1.2 Alkaloidal composition of coca leaves and illicit cocaine samples, expressed as 
% values relative to cocaine content. Data compiled from ref. [75].   
Alkaloid Coca leaf (%)a Illicit cocaine (%)a 
Cocaine 0.23-0.96 80-97 
Cis-cinnamoylcocaine 0-53 1.9 
Trans-cinnamoylcocaine 0-170 1.2 
Tropacocaine 0.2-5 0.02 
Truxillines 2-60 2-13 
Ecgonine methyl ester 30-60 <3b 
Hydroxycocaines <0.01 <0.01 
Trimethoxycocaines 0.1-1 0-0.1 
Cuscohygrine 10-80 - 
Hygrine 1-25 - 
a All % values are relative to cocaine content, except for the cocaine (absolute content). 
b Present in cocaine samples due to cocaine hydrolysis.     
 
Among the naturally occurring alkaloids and by-products, a variety of other substances 
can be seen in illicit cocaine samples. They are used as cutting agents to increase the mass 
of the drug, thus the profit. Procaine, benzocaine, lidocaine, caffeine, phenacetine and 
sugars (inositol, mannitol, lactose, dextrose) are the most common.   
 
1.5.4 Gas chromatographic methods for cocaine impurity profiling 
 
While heroin profiling studies were first initiated during the 1960s and by the mid-1970s 
such studies were ongoing in several national laboratories [9], one of the first work on 
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cocaine profiling was published by Casale and Waggoner in 1991 [81]. The knowledge 
gathered during the past 20 years in the area of heroin profiling, the greater number and 
frequently the higher relative concentration of impurities encountered in cocaine samples 
compared to heroin samples, plus the fact cocaine alkaloidal impurities are not modified 
by a synthetic step, facilitated the development of this procedure and several cocaine 
impurity and sample comparison methods were published in the next few years [88, 89, 
97-104]. Several other works, even though not related directly to impurity profiling, have 
given a great contribution in this field by characterizing a large number of impurities 
present in coca leaves and cocaine samples. Among other components, 11 truxillines [82], 
N-formyl cocaine [73], several N-nor series [74] and hydroxycocaine impurities [83], four 
trimethoxy-substituted analogs of cocaine [84], hygrine and cuscohygrine [85], and 
recently detected four cinnamoyl-oxidation products [78] and 6 tropane ethyl ester 
homologues [77], have been characterized. Furthermore, about 100 uncharacterized 
impurities have been detected in South American coca leaves [86], many of them being 
removed during the production/purification process.      
 
LeBelle et al. [87] have reported a sample comparison method based on the relative ratio of 
the three main alkaloids: cocaine, cis- and trans-cinnamoylcocaine, supported by visual 
inspection of chromatograms and occluded solvents present in samples. The methodology 
was similar to the methodology used in heroin profiling [19]. The high frequency 
occurrence of cinnamoylcocaines in cocaine samples and their stability have shown to be a 
good marker for distinguishing large production batches or manufactures. Janzen et al. 
[88] have added two more alkaloids (tropacocaine and norcocaine) in their sample 
comparison method based on NPD detection and statistical evaluation of similarity. 
However, the final confirmation was achieved after visual inspection of the 
chromatograms of possibly related cocaine samples. The method has been successfully 
applied in solving a real forensic case. 
 
A review of potentially good impurities for profiling of cocaine samples has been given by 
Ensing et al. [89]. After detailed consideration of the known cocaine alkaloids, selection 
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has been made of 6 components, excluding the main drug. The fingerprint profile of each 
sample was constructed in this manner: a) each peak’s height is measured; b) the highest 
peak is given a reference value 10; c) the value for all other peaks is calculated as the ratio 
to the highest peak multiplied by 10. The calculated component values drawn against their 
retention times, so called pictograms, represent an easy way of sample comparison, similar 
to the mass spectra similarity comparison. The method results have been seen as useful 
contributing evidence to the total investigation rather than a definite proof of linked 
samples.  
 
A simple one-step derivatization procedure for obtaining chromatographic impurity 
signature profile analysis (CISPA) of cocaine samples has been developed by Casale and 
Waggoner [81]. 14 components from the chromatogram have been selected as variables for 
statistical evaluation of sample similarities by using PCA. Good overall absolute error of 
the assay (less than 1%) has been reported, most probably because of the derivatization 
step applied and the very good chromatographic profiles obtained during separation of 
the components on DB-1701 capillary column. It has been shown that different and unique 
impurity profiles were obtained for hundreds of samples from different batches, and very 
similar profiles from linked samples (from same batch). Based on this method, Casale and 
Watterson [90] have added two new impurities and have applied a neural network pattern 
recognition software to ascertain whether the impurity signature comes from the same 
batch. Only 7 out of 50 laboratory reports provided for cocaine conspiracy investigation 
were inconclusive, the rest confirming the linked or non-linked samples. However, the 
authors have suggested that in no instance the conclusion should be based solely on 
computerized search. Visual comparison of the reference chromatogram to narrow field of 
possible matches was necessary.    
 
An excellent review on in-depth chromatographic analysis of cocaine and coca leaves has 
been published in 1994 by Moore and Casale [75]. The rationale for presence of impurities 
and artefacts in cocaine samples has been discussed, and a comprehensive compilation of 
mass spectra of derivatized and underivatized major components and impurities is given. 
Introduction 
 48 
A brief review on analytical methods used in comparison of heroin and cocaine samples 
has been given later by Chiarotti and Fucci [30]. 
 
Recently, an effort has been made for harmonization of cocaine profiling method for data 
exchange between two laboratories from two different countries [9, 106], in a similar 
manner as previously done on amphetamine-like substances (ALS) [91] and heroin [31]. 
Eight main alkaloids have been selected and the most influential parameters have been 
optimized for the best performance. It has been demonstrated that the varied storage 
conditions (temperature and humidity) do not influence significantly the impurity profiles 
during the studied period of at least three months and the selected eight alkaloids were 
convenient for cocaine profiling. The chromatographic conditions were based on 
previously published methods [81, 88]. Six pre-treatment steps and eleven data treatment 
methods were tested for best discrimination between linked and non-linked samples. 
Normalization plus standardization followed by cosine function or Pearson correlation 
coefficient (N + S / cosine and N + S / Pearson) have been shown to be the best 
combinations. The correlation coefficient, based on similarity of linked samples and 
dissimilarity of non-linked samples, was lower for between-laboratories comparison than 
within-laboratory, but still discrimination of linked from non-linked samples based of the 
data from two laboratories was possible. This has demonstrated that sharing of databases 
and chemical profile results between two laboratories using instruments from different 
producers is possible and apparently there is no need for analyses to be centralized (done 
in a unique laboratory) in order to compare cocaine sample. However, the authors have 
stressed the precautions when more than two laboratories are to be included in the 
harmonisation process, as an expected flattening of the conclusive discriminations, 
lowering the threshold level for similarity of linked samples and overall reduction in 
method efficiency would occur.      
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1.5.4.1 Profiling of solvents occluded in cocaine 
Most of the clandestine amine drugs, including cocaine, are produced in hydrochloride 
salt form. This is obtained either by adding concentrated HCl dispersed in water miscible 
organic solvent or by bubbling HCl gas into the organic phase of the respective free base 
[47]. The rapid precipitation of the salt is followed by trapping significant quantities of 
solvent into the crystal matrices, so called occluded solvents. Residual solvents due to 
incomplete drying can also be detected, especially in freshly prepared samples. The 
variety of these solvents and their relative ratio can be used to support both strategic 
(origin determination) and tactical (sample-to-sample comparative analysis) intelligence.   
 
Detection and characterisation of solvents encountered in illicit cocaine samples [48] have 
proceeded on the occluded solvents profiling methods. One of the first applications of 
solvent profiles in sample comparison was published in 1991 [87]. It has been 
demonstrated that this profile can further discriminate an accidental coincidence of linked 
cocaine samples and erroneous conclusions based on major alkaloid ratio similarity. 
However, the authors did not comment on the possibility of different post-production 
treatment of the linked samples, which in fact can produce a change in the solvent profiles.  
 
A great contribution in solvent profiling has been done by the work of Morello et al. [47] in 
which the residual solvents composition in 75 cocaine and 826 heroin samples were 
determined. From 2 to 14 solvents were detected in cocaine HCl samples, compared to 0 to 
8 solvents detected in heroin HCl exhibits, which is mainly due to the much larger cocaine 
HCl crystals compared to heroin. Static head space was used for concentration and 
sampling of volatiles and the few co-elutions reported did not interfere with 
determination due to the selectivity of MS detection. The method can also be applied on 
diluted samples since adulteration had no significant influence on quantitative data.    
 
Activated charcoal has also been used for trapping and concentration of solvent vapour in 
cocaine samples [48] with subsequent elution with carbon disulfide (CS2). A larger number 
of solvents (16) have been detected in cocaine samples than in heroin samples (12), which 
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is in agreement with the previous finding [47]. However, combination of CS2 from 
different producers is recommended to use in this method since some impurities found in 
commercial CS2 interfered with the determination.  
 
A method for occluded solvents profiling based on SPME concentration and sampling has 
been developed by Chiarotti et al. [92]. The method overcame the abovementioned 
problem with impurities present in CS2 since no solvent was needed for extraction of 
volatiles. 32 different volatiles have been detected in 47 analysed cocaine samples, with 
acetone, diethyl ether, ethyl- and propyl acetate, 2-butanone, methyl chloride and 
hydrocarbons being the most encountered. Statistical evaluation of 11 selected solvents by 
using PCA and HCA has successfully classified the samples in four distinct groups. The 
method has been proposed as an additional tool for comparative analysis of cocaine 
samples, adding more details about the chemical fingerprinting of compared samples.  
 
A comprehensive method for solvent residue profiling of cocaine samples has been 
recently published [93]. The method is based on HS sampling and GC separation on a non-
polar HP-1 column with FID detection. 18 residual solvents were selected for statistical 
evaluation of samples similarity by using computerized and fully automated data 
analysis. Cosine function, already applied in cocaine [94] and heroin [38] impurity 
profiling, showed a good discrimination between linked (correlation value 100) and non-
linked (correlation value 0) samples, based solely on the residual solvent profiles. The 
threshold value which differentiates these two groups was fixed at 99.4 providing 
minimum false positives (0.01%) and false negatives (0%). However, several coelutions of 
solvents have been reported. 
 
1.5.5 Stable isotope-ratio profiling for cocaine samples 
 
The isotopic composition of plant materials, i.e. cocaine, is fixed during biochemical 
synthesis and is highly dependant on the variations in the metabolic pathway or 
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environmental conditions during growth [60]. For example, plants grown under high 
humidity or water-rich soil may have δ13C values up to 4-6 ‰ more negative than plants 
produced under low humidity or water-stressed conditions. Similarly, the type of soil and 
its microbial N2 conditions can influence the δ15N composition. This feature is used to trace 
the geographic origin of natural materials, i.e. cocaine, or the “natural” part of the semi-
synthetic products, i.e. heroin. Unlike other methods, isotope-ratio profiling is production-
process independent and is solely related to the growing region and conditions.  
 
Ehleringer et al. [58] have shown for the first time that successful growth-region 
classification of cocaine samples can be done according to their δ13C and δ15N stable-
isotope abundances. Whilst based on a limited number of cocaine samples (28) all samples 
were correctly classified according to their geographic origin (Bolivia, Peru, Ecuador and 
Colombia). In an extended work conducted soon after the above [95], 90% of 200 cocaine 
samples have been clearly classified according to their geographic origin, based solely on 
δ13C and δ15N abundances. When these results were combined with the impurity profiling 
results of the same samples, the ratio of successfully classified samples was 96%. Similar 
results were obtained later by Galimov et al. [60] by using both GC-combustion (GCcIR) 
and elemental analysis (EAIR) isotope ratio. However, while the former is recommended 
for diluted samples, the latter one is more suitable for undiluted samples.  
 
The conclusions drawn for application of SNIF-NMR in heroin profiling [62] are applicable 
also for cocaine samples. The only difference is the completely natural moiety of cocaine 
molecule and the lower molecular mass, which partially improve the S/N ratio of NMR 
spectrum.  
    
1.5.6 Trace metal contaminants profiling 
 
The general conclusions regarding trace metal profiling of cocaine samples are basically 
the same as the ones given for heroin. Difficulties in data interpretation and rationale for 
Introduction 
 52 
elements present make this profile less useful in geographic origin determination, while 
sample-to-sample comparison can be greatly enhanced by using this data. Limited number 
of works has been published in the literature.  
 
Violante et al. [53] have applied ICP-AES for cocaine sample comparison based on data 
from analysis of 11 elements but no conclusive relationships have been attained due to the 
largely uncertain sources of the samples analysed. On the other hand, cocaine samples 
entering Spain at Galicia have been successfully grouped into three groups, two of them 
related to the international airline flights coming from Colombia and Venezuela [96]. 15 
elements have been analysed in 46 samples and pattern recognition analysis (PCA, HCA) 
have been used for classification. Authentic cocaine samples and additional data on 
volatiles and impurity profiling are necessary in order to elucidate the geographical origin.   
 
1.5.7 Other methods used in cocaine profiling 
 
Several other techniques have been used in selected cocaine trace components and by-
products analysis rather than in comprehensive impurity profiling. HPLC has been used 
for separation of the main acidic components (benzoic acid, cinnamic acid, isomers of 
truxillic/truxinic acids) and some minor components present in cocaine samples [97]. CE 
has been found superior in heroin and cocaine impurity analysis, separating twice as 
many peaks as in HPLC, but at an increasingly lower sensitivity [98]. However, CE 
coupled to laser induced fluorescence (LIF) detector has been found 100 times more 
sensitive than PDA for cocaine components exhibiting native fluorescence [99]. Although 
these detectors can be useful in drug analysis, their highly selective response to analytes 
makes them unsuitable for comprehensive impurity profiling [100]. The recent advance in 
coupling with MS will probably widen the applicability of these liquid phase separation 
techniques in drugs impurity profiling.  
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1.6 ECSTASY PROFILING 
 
Ecstasy is a street name of the tablets (pills) containing the purely synthetic drug 3,4-
methylenedioxymethamphetamine. Synthesized at the beginning of the last century and 
seemingly forgotten until a few decades ago, the drug became a widespread especially 
among youth. It is estimated that 9 million people worldwide aged 15-64 had consumed 
ecstasy in 2006 [1].  
  
1.6.1 MDMA history 
 
3,4-methylenedioxymethamphetamine (MDMA, ecstasy, 71) is a ring-substituted 
phenethylamine, the core structure (the blue in Figure 1.16) of central nervous stimulants 
(CNS) – amphetamines. Although synthesized in 1913 by Merck and patented in 1914 as 
an appetite suppressant, the drug was never marketed and was rapidly forgotten. 
  
NHO
O
 
71 
Figure 1.16 Chemical structure of MDMA (71) 
 
The drug re-appeared in the late 1970s when it was first used to aid psychotherapy (the 
results of which are poorly documented) and later for recreational use. In 1990’s its 
popularity rocketed and illegal production has risen significantly. Users of the drug say it 
produces a positive sense of well being and empathy to others but prolonged abuse seems 
to cause brain damage and impairments in visual and verbal memory. After several 
reported MDMA fatalities, it has been prohibited since 1986 as a drug with no legitimate 
medical use, and is probably best known as the controlled substance in the club drug 
Introduction 
 54 
“ecstasy”. Today, ecstasy tablets refer to clandestine produced tablets containing purely 
MDMA (in Europe and North America) or MDMA and/or other controlled drugs such as 
3,4-methylenedioxyamphetamine (MDA), ketamine, amphetamine, methamphetamine etc. 
(in Asia). They have become a “necessary part” of rave scenes organized all around the 
world.      
 
1.6.2 MDMA synthesis 
 
Many precursors and routes of clandestine MDMA (71) production have been reported in 
the literature and the choice is generally driven by the precursors’ availability, the 
simplicity of the synthesis, the “underground chemist’s” skill etc. However, most of the 
synthesis routes start with materials with pre-formed methylenedioxyphenyl ring such as 
safrole (72), isosafrole (73), piperonylmethylketone (PMK, 74) and piperonal (79). PMK is 
mainly obtained by oxidation of isosafrole, which is obtained by isomerisation of safrole 
extracted from sassafras oil (Figure 1.17). 
 
O
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oxidationisomerisation
 
  72             73       74 
Figure 1.17 Scheme of PMK production from safrole: 72. safrole, 73. isosafrole, 74. PMK 
 
It seems reductive amination of 3,4-methylenedioxyphenyl-2-propanone (3,4-MDP-2-P, 
PMK, 74) with methylamine via a Schiff base (75) formation is the most used synthesis 
route in clandestine ecstasy production (Figure 1.18a). At least 6 different routes have been 
reported in the literature [101]. Borohydride (NaBH4) reduction at low temperature, 
dissolving metal reduction (Al/Hg) and cyanoborohydride (NaBH3CN) reduction are the 
most often encountered. The general scheme of this reaction is given in Figure 1.18a.  
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Figure 1.18 Schemes of the main ecstasy production routes: a) reductive amination, b) 
Leuckart reaction, c) safrole bromination.    
 
Leuckart reaction (Figure 1.18b), which involves reaction of PMK with formamide in 
presence of formic acid and consequent hydrolysis of the obtained intermediate (76), is 
less encountered, though it is predominantly used in clandestine amphetamine synthesis. 
Safrole bromination is also used where safrole is brominated by HBr to 77 followed by 
methylamine substitution (Figure 1.18c). 
 
In 2007 a new pre-precursor (methyl 3-[3’,4’-(methylenedioxy)phenyl]-2-methyl glycidate, 
78 in Figure 1.19) was encountered in Australia, as an alternative route for 3,4-MDP-2-P 
production, the main MDMA precursor [102]. It seems the list of the precursors and 
production methods of designer drugs is never ending.  
 
According to the batch concept (see section 1.3.2), each sample from the same batch has 
the same, or almost the same, compositional pattern which depends on the precursors 
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used, the synthetic route and the purification processes applied in the production. Minor 
amount of precursors and their impurities, and by-products formed during the synthesis 
are usually co-extracted in the final product, and together with the components added as 
binders, lubricants and excipients in the tabletting process, comprise the chemical profile 
of samples. The variety of components encountered in clandestine produced ecstasy and 
their relative ratio enables comparative analysis of exhibits. Moreover, the synthetic 
method can be assigned based on the specific markers (precursors, by-products and 
intermediates) characteristic to that route. Selected impurities and by-products found in 
ecstasy samples are given in Figure 1.19. 
 
Swist et al. [103] have compared impurities found in MDMA samples which were 
synthesized by five different routes of production and they found several unique markers 
or groups of components characteristic for only a particular route. Reductive amination 
has been found to be the predominant route of synthesis of ecstasy tablets seized in France 
based on some key markers [118, 119]. However, the possibility of different origin for the 
same impurity, i.e. the overlap between impurities generated by different routes [104], 
which may be interpreted as “inefficient chromatographic separation of some impurities or their 
low levels” [105], hinder the determination. 
 
Once the synthesis is completed, the final product is purified by liquid/liquid extraction 
(LLE), vacuum distillation and crystallization. The powder from a single production batch, 
or more likely from several production batches, is then mixed with substances necessary 
to produce solid form of drugs (excipients), artificial colours, lubricants (palmitic and 
stearic acids) and adulterants (caffeine, ketamine), homogenized and pressed into tablets. 
Tabletting usually occurs at remote locations. Different logos are usually stamped on the 
top as a sign of “quality”, and the list of logos is ever increasing. Some of the tablets seized 
in Macedonia in the period from 2000 to 2003 are given in Figure 1.20.  
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Figure 1.19 Selected precursors and by-products frequently encountered in ecstasy 
tablets (adapted from ref. [106]). 
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Figure 1.20 Ecstasy tablets seized in Macedonia in the period from 2000 to 2003 
 
The ecstasy production process does not include purely natural components as in the case 
of heroin (opium) and cocaine (coca leaves), and is not region-related. Clandestine 
synthesis can be done virtually anywhere, from rural sheds and farms, through storage 
facilities, to kitchens in urban areas. The production scale is from personal use level 
(several grams) to as large as a ton. The estimated annual production for 2006 was 4.5 
metric tonnes and the largest producers are The Netherlands and Belgium [1]. According 
to the WDR for 2008 [1], regional shift in ecstasy production has been observed in the last 
decade. Despite the dominance of West and Central Europe in the ecstasy trade, the 
general trend has been towards an increase in ecstasy production, trafficking and abuse in 
North America. This is clearly reflected in seizure statistics where the share of West and 
Central Europe in global ecstasy seizures fell from 79% in 1995 to 43% in 2006. In contrast, 
in 1995 North America accounted for 20% of ecstasy seizures, rising to 34% by 2006. 
Similarly, Oceania's proportion increased from 1% to 12%. According to Australian 
authorities the main origin countries in 2005/06 for shipments of ecstasy to Australia were 
Canada, Belgium, the UK and France.  
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1.6.3 Gas chromatographic methods for ecstasy impurity profiling 
 
While volatile components and metal contaminants have been reported in ecstasy 
profiling, minor organic impurities and stable isotope-ratio are the most exploited. 
Extraction of impurities with organic solvent is a common practice since some markers are 
present at a very low level. However, the impurity profile is strongly influenced by the 
pH. Most of the basic impurities are efficiently extracted from alkaline medium but the 
huge MDMA peak can interfere with some co-eluting key markers. On the other hand, 
MDMA is almost absent in the acidic extract, but far fewer impurities, with those being at 
low levels, are obtained in this way.     
    
Palhol et al. [101] have developed a method for profiling of ecstasy tablets based on 
capillary gas chromatography separation of the impurities extracted with dichloromethane 
from alkaline aqueous solution. Almost 30 compounds (in 52 samples) were identified as 
precursors, intermediates and by-products. The presence/absence of the key marker 
components and their relative ratio were used as criteria for grouping the samples in three 
main classes, while further discrimination is obtained by applying HCA to the 27 
impurities as variables. Two case samples have been reported as an example of 
applicability of the method in forensic sample comparison.  
 
Soon after this work, a similar method was developed [104], based on impurities extracted 
by diethyl ether from an alkaline (pH = 12.8) aqueous solution. Several new impurities 
such as p-methoxymethamphetamine (PMMA, 85) and 3,4-methylenedioxy-N,N-
dimethylbenzylamine (91) were detected and characterized. Chemical ionisation (CI) and 
tandem MS were used for confirmation along with electron ionisation mode. The overlap 
of the impurity origin, or the possibility for some markers to originate from different 
routes, was stressed. The cosine function was used for comparison of chromatographic 
profiles and for evaluating similarity/dissimilarity among exhibits.   
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Gimeno et al. [107] developed an optimized and reproducible method for ecstasy impurity 
profiling, since they had found great variation in the extraction procedures and conditions 
used and reported in the literature. Slow evaporation of the diethyl ether extract obtained 
at pH of 11.5 with solvent volumes precisely controlled, were among the main 
conclusions. For best results the extracts should be analysed the same day they are 
prepared. 8.5% within-day and 10.5% between-days RSD for repeated extraction under 
optimized condition were achieved.   
 
Profiling of ecstasy tablets based on major components and physical characteristics 
(ballistics) has been reported on exhibits seized in Japan [108], and profiling based on 
minor organic impurities in Hong Kong [109] and The Netherlands [106]. In the latter case 
a statistical approach (Pearson correlation) was used for sample similarity assessment.  
 
An excellent review covering organic impurity, composition and trace metal profiling, as 
well as future directions in ecstasy profiling, has been published [110]. SPME, ICP-MS and 
ANN have been recognized as the areas where significant development is to be expected 
in the future.    
  
The most comprehensive ecstasy profiling work so far has been conducted under the 
auspices of the European project “Collaborative Harmonisation of Methods for Profiling of 
Amphetamine Type Stimulants” (CHAMP), in cooperation between 6 European countries 
[124, 125]. Since MDMA is mostly distributed in form of tablets, and the tabletting process 
is separated from the production process, pre-tabletting (pre-TB) and post-tabletting (post-
TB) batch terms have been introduced. In this way irrespective of the post-TB process (i.e. 
tablets with different colour, logo and dimensions), samples from the same pre-TB batch 
can be linked based on their impurity profiles. Moreover, irrespective of their pre-TB 
process (i.e. tablets from different production batches) samples from the same post-TB can 
be linked based on the physical characteristic of the tablets. While diameter, thickness, 
weight and score are reliable and reproducible parameters colour, shape side, edge profile 
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and logo are excluded as highly operator-dependent (low reproducibility for a given 
manufacturing process). However, the link between samples based on physical 
characteristic has been found far less reliable than the link based on impurities present in 
samples. The discrimination power of the final target eight selected components was 
found to be nearly the same as the discrimination power of the 32 previously selected 
impurities. 46 organic impurities in total have been detected in chromatograms of the 
samples analysed, based on the method developed by van Deursen et al. [106]. The 
applicability of the method on an international basis was confirmed through a case in 
which two tablets seized in different countries (The Netherlands and Switzerland) were 
linked based on their impurity profiles.       
 
1.6.4 Stable isotope-ratio methods for ecstasy profiling  
 
The synthesis of the majority of the designer drugs starts from natural products (essential 
oils) and their characteristic native isotope abundance is transferred to the final product, 
or at least on the “natural part” of the final product. As already stated, safrole, isosafrole 
and piperonal are widely used natural products in precursors and/or ecstasy production, 
and catechol, apiol, sesamol and myristicine aldehyde use are reported in the literature 
[126, 127]. Broader explanation of the stable isotope fixation in natural products is given in 
section 1.4.8. Grouping the samples according to their isotope-ratio similarities gives 
additional criteria in sample differentiation and common-batch origin relations.     
 
One of the first works on stable isotope-ratio in ecstasy profiling was by Mas et al. [111]. 16 
ecstasy tablets have been classified in four groups according to the δ13C values of MDMA 
molecules. Further discrimination was obtained by applying δ15N ratios, which resulted in 
improved selectivity of the method. Some samples which were previously belonged to the 
same δ13C group were discriminated according to their δ15N values. Palhol et al. [112] have 
extended the research, by analysing 106 ecstasy tablets. The large range of δ15N (from -17 
‰ to +19 ‰) allowed discrimination between different samples and the formation of five 
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groups with very similar profiles, which probably have similar synthetic pathway. Since 
the δ15N range of commercially available precursors commonly used in clandestine 
production has been found narrow (from -5.8 ‰ to +5.5 ‰), the δ15N variation in MDMA 
was attributed to isotopic fractionation during the production process, which vary 
depending the routes of production, reagents and conditions applied [126, 127]. However, 
classification of the samples based solely on δ15N was in good agreement with the 
observed impurity profiles (synthetic route dependent).  
 
Further discrimination between ecstasy samples has been obtained by adding δ2H ratio to 
the δ13C and δ15N results [129, 130]. Recently published work [113] has demonstrated that 
δ2H ratio can discriminate ecstasy samples produced by the same route (reductive 
amination) through three different reduction systems (Al/Hg amalgam, NaBH4 and Pt/H2). 
Accurate discrimination of the synthetic route was achieved only when δ2H data was 
included on its own or in conjunction with δ13C and/or δ15N. The discrimination power of 
the stable isotope-ratio enrichment follows this order: δ2H > δ15N > δ13C. This is expected 
since the variation of δ2H was found the widest (-93.9 ‰ to +6.3 ‰) and the δ13C was the 
narrowest (-26.5 ‰ to -28.1 ‰). The δ15N variation was in the range from -3.6 ‰ to 23.8 ‰ 
and it was attributed to the fractionation during the production rather than due to the 
precursor. Similarly to the applications in heroin and cocaine profiling, SNIF-NMR has 
also been applied with limited success in ecstasy samples discrimination [114]. 
  
1.6.5 Trace metal profiling of ecstasy tablets 
 
Possible relation between ecstasy samples with common origin has been demonstrated on 
the basis of 10 elements analysed [115]. Nine clusters have been defined from 91 unrelated 
samples. An extensive statistical data treatment has been applied on the results based on 
analysis of 14 metals in 99 ecstasy tablets obtained by ICP-MS [116]. Artificial neural 
network algorithms were superior compared to PCA and HCA in trace metal classification 
of ecstasy according to the seizure, showing 96-99% successful prediction of origin. The 
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limited ability of PCA and HCA was attributed to the significant variation in the intensity 
of metals present within each seizure.  
 
The catalyst or reducing agents most used in reductive amination were used as a base for 
synthetic route determination of ecstasy tablets [117]. The great variation in Pt, B, Hg, Li, 
Pd and Ni abundances has been shown to be a good discrimination parameter. The correct 
synthetic route (including the catalyst/reducing agent) was properly assigned in 48 out of 
57 tablets based on Pt, B and Hg content. Al and Na, even though present in some 
reducing agents, were excluded from the calculation and classification because they are 
found to be present in many excipients and adulterants used in ecstasy tabletting. The 
authors concluded that the elemental composition analysis is the only way to discriminate 
different variations of the same reductive amination route of ecstasy production. 
However, the great variation in metal intensities between batches from the same 
production site limited the method applicability in production-specific origin 
determination. On the other hand it has been shown to be a valuable tool next to profiling 
based on the organic impurities in sample-to-sample comparison.   
 
1.6.6 Volatile organic components profiling of ecstasy tablets 
 
As for the other drugs, volatile components encountered in ecstasy tablets can play an 
important role in impurity profiling. The relatively volatile precursors and by-products 
are expected to be amenable for complex volatile profiles giving an additional tool in 
sample comparison. However, relatively few works so far have been conducted on 
volatiles in ecstasy.  
 
The first work in ecstasy profiling by using SPME for extraction and pre-concentration has 
been published by Kongshaug et al. [118]. A mixed phase SPME fibre polydimethyl-
siloxane-divinylbenzene (PDMS/DVB) was found superior compared to the non-polar 
polydimethylsiloxane (PDMS), extracting both polar and non-polar impurities. In order to 
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suppress the recovery of the bulky MDMA, and owing to its basic nature, slightly acidic 
medium (pH 5.0) was chosen for extraction. Under this condition the majority of MDMA 
is ionized and principally retained in the aqueous layer. Discrimination power of the 
volatile impurity profiles has been demonstrated on four non-linked ecstasy samples 
seized in Norway.  
 
Recently, a comparison between LLE and SPME extraction of organic impurities in ecstasy 
has been conducted [135, 136]. LLE extraction has shown higher efficiency extracting 46 
components compared to 31 extracted by SPME. This discrepancy could be explained by 
the fact that in the case of SPME the extraction of components is based on its volatility, 
while for LLE the extraction relies on its solubility. However, the most discriminative 
components related to the production route have been detected by both techniques. The 
applicability has been demonstrated in a case where three different specimens were linked 
based on both SPME and LLE extraction impurity profiles. The simpler sample 
preparation and the absence of solvents in the SPME procedure represent an 
unquestionable gain compared to LLE, considering health and environmental issues.       
 
1.6.7 Other methods applied in ecstasy profiling 
 
Other methods for ecstasy profiling have also been reported in the literature. A simple and 
fast procedure for sample screening before profiling has been proposed [119] by using SPE 
extraction and TLC separation of impurities. Different composition patterns were 
observed under UV light (366 nm and 254 nm) between samples produced by different 
synthetic routes. The method has been proposed as an inexpensive screening before more 
advanced and expensive methods (GC-MS, HPLC) are applied. 
    
Raman spectroscopy has been used as a fast (50 tablets per hour) and simple method for 
discrimination of ecstasy tablets based on the relative ratio of the major components 
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(MDMA and excipients) [120, 121]. The inhomogeneity of sample composition, even 
within the same tablet, has been identified as the major problem in this method. 
 
HPLC at elevated pressure with 1.7 µm particles has been found superior over 
conventional HPLC, offering more separated components and higher peak capacity for 
ecstasy impurity profiling [65]. An impurity profiling method based on SPE extraction and 
subsequent HPLC separation with 2 µm particles has been proposed [122]. Proper 
classification based on 30 selected impurities was achieved for all analysed samples 
according to their synthesis route.            
 
 
1.7 INTRODUCTION TO DOPING AND DOPING CONTROL 
 
It is in a human nature to compete against others in every field of endeavour. The sports 
arena is probably the most competitive. Athletes will attempt to gain advantage over their 
opponent in order to achieve superiority and to win the competition. However, there are 
many different pathways to the win.  
 
Special diet and its effect on athletes’ performance had been recorded in ancient times, as 
early as 668 BC during the Ancient Olympic Games [123, 124]. The sporting industry has 
capitalized on the desire for superiority among athletes, spending millions of dollars in 
development and continuously improvement of exercise equipment and apparel. 
Professional coaching and special training methods [124], as part of the “winning 
principles” provided by many professional sports trainers, are other legal ways to “beat” 
competitors.   
 
But, what happen when all legal methods are exhausted and the desire for superiority and 
advantage over other competitors is still sought? Ergogenic aids in the form of natural 
products, bland chemicals and animal extracts have been known since Greco-Roman 
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times. In recent times, the remarkable advances in science and biotechnology have 
favoured the introduction of synthetic molecules, recombinant hormones and genetic 
manipulation of athletes in the attempt to push human performances to the limit.      
 
1.7.1 Brief history of doping in sport 
 
The word doping originates from “dop”, a term used by tribes in South Africa that 
conventionally refers to a stimulant drink used in tribal ceremonies during the eighteenth 
century [125]. Its first appearance in English dictionary was in 1879, where it describes 
“the use of a drug in an attempt to enhance sporting performance” [123].  
 
Doping has a long history, contrary to the opinion that it is a recent “fashion”. Ancient 
Greeks have used dried figs, honey, a portion of brandy and wine, bread with spices from 
juice of the opium poppy as a part of their special diet [124]. Various performance-
enhancing plants extracts and drinks were also used during the ancient Olympic Games. 
Roman gladiators have used caffeine and strychnine to overcome fatigue and injuries. 
Most of these stimulants were derived from plants. The 19th century stimulant list was 
extended to include cocaine, nitro-glycerine, sugar cubes dipped in ether, mixture of 
champagne, brandy, hot drops of morphine, belladonna and strychnine.   
 
In the 19th century doping was mainly associated with cycling and it is not surprising that 
the first reported fatality occurred during such an event. The English cyclist Arthur Linton 
died in 1886 during the 600 km race between Bordeaux and Paris. He is alleged to have 
overdosed on “tri-methyl”, thought to be a compound containing either caffeine or ether 
[123].  
 
The beginning of the 20th century was characterized by the discovery of the potential of 
testosterone in sports. The use of testosterone skyrocketed when an 18-year-old horse won 
many races after testosterone treatment. Many sport trainers have realized the potential of 
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this and many more anabolic steroids, and began to advocate their use [124]. The 
unrealistic body shape and extremely large muscles of many body-builders at that time 
have been mainly attributed to testosterone and other anabolic steroids. Not surprisingly, 
anabolic steroids (AS) were referred sometimes as “breakfast for champions” in 1970s.   
 
Stimulants were also prevalent in cycling. The 1960s and 1970s were known also as the 
“amphetamine decade” for anyone competing in cycling. Another English cyclist died 
during the 1967 Tour de France due to methamphetamine overdose [124]. However, not 
only anabolic steroids and stimulants were used in sport competition. Performance 
enhancing potential of many other molecules and methods has been discovered, used and 
abused during the last few decades of the “bio-technology revolution”. As the doping 
revolution “progresses” the awareness of the side effects and health risks in competition 
push authorities to tighten doping control in sport.  
 
1.7.2 Brief history of anti-doping control 
 
Although several athletes died during the late 19th and early 20th century, sports authorities 
remained passive. The first reported fatality at the modern Olympic Games which 
triggered an official action happened in 1960 when a Danish cyclist died during a road 
race in Rome. It was obvious that doping had been practiced for many years and the giant 
gap between use and control needed to be closed. The Union Cycliste Internationale (UCI) 
began to develop a set of rules and in 1967 the International Olympic Committee (IOC) 
created a “Medical Commission” (IOC-MC) to combat the misuse of drugs in Olympic 
Sports. This resulted in the first IOC banned substances list, produced in 1968 [123].  
 
The first large scale doping control at modern Olympic Games occurred in Mexico (1968) 
when the first known positive case was recorded. At the 1972 Munich Olympic Games 
urine samples were screened for stimulants and narcotics by gas chromatography and for 
the first time mass spectrometry was introduced in doping control [126]. Seven positive 
Introduction 
 68 
cases were reported. By the time of the 1976 Montreal Olympic Games, IOC had banned 
anabolic steroids (AS) due to their widespread misuse in sport. As a result, eleven athletes 
tested positive for AS. The number of positive samples at several consecutive Olympic 
Games is presented graphically in Figure 1.21.   
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Figure 1.21 Number of adverse analytical findings (positive cases) at several consecutive 
Olympic Games that resulted in sanction [126] 
 
In the decades to follow, the use of performance enhancing drugs changed - rather than 
decreased - and became more secretive. As doping control tests improved in their 
identification of synthetic steroids, users moved on to testosterone (T) and other 
endogenous sterols. Unfortunately, neither GC nor LC can distinguished T produced by 
human body from exogenous T from the pharmacy or the black market. Extensive studies 
conducted between Moscow and Los Angeles Games resulted in introduction of a 
testosterone/epitestosterone ratio (T/E). T/E was introduced in 1983 as a criterion for 
exogenous testosterone doping and re-analysis of anonymous urine samples collected 
during Moscow Olympics in 1980 showed administration of testosterone in a considerable 
percentage of the samples [126]. In spite of this clear contravention of the spirit of the 
Games, no positive case was reported at the Moscow Games.   
 
One of the most featured positive cases in the modern Olympics was the stripping of Ben 
Johnson’s gold medal at the 1988 Seoul Olympics, after setting a new world record of 9.79 
s in the 100 m race. Two stanozolol metabolites were detected in the urine free fraction 
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after LLE, derivatization and GC-MS analysis. Interestingly, the subsequent investigation 
has shown that “at least half of the athletes who competed in Seoul used anabolic steroids 
to enhance their performance” [127].     
 
However, the use of AS in sports posed a new problem for sport authorities. Unlike 
stimulants, which act immediately, the effects of AS have a gradual onset. Among the fact 
they allow more intense and efficient training, the athletes learned to “bulk-up” during 
training and discontinue the drug intake when the test is to be conducted, in order to 
avoid a positive test result. This resulted in out-of-competition testing, first introduced in 
1991 by the International Association of Athletic Federations (IAAF) [128].  
 
In the next decade other ways of enhancing performance were revealed. As a result, 
hormones and related substances (erythropoietin (EPO), human growth hormone (hGH), 
insulin etc.), beta-2 agonists, diuretics and other masking agents, beta-blockers, and others 
were added to the list of banned substances. The list was further extended with prohibited 
methods: plasma expanders, blood transfusion, gene doping and others. The 1996 Atlanta 
Olympic Games were termed the “Growth Hormone Games” by some athletes [124].   
 
The need for harmonisation of the procedures and rules between different International 
and National Sports Federation has pushed IOC to formation of a new anti-doping agency 
acting as a central body. After considerable discussion between IOC and participating 
governments, the World Anti-Doping Agency (WADA) was created in 1999. After WADA 
was created, the term doping was extended not only to intake of prohibited substances but 
also prohibited methods by an athlete. The Code [129], which spells out the anti-doping 
rules, now states that doping is also an attempt to use a prohibited substance or method, 
refusing or failing to submit for sample collection, violation of applicable requirements 
regarding athlete availability for out-of-competition testing, trafficking in any prohibited 
substances or methods etc.         
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An extraordinary example of how doping and anti-doping efforts compete is the Marion 
Jones case at Sydney Olympic Games in 2000. She won five medals, and although she later 
admitted to be using steroids, she had never been caught. The reason was the 
“transparency” of the screening procedure for anabolic agents at that time. The screening 
approach even today is still based on monitoring a few characteristic fragmentation ions of 
each of the substances on the list by using for example gas chromatography with mass 
spectrometric detection (GC-MS) in selected ion monitoring (SIM). If the substance is not 
on the list and it doesn’t give a mass fragment which is monitored, the screening method 
is blind to that substance. Probably that is the main reason why the newly designed 
molecule used by Marion Jones – tetrahydrogestrinone (smartly derived from gestrinone 
to avoid detection) has been known as “The Clear”. It is often the case in the history of 
sport, the athletes found a way to circumvent the testing method before scientists could 
develop a suitable method [124]. It wasn’t until 2007 when Jones pleaded guilty, that the 
IOC stripped her of the Sydney Olympic medals. Eleven adverse analytical findings had 
been reported but the large number of articles discussing performance enhancing drugs at 
the games caused the games to be nicknamed as “the dirty games” [124]. In contrast, the 
2004 Athens Games are known as “the cleanest games” even though the number of doping 
violations was doubled (23). Two Greek top athletes were removed right before the Games 
for skipping a mandatory test, and seven medals in total were taken from athletes who 
tested positive or refused tests [123].   
 
1.7.3 Endogenous sterols 
 
Steroids are compounds possessing the skeleton of cyclopenta[a]phenanthrene, or so 
called sterane structure, and other functional groups. The sterane carbon core consists of 
four fused rings, labelled as A, B, C and D shown in Figure 1.22. Methyl groups are 
normally present at C-10 and C-13 and an alkyl side chain may also be present at C-17. 
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Figure 1.22 Sterane carbon skeleton, the core structure of steroids. Note that the rings 
are denoted with A, B, C and D, and the carbons are numbered from 1 to 17. 
 
Estranes are steroids with a methyl group present at C-13 but not at C-10, and with no side 
chain at C-17. If methyl groups are present at both C-10 and C-13, with no side chain at C-
17, steroids are called androstanes. Cholestanes and pregnanes are steroids with side chain 
at C-17. Steroids with 21 carbons containing ethyl functional group at C-17 are called 
pregnanes and those 27 carbon steroids containing -(CH3)CH-(CH2)3-CH(CH3)2 at C-17 are 
called cholestanes.   
 
There is no strict definition of sterols. However, they refer to a special group of steroids 
carrying a hydroxyl group at position 3 and most of the skeleton of cholestane.  Additional 
carbon atoms may be present in the side chain. Hundreds of different sterols are found in 
animals (zoosterols) and plants (phytosterols). They are widely distributed and are 
important in cell membrane structures. Cholesterol is the most well known zoosterol and 
is the precursor of almost all other sterols. It is mainly produced in the cell membrane and 
its role is to establish proper membrane permeability and fluidity. A small portion is 
produced by the brain.   
   
In the 1930s it was already known that testes contained a powerful androgen, and several 
years later the hormone was isolated and identified. It was named the hormone 
testosterone, from the stems of testicle and sterol, and the suffix of ketone. The two most 
credited scientists (Ruzicka and Butenandt) were offered the 1939 Nobel Prize for 
Chemistry for their work on testosterone synthesis. Clinical trials on humans began soon 
after. There are often reported rumours that German soldiers were administered anabolic 
steroids during the Second World War, in order to increase their aggression and stamina, 
but these are unproven. 
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Among the exogenous steroids used for doping in sport, endogenous (i.e. naturally 
occurring) anabolic steroids have also been used for performance enhancement. The best 
known natural anabolic androgenic steroids are testosterone and dihydrotestosterone 
(DHT).   
 
The urinary steroid profile, recently coined as part of the “biological passport” of athletes, 
represents concentrations and ratios of a range of endogenously produced steroids, their 
precursors and metabolites. The majority of their parameters are not affected by exercise, 
severe physical endurance performance nor menstrual cycle, and their concentration and 
relative ratio is a valuable tool in doping control. However, the administration of 
endogenous steroids in the body produces variations of steroidal profile following partial 
suppression or enhancement of the endogenous steroids. These changes in the steroid 
profile can be used as a marker for endogenous doping [130].   
 
In 1983 Donike et al. [131] described a method for the detection of the administration of 
testosterone in urine samples based on increased concentration of T in comparison to its 
epimer – epitestosterone (E). E is normally present in the urine but it does not increase 
after testosterone administration. However, the T/E ratio can be artificially kept in the 
“desired” range by administration of E together with T. That is the reason why WADA 
had listed epitestosterone as a masking agent and laboratories have to report its urinary 
concentration exceeding 200 ng mL-1. The endogenous doping with DHT, similarly to T 
doping, is based on monitoring the Androsterone/Eticholanone ratio (A/Etio). 
Androsterone is a metabolite of DHT and elevated ratio A/Etio is a good marker for DHT 
doping.  
 
Many steroids are sold over-the-counter as food supplements and they can be used by 
athletes for performance enhancement. Dehydroepiandrosterone (DHEA) is an orally 
ingested weak endogenous androgen. It is used by athletes in order to increase the levels 
of more potent androgens such as testosterone and DHT, which are part of its metabolic 
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pathway [132]. The T/E value and the urinary concentrations of testosterone, 
epitestosterone, androsterone, etiocholanolone and other endogenous steroids are 
quantitated precisely during the screening procedure in doping control.  
 
1.7.4 Anabolic agents 
 
Anabolic androgenic steroids or simply anabolic steroids (AS) are drugs derived from 
natural male sex hormone testosterone. They stimulate protein synthesis resulting in an 
acceleration of the food conversion rate, muscle grow, body mass build up and enhanced 
performance. Because of this they are used as therapeutics to stimulate the recovery of 
protein deficiency and protein-wasting disorders (e.g. osteoporosis, cancer, AIDS, bone 
marrow failure anaemia). However, athletes have recognised the “positive” effects on 
their performance and they became the most abused doping substances today. Through a 
number of mechanisms anabolic steroids stimulate the formation of muscle cells and 
hence cause an increase in the size of skeletal muscles leading to increased strength.  
 
Historically IOC banned AS in 1976, but later this group of substances was renamed to 
anabolic agents (AA) because some anabolic substances abused in sport competition are 
not steroids, i.e. clenbuterol. The name comes from anabolic, meaning induction of protein 
synthesis and muscle build up (growth), and androgenic meaning pronouncing male 
phenotype such as development of the vocal cords, secondary sex organs, facial and body 
hair, etc.  
 
Anabolic androgenic steroids are derived from testosterone structure (Figure 1.23) mainly 
by altering C-3 and C-17 positions. Many other powerful anabolic agents have been 
developed with slightly different androgenic or physiological properties. Alkylation at C-
17 position with methyl or ethyl group created orally active compounds because it slows 
the degradation of the drug by the liver, and esterification at the C-17 position allows the 
substance to be administered parenterally. In this way the duration of effectiveness is 
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increased because agents soluble in oily liquids may be present in the body for several 
months. Finally alterations of the ring structure were applied for both oral and parenteral 
agents to obtain different anabolic to androgenic effect ratios. Higher anabolic / 
androgenic ratio steroids are preferred in sport doping. 
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Figure 1.23 Chemical structure of testosterone 
 
There are two known techniques of steroids use by athletes: “cycling” and “stacking” 
[130]. Cycling refers to the timing of steroid use. The perceived benefit is that after 
prolonged steroid use muscles’ receptor sites fail to recognize the steroid and if this occurs 
the steroid may lose its effectiveness and even higher doses may not provide significant 
increase in muscle. Accordingly, “on” and “off” cycles are designed for maximum benefit 
of the steroid, by allowing the cells to become receptive to steroid once again. The use of 
two or more different agents at the same time is referred to as stacking. It is based on the 
belief that this will saturate the muscles’ steroid receptors and will provide a synergistic 
effect. Three different agents with a cycling time of 5-10 weeks is the preferred technique 
according to a recent internet based study [130].  
 
Even though the cycling and stacking techniques reduce the risk of adverse side effects of 
illegal use of steroids, the usual doses are 5-100 times greater than the normal body 
production of testosterone, and side effects can occur. The most pronounced is the 
suppression of the normal production of gonads (testis and ovary), which can reduce the 
sperm count to minimal levels and even cause infertility. Conversion of testosterone to 
dihydrotestosterone (DHT) can accelerate the rate of premature baldness for males who 
are genetically predisposed, but testosterone itself can produce baldness in females. 
Virilisation is another side effect, more dramatic in women. Acne and inappropriate facial 
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and body hair, combined with deepening of the voice are the most predominant. High 
doses of oral anabolic steroid compounds can cause liver damage, as the steroids are 
metabolized (C-17-alkylated) in the digestive system to increase their bioavailability and 
stability. The list of side effects is much larger and exceeds the scope of this thesis.  
 
The rapid metabolization of steroids leading to low concentration levels of the parent 
compound, combined with the habit of athletes to stop using illicit substances before 
competition, has pushed anti-doping authorities to lower the minimum required 
performance limit (MRPL) of the techniques used for detection. Most of the detection 
methods are based on monitoring steroid metabolites rather than the parent compound, 
since they can often be detected much longer. Although all anabolic steroids are 
considered as doping agents, most of the positive cases detected by the IOC anti-doping 
laboratories refer to the illicit use of four specific compounds (methandienone, 
methyltestosterone, nandrolone and stanozolol). In addition to androgenic steroids, also 
beta-2-agonists have been banned by the IOC for their putative anabolic actions; among 
them, clenbuterol is supposed to be illicitly used by some athletes due to its 
“repartitioning effects”. The IOC Medical Commission has therefore stated that each 
WADA accredited laboratory should detect the presence of clenbuterol and/or the 
metabolites of the four anabolic androgens at a certain minimum required performance 
limit for the technique used for detection. The WADA technical document TD2004MRPL 
[133] stated the MRPL for anabolic agents to be 10 ng mL-1. However, the MRPL for 
clenbuterol, 19-norandrosterone (nandrolone metabolite), epimethendiol (metandienone 
metabolite), methyltestosterone metabolite 2 (M2 metabolite) and 3’hydroxystanozolol 
(stanozolol metabolite) has been set at 2 ng mL-1, making them the most difficult to detect 
of the anabolic agents. That is the reason why they are called the “key” WADA anabolic 
agents, required to be analysed by WADA accredited laboratories. 
 
Nandrolone (Figure 1.24a) is an exogenous anabolic androgen steroid which is used in the 
treatment of osteoporosis in postmenopausal women (though now not recommended). It 
is also used for some aplastic anaemias, osteoporosis and some forms of neoplasia 
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including breast cancer. Apart from its legal use in medicine, nandrolone (19-
nortestosterone) is one of the most popular anabolic androgens used by athletes to 
increase muscle mass, red blood cell production and bone density. The list of publicized 
nandrolone positive cases is relatively large [134]. 
 
Nandrolone is administered via intra muscular injection and its two major metabolites 19-
norandrosterone (Figure 1.24b) and 19-noretiocholanolone (Figure 1.24c) can be detected 
for a long time past-administration. The screening procedure in doping control is common 
for all anabolic agents and consists of SPE or LLE, β-glucuronidase hydrolysis of the 
conjugates, extraction, derivatization and GC-MS analysis. The same methods for 
confirmation are used as in the case of clenbuterol. The limit of detection for this potent AS 
is the lowest ever set (1 ng mL-1). Some false positive and incorrect urine analysis have been 
reported due to its low concentration levels and the presence of metabolites from other anabolic 
agents [134].  
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Figure 1.24 Structure of nandrolone (a) and its major metabolites 19-norandrosterone (b) 
and 19-noretiocholanolone (c) 
 
Metandienone (methandrostenolone, Figure 1.25a) is another exogenous anabolic 
androgenic steroid; its popularity among bodybuilders persists. Despite the lack of any 
known therapeutic applications, the drug remained legal from its discovery in early 1960s 
until the early 1990s. It is typically being combined (stacked) with injectable compounds, 
such as testosterone, nandrolone or trenbolone. Several successful athletes and 
professional bodybuilders have come forward and admitted long-term metandienone use 
before the drug was banned, including Arnold Schwarzenegger [135]. 
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Metandienone anabolic effects are similar to the effects of other AS and it is screened and 
confirmed by using the same abovementioned methods. Epimethendiol (EMD, Figure 
1.25b) is one of the metabolites of metandienone which can be detected for a longer period 
of time after administration and the screening is based on monitoring some characteristic 
mass fragments of this metabolite. 
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Figure 1.25 Structure of metandienone (a) and its major metabolite epimethendiol (b) 
 
Stanozolol is an anabolic steroid derived from testosterone but in a different way. Unlike 
most of the AS, it contains pyrazole nucleus attached to the A ring (Figure 1.26a), which 
makes its extraction and GC analysis eminently difficult [136]. It is one of the most difficult 
AS to analyse by GC.  
 
Its anabolic effects are similar to others AS with a slightly better anabolic/androgenic ratio. 
That is the reason why it is preferred by women [137]. Despite the ban, this AS is still 
illegally used as a growth promoter in cattle and widely used as a doping agent in sport 
competition. The list of positive cases is large, but probably the most featured case is Ben 
Johnson’s test result in 1988 Seoul Olympic Games.  
 
The methods for screening and confirmation are the same as for the other AS, where the 
most characteristic fragment masses of its major metabolite 3’hydroxystanozolol (3’OH-
stanozolol, Figure 1.26b) are monitored. This is one of the longest lasting metabolite in the 
urine, enabling doping violation to be detected long after stanozolol administration.   
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Figure 1.26 Structure of stanozolol (a) and its major metabolite 3’OH-stanozolol (b) 
 
Methyltestosterone (17-α-methyltestosterone, MT, Figure 1.27a) is a 17-methyl derivative 
of testosterone with similar properties and effects to the other AS. It hasn’t been detected 
in urine unchanged and this, along with the structure similarity to testosterone-derived 
AS, is the main reason why it is the most frequently used internal standard in doping 
control. Its detection and confirmation is based on monitoring its two main metabolites, 
namely 17α-methyl-5α-androstane-3α,17β-diol (M1 metabolite, Figure 1.27b) and 17α-
methyl-5β-androstane-3α,17β-diol (M2 metabolite, Figure 1.27c).    
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Figure 1.27 Structures of 17α-methyltestosterone (a), and its two major metabolites (b) 
M1 and (c) M2 
 
Clenbuterol (Figure 1.28) is a beta-2 receptor agonist administered as a bronchodilator for 
the treatment of respiratory diseases, i.e. bronchial asthma [138, 139]. It shows 
“repartitioning effect” defined as the increase of lean muscle mass and the concomitant 
decrease of fat deposition. The effect is achieved through both an increased muscle protein 
deposition and an augmented lipolysis. Its ability to increase the muscle-to-fat body ratio 
makes its illegal use in livestock popular to obtain leaner meats. However, several massive 
poisonings have happened around the world (China, USA, Italy) by eating pork 
Introduction 
 79 
contaminated by clenbuterol that had been fed to the animals to keep their meat lean. 
Athletes have recognized the benefits of this effect and clenbuterol has been extensively 
used in the past several decades.  
       
Clenbuterol is mainly excreted in urine as unchanged and almost all methods for its 
detection are based on the parent drug. Even though the average urine level following oral 
administration of therapeutic doses is above 10 ng mL-1, WADA has set the threshold at 2 
ng mL-1. This is mainly because of the “bulk up” of athletes, especially in the case of in-
competition testing, where its effect can be “enjoyed” a long time after drug intake stops, 
which occurs long time before urine sample collection.  
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Figure 1.28 Structure of clenbuterol, a beta-2 agonist frequently abused by athletes 
   
Detection methods are based on gas or liquid chromatography separation and UV or MS 
detection. GC-qMS is a golden standard for anabolic agents in doping control, where 
screening is based on monitoring the most characteristic fragment ions of beta-2 agonist 
fragmentation. In case of positive screening result, confirmation is achieved by applying 
HRMS or tandem MS. Amendola et al. [138] have proposed a GC-MS3 method for 
clenbuterol confirmation, offering significant background reduction and reliable 
identification. 
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1.8 SCOPE OF THE THESIS 
 
The thesis will commence with an introductory section – Chapter 1 – that describes the 
role of general profiling for drugs analysis, how it is conducted, and the use of gas 
chromatography for this purpose. Chapter 2 gives details for the samples and analytical 
methods. A thorough consideration of multidimensionality in analysis follows – Chapter 3 
– with particular attention on the two key platforms of importance to gas chromatography 
technology – the separation dimension and the detection dimension. This theme will then 
be developed through the applications in the drugs area, which will be the bulk of the 
thesis original research. 
 
Steroids in doping control occupy three chapters – Chapters 4-6 – and constitutes firstly 
the development of understanding of the technology of GC×GC and GC×GC-MS, then the 
use of GC×GC for doping analysis, and finally an evaluation of the requirements of the 
World Anti-Doping Authorities for steroids analysis in national drug testing laboratories. 
   
Based on the success of the above research, attention will then focus on illicit drugs, the 
relevance of GC×GC for such studies, and the new capabilities which GC×GC can bring to 
ecstasy – Chapter 7 – and heroin and cocaine – Chapter 8 – analysis. 
 
The conclusion – Chapter 9 – summarises the major outcomes and recommendations that 
arise from the research reported.   
 
 
 
 
  
 
 
 
 
 
 
 
Chapter 2 
 
2 MATERIALS AND METHODS 
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2.1 MATERIALS 
2.1.1 Endogenous sterols 
 
The following endogenous sterols (min. 99% purity) were obtained from Steraloids Inc. 
(Newport, RI, USA) except as noted: 5α-androstan-3β-ol (1), 5β-androstan-3β,17β-diol (2), 
5β-estran-3α-ol-17-one (3), 5α-androstan-3α-ol-17-one (4), 1,3,5(10)-estratrien-3,17β-diol 
(5), 5-androsten-3β-ol-17-one (6), 5α-androstan-3β-ol-17-one (7), 5α-androstan-3α,11β-diol-
17-one (8), 5α-androstan-17β-ol-3-one (9), 5-androsten-3β,16α-diol-17-one (10), 5β-
androstan-3α-ol-11,17-dione (11), 4-androsten-17α-ol-3-one (12), 4-androsten-17β-ol-3-one 
(13), 5α-cholestane (14), 1,3,5(10)-estratrien-3-ol-17-one (15), 5-cholesten-3β-ol (16), 4-
androsten-3,17-dione (17), 5,22-cholestadien-24β-ethyl-3β-ol (18), 5-cholesten-3β-ol-n-
butyrate (19), 5β-pregnane-3α,20α-diol (20) (from Acros Organics <www.acros.com>), 5β-
pregnan-3α,17,20α-triol (21), 5β-pregnan-3α,21-diol-11,20-dione (22), 5β-pregnan-
3α,11β,21-triol-20-one (23), 5β-pregnan-3α,17,20α,21-tetrol-11-one (24), 5β-pregnan-
3α,17,21-triol-11,20-dione (25), 5α-pregnan-3α,11β,17,21-tetrol-20-one (26), 5β-pregnan-
3α,11β,17,21-tetrol-20-one (27). Methyl testosterone (IS, 99.3% purity) used as an internal 
standard was purchased from Sigma-Aldrich. Their structures are given in Figure 2.1. 
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Figure 2.1 Structure of sterols used in the study (Continued on page 83)  
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(Figure 2.1) 
 
2.1.2 WADA key sterols 
 
Clenbuterol (Clen.), 19-norandrosterone (19-nor.), epimethendiol (EMD), 17α-methyl-5α-
androstane-3α,17β-diol (M1), 17α-methyl-5β-androstane-3α,17β-diol (M2), 3’-hydroxy-
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stanozolol (3’OH-stan.), methyltestosterone (IS, 99.3% purity) were purchased from 
National Measurement Institute (NMI, Pymble, Australia). Their structures are given in 
Chapter 1, section 1.7.4.  
 
2.1.3 Illicit drugs 
 
24 ecstasy tablets in total were used in the experiments. Nine were seized in Macedonia 
during the period end-2007 – early-2008 and were provided by Macedonian Police, and 15 
were seized in Australia at the end of 2009 and were provided by Australian Federal 
Police (AFP). Macedonian samples were from 9 different seizures (one tablet from each 
seizure), but were classified in three groups each of three tablets according to their post-
tabletting (post-TB) physical characteristics (logo, colour, diameter and thickness). Three 
tablets were off-white in colour with “dove” logo (XTC3 in Figure 2.2), three were brown 
with “bird” logo (XTC4), and three were pink with “Toyota” logo (XTC5). The three XTC3 
tablets are labelled as XTC3-1, XTC3-2 and XTC3-3. The three XTC4 and three XTC5 tablets 
were labelled accordingly. Intelligence information provided by Macedonian Police 
indicated that the tablets with the same post-TB are likely related. The Australian samples 
were from one recent seizure and were classified in five groups, each of three tablets 
according to their physical characteristics. Their labels and logos are given in Figure 2.2.  
 
 
Figure 2.2 Photos of the ecstasy tablets used in the study, showing all their logos 
 
XTC3 XTC4 XTC5 ECS1 
ECS2 ECS3 ECS4 ECS5 
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Heroin profiling study was performed by analysing samples from three different seizures 
made in Macedonia in 2006-2008 (Ha, Hb and Hc). Each sample was divided in three 
separate aliquots (subsamples) simulating different but linked seizures and each were 
labelled as Ha1, Ha2, Ha3, Hb1, Hb2 etc. They were light-brown to brown in colour and 
their physical appearance and intelligent information, combined with the major 
components profile, suggested they resemble SWA heroin. Three blend samples (B1, B2, 
B3) composing of equal amount of Ha, Hb and Hc was used to test the statistical methods 
for sample classification. Additionally, the profiles of nine heroin samples seized in 
Australia and provided by AFP were compared to the SWA heroin sample profiles. 
Australian heroin samples (H1 to H9) were white to pale brown in colour and their major 
components profiles likely resemble SEA heroin.          
 
Three cocaine samples seized in Macedonia (Ca, Cb, Cc) in 2005-2007 were used in the 
cocaine profiling study. They were white to off-white powders in colour, each weighted 
0.6 g. Each sample was divided in three subsamples, labelled as Ca1, Ca2, Ca3, Cb1, Cb2 
etc. simulating different but linked samples. Sample Cc was taken from the biggest ever 
single seizure of cocaine in Macedonia: 438 kg. Additionally, nine cocaine samples (C1 to 
C9) seized in Australia (provided by AFP) were included in the study. No information 
related to their origin was supplied. All cocaine samples were white in colour.   
 
 
2.2 REAGENTS AND CHEMICALS 
 
Methanol (HPLC grade), N,O-bis(trimethylsilyl) trifluoroacetamide (BSTFA) + 1% 
trimethylchlorosilane (TMCS), N-methyl-N-(trimethylsilyl)-trifluoroacetamide (MSTFA), 
heneicosane, toluene and methyl tert-butyl ether (MTBE) were purchased from Sigma–
Aldrich, sulfuric acid, anhydrous sodium sulfate, ammonium iodide (NH4I) and 
potassium carbonate (K2CO3) from BDH Chemicals (Kilsyth, Australia), 
phosphorouspentoxide (P2O5) and ethanethiol from Merck (Darmstadt, Germany), and 
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pyridine from Alltech. β-glucuronidase (from E. Coli, K12) was supplied from Roche 
(Mannheim, Germany). All chemicals and reagents were of analytical grade or higher. 
Water used in the experiments was of Milli-Q® (Millipore Corp., MA, USA) grade. 
 
 
2.3 SAMPLE PREPARATION 
 
2.3.1 Endogenous sterols sample preparation 
 
Two stock solutions of sterols were prepared – one a 27 component mixture, the other a 19 
component mixture when pregnanes were excluded – by dissolving a known amount of 
each sterol in HPLC grade methanol to a concentration of each between 0.3–1.2 mg mL−1. 
Working solutions were prepared by progressive dilution of the stock solution. A stock 
solution of internal standard was prepared by dissolving 10 mg of MT in 10 mL methanol 
and the working solution by further dilution of 100 μL of stock solution in 10 mL 
methanol. Solutions were stored at 4 °C when not in use. 
 
Free sterols were extracted from spiked and blank urine samples by a procedure described 
elsewhere [139]. Hydrolysis of steroid glucuronide conjugates, as is customary in many 
steroid preparation protocols, was not performed for the present studies. Briefly, 5 mL 
urine was spiked with 19 sterols at a concentration from 0.1 ng mL−1 to 10 ng mL−1 and to 
each sample 50 μL of internal standard (10 μg mL−1) was added. The samples were made 
alkaline with 0.5 mL of 5% K2CO3 to pH of 9–10 and shaken well for 1 min. Sterols were 
extracted with two aliquots of 2.5 mL TBME, after shaking for 5 min and centrifuging for 
20 min at 3500 rpm. The two extracts were combined, dried and kept in a desiccator over 
P2O5 for 20 min. Extracts were then derivatized by adding 50 μL pyridine, 50 μL BSTFA 
and heated for 30 min at 80 °C. After transferring the derivatized mixture to micro inserts, 
3 μL were injected using splitless injection mode. Blank urine samples were processed in 
the same manner without addition of sterols. 
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Standard mixtures of sterols were prepared by drying aliquots of diluted solutions, and 
derivatized as described. Each of the 27 sterols were sampled and derivatized individually 
by drying an aliquot of each then derivatizing as described above to a final concentration 
of 100 μg mL−1. 
 
2.3.2 WADA key sterols sample preparation 
 
Stock solutions of anabolic agents were prepared by dissolving a known amount of each in 
HPLC grade methanol to a concentration of 0.2 mg mL-1. Working solutions and standard 
mixtures were prepared by progressive dilution of the stock solutions. A stock solution of 
internal standard (methyltestosterone) was prepared at a concentration of 1 mg mL-1 in 
methanol, and the working solution at a concentration of 5 μg mL-1. The derivatization 
mixture (MSTFA-NH4I-ethanethiol) was prepared in a ratio 1000:2:6 (v/w/v). Solutions 
were stored at 4 °C when not in use.  
 
Urine samples spiked with anabolic agents were prepared in the concentration range from 
0.5 ng mL-1 to 20 ng mL-1 by adding an appropriate volume of the standard mixture and 25 
μL of the internal standard solution to the blank urine extracts and they were prepared 
according to the widely accepted sample preparation procedure [139, 140] for anabolic 
agents. Briefly, 2.5 mL urine was applied to a 500 mg C-18 SPE column (Bond Elut, 
Varian), previously conditioned with 3 mL methanol and 3 mL water. Anabolic agents 
were eluted with 3 mL methanol and the solvent was evaporated under a steam of 
nitrogen. 1 mL of phosphate buffer (pH 7.0) and 50 μL β-glucuronidase were added to the 
residue and the mixture was incubated in a water bath at 55 °C for 1 h. After cooling, 0.75 
mL potassium carbonate solution (5%) was added, shaken for 5 min and anabolic agents 
were extracted with two portions of 2.5 mL TBME. The two extracts were combined, dried 
under a steam of nitrogen, and spiked with anabolic agents and IS at appropriate 
concentration, dried again under nitrogen and kept in a desiccator over P2O5 for at least 20 
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min. Prior to analysis, the residue was derivatized by dissolving in 50 μL of derivatization 
mixture (MSTFA-NH4I-ethanethiol) with heating at 80 °C for 30 min. Standard mixtures of 
derivatized anabolic agents were prepared by drying aliquots of diluted solutions, and 
derivatized as described. Bis-TMS derivatives (2TMS) of clenbuterol, 19-norandrosterone, 
EMD, M1, M2, and methyltestosterone (IS) were monitored and tris-TMS (3TMS) 
derivative of 3’OH-stanozolol.   
 
A urine positive control sample (UPC) spiked with 5 anabolic agents at a concentration of 
5 ng mL-1 was prepared at the National Doping Control Centre (NDCC), Mahidol 
University in Bangkok, Thailand (WADA accredited laboratory). M1 metabolite was not 
spiked in the UPC sample, since this epimer is not monitored at the MRPL of 2 ng mL−1. 
The sample was used for checking the performance of the present method.  
 
2.3.3 Illicit drugs sample preparation   
 
2.3.3.1 Ecstasy samples preparation 
Ecstasy (MDMA) tablets were quickly crushed and homogenized by using mortar and 
pestle. 20 mg of the fine powder was placed in a 4 mL septum-sealed vial, equilibrated for 
30 min at 80 °C and then a PDMS/DVB SPME fibre (Supelco, Bellefonte, PA, USA) was 
inserted and exposed to the headspace for another 30 min. The samples were desorbed in 
the GC injection port for 5 min at 250 °C. No additional chemicals or reagents were used in 
the ecstasy profiling study.  
 
2.3.3.2 Heroin samples preparation 
Organic impurities present in heroin samples were extracted by the procedure described 
by Stromberg et al. [31]. Briefly, a 30 mg sample is dissolved in 5 mL of 0.5 N sulfuric acid 
and mixed vigorously for 5 min. 5 mL MTBE (or toluene, for comparison purpose) is 
added, mixed vigorously for 10 min and centrifuged for 10 min at 3500 rpm. 3.2 mL of the 
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upper organic layer is removed, dried under nitrogen and reconstituted with 200 μL of the 
extracting solvent. Two blanks (one of each extracting solvent) are prepared in the same 
manner for compensation of the background components.         
 
Volatile components present in heroin samples were extracted by means of SPME 
extraction. Because there was no method described in the literature, except the one applied 
on a macro scale (10 g sample) in a dog training program [49], we applied SPME 
procedure similar to the one described for ecstasy profiling, with slightly prolonged 
equilibration and absorption times and increased sample amount. Briefly, heroin samples 
were homogenized and 40 mg of each was transferred to a 4 mL septum-sealed vial and 
equilibrated for 40 min at 80 °C. After the equilibration period, PDMS/DVB or 
divinylbenzene/carboxen/polydimethylsiloxane (DVB/CAR/PDMS) SPME fibres were 
inserted and exposed to the headspace for another 40 min. Volatile components were 
desorbed in the GC injector (for 5 min at 250 °C).      
 
2.3.3.3 Cocaine samples preparation 
Cocaine samples for liquid injections were prepared by the method described in [141]. 
Briefly, 30 mg finely powdered sample was dissolved in 0.5 mL chloroform/pyridine (5:1) 
containing 1 mg mL-1 heneicosane (C21) as internal standard. 100 μL of MSTFA were 
added to the mixture, shaken vigorously and derivatized at 80 °C for 60 min. 
  
The comprehensive cocaine impurity profiling method, as described by Moore and Casale 
[142] and currently used by the Special Testing and Research Laboratory (STRL) in USA, 
has not been applied due to three main reasons: 
 
1. the high cocaine amount required (500 mg); 
2. the complex and lengthy procedure where alumina column chromatography is 
used for impurity fractionation, collection and consequent analysis; 
3. relatively simple chromatographic profiles of each of the fractions. 
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The average amount of cocaine samples available was 600 mg per sample, so it was 
decided to explore the new possibility of profiling rather than to use the whole amount for 
one sample preparation and analysis only which would prevent replicate sampling.  
       
Volatile components present in cocaine samples were extracted by using the same SPME 
sample preparation method previously described for heroin.  
 
2.4 INSTRUMENTATION 
 
An Agilent 6890 gas chromatograph (Palo Alto, CA, USA) equipped with split/splitless 
injector and Agilent 7683 series auto samplers was used in all one dimensional (1D) and 
two-dimensional (2D) GC experiments. The modulator used in 2D GC experiments was a 
Longitudinal Modulation Cryogenic System (LMCS, Chromatographic Concepts Pty Ltd., 
Doncaster, Australia) retrofitted to the GC. Liquid CO2 was used for cryotrapping of 
components and nitrogen at 15 psi as a flush gas for prevention of sticking the column to 
the cooled (frozen) trap.    
 
The GC was equipped with a flame ionisation detector (FID) for the GC-FID and GC×GC-
FID experiments or coupled to an Agilent 5973 quadrupole mass selective detector (qMS) 
upgraded with fast electronics for GC-MS experiments. Unless otherwise stated, the MS 
transfer line and ion source temperatures were 280 °C and 230 °C, respectively, and the 
MS detector voltage and electron impact (EI) ionization energy were 1.8 kV and 70 eV, 
respectively.  
 
A LECO time-of-flight mass spectrometer (TOFMS) model Pegasus III (LECO Corp., St. 
Joseph, MI, USA) was coupled to the GC in all GC-TOFMS and GC×GC-TOFMS 
experiments. The applied MS transfer line temperature, ion source temperature and 
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electron ionization energy were the same as in GC-MS experiments. The detector voltage 
was 1.6 kV, unless otherwise stated. 
 
Experiments in high resolution mass spectrometry were conducted using a GCT Premier 
(Waters, Manchester, UK) accurate TOFMS, connected to an Agilent 7890 gas 
chromatograph. The TOFMS detector was operating at 7000 FWHM (full width at half 
maximum) resolution with specified mass accuracy of less than 5 ppm.   
 
 
2.5 METHODS 
 
The GC columns and column sets used in 1D and 2D GC experiments are listed in the 
following Chapters (under Experimental subheadings). All BP columns were products of 
SGE International (Ringwood, VIC, Australia) and DB-1 and DB-5 were products of 
Agilent J&W Scientific. Unless otherwise stated, experiments in 1D GC were carried out 
under the same chromatographic conditions as in 2D (including the column 
configuration), but without activating the cryogenic modulation process. The modulation 
period and the modulator temperature were different for different type of analytes and 
details are given in the following Chapters.      
 
Helium was used as a carrier gas in qMS and TOFMS experiments and hydrogen in FID 
experiments. One μL sample volume was injected in all methods, except in P/NP column 
configuration in GC×GC-TOFMS methods for endogenous sterols, where 3 μL were 
injected. The acquired mass range was from 45 m/z to 700 m/z in TOFMS and from 45 m/z 
to 650 m/z in qMS experiments, unless otherwise stated.    
 
A separate GC×GC-TOFMS based in-house library of endogenous and WADA key sterols 
was generated using standard solutions at a concentration of 1 μg mL-1 and 0.5 μg mL-1, 
respectively. Spectra similarity was performed against NIST05 commercial MS database 
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and the in-house created TOFMS library in sterol work by using NIST algorithm and 
against NIST05 and Wiley7 commercial databases in illicit drug study by using both NIST 
and PBM spectral search algorithms.  
 
2.5.1 Data acquisition and processing 
 
FID data were acquired at 100 Hz and processed by Agilent ChemStation software. The 
data were then exported to csv (comma separated values) file format and converted in 
two-dimensional matrix by using an in-house (RMIT University, Melbourne, AU) 
developed software. Transform (Fortner Research, VA, USA) was used for 2D and contour 
plots presentation. Agilent MSD ChemStation software was used for data acquisition and 
processing in GC-qMS study. 
 
TOFMS data were acquired and processed by ChromaTOF (LECO Corp., St. Joseph, MI, 
USA) software ver. 2.32. Data acquisition rate was 100 Hz in WADA sterols experiments 
and 50 Hz in endogenous sterols and illicit drugs studies, both conducted in 2D GC mode. 
The sampling frequency in 1D GC mode in all experiments was adjusted to 20 Hz to 
closely resemble the usual acquisition rate in classical gas chromatography. 2D image and 
contour plots of TOFMS data were created by ChromaTOF software, and all other 
chromatograms and 2D plots were constructed by using Origin ver. 7.5 (OriginLab Corp., 
Northampton, MA, USA), after conversion of the raw data into “csv” files. 
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3 MULTIDIMENSIONAL GAS CHROMATOGRAPHY 
WITH SPECIAL EMPHASIS ON ITS USE IN DOPING 
CONTROL AND DRUG ANALYSIS 
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3.1 INTRODUCTION TO MULTIDIMENSIONALITY 
 
That there is a need for improved methods of analysis for many sample types is a truism. 
Rarely will advances in analysis techniques be rejected as inappropriate or undesirable, 
except for the simplest analysis task. The most pressing questions that exercise the 
strategies of analysts are: 
 
• What constitute truly advanced methodologies? 
• How do they compare in delivery of improved analytical capability? 
• Are they needed for the task at hand? 
 
Usually these questions revolve around the ability of the method to measure compounds 
at lower abundances, perhaps over a greater order of magnitude response, and with better 
selectivity in the presence of other compounds. These in turn lead to a greater capacity to 
record, measure and quantify more of the total analytical response of a sample.  
 
Here, the focus is on gas chromatography (GC) with particular reference to how 
multidimensional methods offer new capabilities for analysis. The first part presents an 
introduction to considerations of multidimensionality and hyphenation, with discussion of 
the role of the separation step in GC, then the detection step, and finally 
multidimensionality of the total method. Here, drugs analysis and anti-doping control will 
be used for demonstration of the different concepts in multidimensionality.  
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3.2 HYPHENATION vs. MULTIDIMENSIONALITY IN 
CHROMATOGRAPHY 
 
The term “hyphenated” technique has a variety of meanings in the scientific community. 
While the meaning for some authors is almost limited to the coupling of a separation 
technique to the mass spectrometer (MS), for others it includes coupling of a sample 
preparation technique to one or more separation techniques, coupled to one or more 
detection systems [143]. For some authors [144] the hyphenation just means close 
relationships between two devices or techniques, and does not even mean on-line 
coupling, and for some [145] it is even equivalent  to the term multidimensionality. Ali et 
al. [147] have stated that hyphenation is nothing but coupling of a sample preparation unit 
with the core analytical instrument. Having in mind the abovementioned, sometime there 
is contradiction in the terminology, e.g. if hyphenation is equal to multidimensionality, 
how can SPE coupled to HPLC be defined as a multidimensional technique? Or can off-
line L/LE and subsequent injection in GC be considered as a hyphenated technique? 
However, most analysts agree in the following: appropriate hyphenation brings faster 
analysis time, lower detection limits, involves less manpower and reduces chances of 
human error, limits sample contamination and analyte degradation, with enhanced 
analytical precision etc. [146].       
 
In the author’s best knowledge, the review of Bogusz [147] best describes the term 
hyphenation so far. He compares the hyphenated technique to the hyphenated man: a 
naturalized citizen believed to be ambivalent in his loyalty; so called of his tendency to 
style himself according to his former and present nationalities, using hyphen (as defined 
in Webster Encyclopaedic Unabridged Dictionary). In this meaning the freshly combined 
techniques are seldom treated as a complete and integer system, in the same manner as a 
freshly naturalized citizen is still ambivalent. Historically, the operation of the hyphenated 
techniques derives from developments by specialists from two or more different fields, 
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who usually were confident in only one analytical aspect (e.g. separation or detection 
problems). As the hyphenated techniques “mature” and the bench top instruments 
become commercially available, the “second generation” of users (like in the case of GC-
MS, HPLC-DAD) do not regard these techniques as hyphenated but take them for granted 
and as a fully integrated “single” system. As a conclusion, Bogusz [147] stated that the 
term “hyphenated” seems to apply only to those techniques which still have not reached 
their maturity.      
    
Even if it is hard to establish a strict definition of a hyphenated chromatography 
technique, most would agree that in the widest meaning it is a carefully adjusted (usually 
involving compromises) and on-line coupling of two or more techniques, or techniques 
and devices, in one, while retaining the appropriate fluid flow through the system as a 
whole. Sample preparation/pre-concentration techniques (SPE, SPME) and detectors (FID, 
NPD, ECD, UV, RID etc.), which are not techniques by themselves belong to this group 
when coupled to the analytical techniques. Off-line coupling of two analytical techniques 
and/or sample preparation techniques is excluded in this definition, since discrete flow 
operation does not mean hyphenation. Also it does not mean the coupling must consist 
solely of separation and mass spectrometry techniques. As an example, GC coupled with 
MS or FTIR is considered as hyphenated, as well as when interfaced with an FID, NPD or 
ECD detector. In the same manner, GC-AED (atomic emission detector), SFC-FTIR 
(supercritical fluid chromatography-Fourier transform infra red), CE-MS (capillary 
electrophoresis-mass spectrometry), LC-GC, SPE-LC are all hyphenated techniques. GC 
coupled to GC (GC-GC, GC×GC), or LC coupled to LC (LC-LC, LC×LC) are classified in 
this group even though they do not comply with the Bogusz definition [147]. In order to be 
fully functional, the “hyphenation” has to be done through an adjustment of the 
conditions, implementing an interface between the two GC columns, adjustment of the 
detector to be able to handle the data etc. However, the term “hyphenated” is usually 
omitted for the mature hyphenated techniques.     
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3.3 MULTIDIMENSIONAL GAS CHROMATOGRAPHY TECHNIQUES  
 
Today, many published articles deal with terms such a ‘two-dimensional’, ‘three-
dimensional’ and even ‘four-dimensional’ techniques, with one common goal: they are all 
intended to accelerate the analysis by time, by number of components resolved, or by 
number of components detected. Here, an interpretation can be given to the relative merits 
and implementation strategies of multidimensional analyses, with various applications 
from the literature on doping and drugs analysis.  
 
Generally, multidimensionality comprises the coupling of two or more dimensions, each 
of which is technique in their own right. Mondello et al.’s text [148] is one of the most 
recent book covering this general topic, although much new research has appeared in the 
years since this book was first published.  For example, both GC coupled to mass 
spectrometry (MS) as a detection system giving GC-MS, and high performance liquid 
chromatography (HPLC) coupled to ultraviolet-visible spectroscopy (UV) giving 
HPLC/UV-vis are multidimensional techniques. In contrast, a technique which comprises 
a separation dimension coupled to a simple detection system which is not itself a 
technique, may be considered as hyphenated, but not multidimensional. Thus GC-flame 
ionisation detection (FID), GC-electron capture detection (ECD), HPLC-refractive index 
detection (RID) are some examples of this group. Another category arises where 
dimensions of the same type (or category) are coupled, such as GC with GC, GC with LC, 
or LC with LC. Are these couplings considered as hyphenated or multidimensional 
techniques? This question will be explored below. It is widely accepted that all 
multidimensional techniques are hyphenated, but the reverse does not necessarily apply. 
This is not to imply that the information content of hyphenated systems are equivalent, or 
for multidimensional systems is equivalent. This will depend on the capabilities for 
molecular specificity and/or capacity of each dimension to characterise an individual 
component. Kidwell [149] expressed the informing power of different multidimensional 
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systems (based on separation with mass spectrometry), but this should now be updated 
with a view to included recent technical developments in instrumentation. Giddings has 
discussed the general concept of multidimensionality of analysis and of separations in a 
number of key works [150-152]. 
 
Even though there is a lack of unique nomenclature defining multidimensionality, liberty 
can be taken to classify GC techniques into two distinguishable classes: GC techniques 
where multidimensionality arises from the separation process (nSEP), and GC techniques 
where multidimensionality arises from the selectivity/specificity of detection (nSEL). Since 
these techniques are widely accepted in many areas of volatiles analysis, focus will be only 
on the application of GC techniques in the field of drugs, their metabolites, and sterols in 
anti-doping control. As a starting point, and given that MS methods will feature herein, 
Figure 3.1 [153] proposes how the GC techniques above are distinguished.  
 
 
Figure 3.1 (A) Gas chromatography normally uses single column, but (B) dual column 
operation (multidimensional GC or GC×GC) is now increasingly common. In 
combination with single dimension MS (quadrupole, high resolution, time-of-flight) or 
multidimensional MS (MS/MS), various types and capabilities of analysis are possible 
[153]. Reproduced with permission of Future Science Ltd.  
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3.3.1 Multidimensionality arising from selectivity (n-SEL)  
 
Here, the focus is on detection selectivity, but since a separation step is still needed, only a 
single dimension of separation is considered.  
 
3.3.1.1 One dimension: One dimension of separation, no detection selectivity 
(1SEP-0SEL)  
There are still many laboratories where the detection system coupled to the separation 
techniques simply registers a signal, rather than constitutes a separate technique. Their 
continued use is because of their robustness, wide linear response range and versatility, as 
in the case of a GC-FID for blood alcohol analysis [154, 155], or their sensitivity for 
instance in the case of the GC-ECD in toxicological analysis of chlorinated pesticides, or 
drugs after conversion to an electron-affinity derivative [156]; or for selectivity toward 
particular groups of compounds in the application of the GC-nitrogen-phosphorus 
detector (NPD) for stimulants and opiate screening in forensic, toxicological and doping 
analysis [157]. However, the availability of a variety of analytical techniques able to be 
coupled to the separation technique, considering their sensitivity, specificity and 
selectivity capabilities toward the analytes and the matrix, reduces the applicability of 
‘1SEP-0SEL’ techniques. Because of this, a focus on multidimensional analytical techniques 
is appropriate, representing a separation technique coupled on-line with a spectroscopic 
detection technique.  
 
3.3.1.2 Two dimensions: One dimension of separation, one dimension of 
detection selectivity (1SEP-1SEL)  
Techniques where sample determination is based on two distinguishable and independent 
dimensions, generating unique data sets, are defined as two-dimensional analytical 
techniques. Conceptually, two different separation mechanisms or two different detection-
based dimensions may constitute the two-dimensional method. However, since it is hard – 
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if not impossible – to couple two detection-based techniques without using a separation 
dimension (0SEP-2SEL), apart from some novel tandem mass spectrometry (MS/MS) 
methods, the 2D approach almost exclusively comprises of a separation technique coupled 
to a selective detection technique – MS, Fourier-transform infra-red (FTIR) or nuclear 
magnetic resonance (NMR). Whilst FTIR is a viable and useful detection method for GC 
[158], and NMR has recently been described for GC [159] and with multidimensional GC 
(MDGC) [160], today it is largely MS methods which comprise the majority of the viable 
multidimensional methods, and have largely replaced 1D GC methods.  
 
Many applications have been developed for routine bioanalysis in a wide diversity of 
matrices – blood, urine, saliva, hair, tissue, etc. In addition to its robustness, simplicity, 
sensitivity and selectivity, the most important attribute is its identification power. Scan 
mode, with full mass spectra of separated compounds acquired, permits widely accepted 
use of MS spectral libraries for identification, but this is best accomplished with well 
separated components, or with spectral deconvolution. Selected ion monitoring mode 
(SIM), where pre-selected ions are monitored, dramatically increases sensitivity since the 
signal is increased by allowing more time for measurement of the few ions monitored; ion 
noise is suppressed, but spectral identification is compromised as few ions are monitored. 
GC-MS is irreplaceable for routine analysis in toxicology, forensic and doping control, and 
it is widely accepted and recommended by many international organisations, e.g. World 
Anti-Doping Agency (WADA), as a “gold standard”. Preliminary screening in almost 
every WADA accredited laboratory for anabolic agents, stimulants and opiates is first by 
GC-MS in SIM mode. The core instrumental tool applied in systematic toxicological 
analysis (STA) is GC-MS in scan mode, with identification through matching mass spectra 
with MS libraries. In forensic analysis the role of GC-MS is critical when dealing with 
unknown components or new designer drugs in seized or biological matrices.  
 
Notwithstanding the widespread acceptance of GC-MS (full scan and SIM modes) many 
endogenous components similar in structure and/or mass to the target analytes are co-
extracted and the probability of co-elution on the chromatographic column is high. 
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Similarity of structure means matrix interferences can bear common mass fragments as the 
analytes, making quantification difficult or almost impossible. This can especially happen 
at low levels of concentration required by the minimum required performance limit 
(MRPL), where minor mass fragments of endogenous components (usually present at 
much higher amount) may strongly interfere with trace amounts of analytes. Thus 
refinements to the basic MS instrumental technique may be imperative. The two main 
improvements in single dimension mass spectroscopy for bioanalysis are the introduction 
of time-of-flight mass spectrometry (GC-TOFMS) and high resolution mass spectrometry 
(GC-HRMS).  
 
Further selectivity of the detection system, accompanied by an increase in signal-to-noise 
(S/N), is obtained through exact mass measurement of ions in the mass spectra through 
HRMS. Differentiation of coeluting components is possible, according to their exact mass-
to-charge ratio (m/z), depending on the magnitude of their fractional mass difference. The 
selectivity of the method depends on the mass resolution, expressed as m/Δm. Routine 
analysis using HRMS is not as common as might be suspected. Magnetic sector 
instruments, and more so Fourier transform MS systems, are expensive and often are 
unsuited to very fast scanning. Recently, high resolution TOFMS (HRTOFMS) with 
moderate resolution of about 7,000-10,000 has become available [161, 162], but is still 
beyond the price of a low resolution spectrometer. However their sensitivity and power 
for empirical and structure elucidation remains attractive.  
 
GC-HRMS has been explored for doping control over the last decade. This technique along 
with tandem mass spectrometry is recommended by the International Olympic Committee 
(IOC) [163] and WADA [164] for confirmation of trace levels of anabolic androgen steroids 
(AS) in urine of athletes. Kokkonen et al. [163] have found GC-HRMS to be 2-10 times 
more sensitive than GC-MS (low resolution). The number of positive samples reported by 
the Cologne anti doping laboratory in 1995 increased dramatically following the 
introduction of this technique; 75 positive samples out of 116 were identified on the basis 
of GC-HRMS [165] demonstrating increased sensitivity and selectivity when compared to 
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GC-MS, even though the two metabolites of stanozolol were not separated under the 
tested conditions. The same group concluded that in order to enhance sensitivity, selective 
isolation procedures could be implemented since the metabolite signal is hampered by 
high biological background. The coelution of one of the 3’OH-stanozolol TMS derivatives 
with an endogenous component which interfered with its mass spectral analysis, was 
resolved by preparation of the tributylsilyl (TBS) derivative of the metabolite.  
 
Few literature articles have used GC-HRMS in drug analysis with most referring to 
improved detection limit and selectivity. Grosse et al. [166] used GC-HRMS to study the 
pharmacokinetics of remifentanil (a fentanyl derivative with potent analgesic activity) in 
blood, with 10 times lower limit of quantification compared to low resolution GC-MS. 
Another study showed even greater difference in sensitivity (20 fold) between these two 
techniques [167].  
 
The coupling of TOFMS to GC is a second identified improvement of the MS detection. 
Recently available with GC, TOFMS provides a mass fragmentation pattern (MS spectra) 
that is effectively instantaneous, so provides an unbiased spectrum for each spectral scan 
over the chromatographic peak [162]. This detector provides a very fast acquisition rate of 
e.g. up to 500 spectra/s, and is of advantage especially when narrow and sharp peaks are 
obtained in fast gas chromatography, or in comprehensive two-dimensional gas 
chromatography [168], where the peak width at the base can be as narrow as 50 ms. The 
high acquisition rate with full mass spectral scanning offers mathematical deconvolution 
for coeluting components so as to generate the unique spectrum of each overlapping 
component, provided they each temporally differ by a few scans.  
 
It has been shown in a recently published study [169] that GC-TOFMS, combined with LC-
TOFMS, can be used as a screening method for a wider number of prohibited drug 
substances, offering great sensitivity and selectivity. However, it seems that the method 
lacks sensitivity, since the authors analysed several AS at 10 ng mL-1, which exceeds the 
required LOD of 2 ng mL-1 (1 ng mL-1 for 19-norandrosterone) [133]. Furthermore, several 
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prohibited substances, including methyltestosterone metabolites M1 and M2 failed the 
test. Despite these limitations, this dual blind screening approach covered a wide range of 
molecular features, from substances difficult to derivatise but amenable to LC-TOFMS 
(ESI), to substances difficult to ionise, but amenable to GC conditions and derivatization.  
 
3.3.1.3 Three dimensions: One-dimension of separation, two dimensions of 
detection (1SEP-2SEL)  
Further improvement in sensitivity and selectivity amongst GC-MS methods can be 
obtained by adding an additional dimension in mass spectrometry selectivity – that of 
tandem mass spectrometry (MS/MS). The coupled mass spectrometry dimensions allows 
the first mass spectrometry dimension (MS1) to serve as a mass filter for pre-defined ion(s) 
(precursors) and the second (MS2) to scan either a single or multiple product ions of the 
precursor ion(s), with the latter formed during the process of collision with a reagent gas. 
This process is termed collision induced dissociation (CID). In this way the pre-defined 
precursor ion(s), which might be a mixture of mass fragments from coeluting components 
which share common fragment ions, is ‘extracted’, filtered (at MS1) and passed to the 
collision chamber. Here further dissociation to well defined product ions (generally free 
from isotope ions since monoisotopic ions will be selected) occurs, and finally scanned (at 
MS2) as a full mass spectrum, or through monitoring as specific product ions. Figure 3.2 
proposes how such an analysis is carried out, with Figure 3.2(A) the triple quadrupole 
example for compounds separated by the GC first dimension. Figure 3.2(B) shows that the 
ions generated by the ionisation process can be scanned or selected by SIM at Q1, 
dissociated at Q2, and then the products interpreted at Q3. Here the wavy line represents 
an ion at Q1 selected by SIM, and then two product ions of the dissociation are monitored 
at Q3. The sensitivity and selectivity is dramatically increased by monitoring only the 
expected product ions from the analyte, while rejecting the product ions of co-filtered ions 
through MS1 (i.e. having the same mass as originally selected analyte ion). This arises 
(ideally) because the primary isobaric ions from interfering compounds will have different 
structure and different CID product(s) to the target ion; specificity is obeyed provided 
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different ion structure holds. GC-MS/MS represents an extremely sensitive and selective 
method, and is often the only solution for detection and confirmation of low level of 
analytes in complex matrices such as urine, hair, meat and meat products, environmental 
samples, food etc. Kidwell [149] has reported the informing power (IP) of the GC-MS/MS 
experiment to be the greatest (~6 × 109), amongst the methods chosen for comparison; EI-
MS was the more informing technology compared with CI-MS, due to the spectral 
selectivity of the full spectral EI-MS scan. The comparative selectivity of GC (IP ~ 550 
separation ‘bits’) when combined with MS spectral matching gave IP ~ 6 × 106 for GC-MS. 
The main limitation of GC-MS/MS is the requirement for prior knowledge about the 
analyte, since it functions by choice of pre-defined precursor and product ions. Thus the 
technique is ideal for confirmation, and therefore widely accepted in doping control, food 
analysis etc.  
 
Enhanced S/N and selectivity compared to GC-MS justifies the use of GC-MS/MS in 
doping control. Whilst the sensitivity gain for GC-HRMS over GC-MS is 10-20 fold, the 
reported gain in sensitivity for GC-MS/MS over GC-MS was somewhat variable. Bowers 
and Borts [170] applied GC-MS/MS for separation and confirmation of anabolic sterols in 
urine using large volume injection (25 μL). After carefully selecting both GC and ion trap 
MS/MS conditions, a factor of 100 fold better detection for 19-norandrosterone (5 pg mL-1) 
was achieved when compared to GC-MS analysis. On the other hand, in other reports 
[171, 172] using GC-MS/MS for analysis of anabolic agents and β-blockers, the reported 
limit of detection was from 0.5 - 20 ng mL-1. The variation most likely resulted from use of 
compromise conditions required for best overall sensitivity (choice of precursor ions, CID 
conditions, selection of product ions etc.). However, it has been demonstrated that tandem 
mass spectrometry offers increased S/N, with concomitant lower detection limit for sterols 
in a complex urine matrix. Reproducible mass spectra at 1 ng mL-1 for anabolic steroids in 
urine were possible by using this technique [170]. 
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Figure 3.2 Scheme of (A) 1D GC with triple quadrupole (Q1, Q2 and Q3) mass analyser. 
Q2 provides collision induced dissociation (CID). (B) The triple quadrupole mass 
analyser can be operated either in scan or SIM modes for each Q1 and Q3. Scan-with-
scan operation is an unlikely mode, but each other mode can be employed for various 
types of method goals. Q: quadrupole. Reproduced with permission of Future Science 
Ltd [153]. 
 
Drugs analysis using GC-MS/MS has proved beneficial, in urine, saliva and hair matrices. 
Detection limits were in the range of 0.1-5 ng mL-1 for cocaine and related compounds in 
saliva, 0.4-1 ng mL-1 for amphetamines in urine and 6-52 pg/mg for drugs of abuse in hair. 
Gambelunghe et al. [173] reported successful application of GC-MS/MS in four forensic 
cases related to recent or past abuse of drugs, with analysis of different lengths of hair 
from the root providing unambiguous evidence of the drug abuse history.  
 
A coupled chromatographic separation with a 2D detection system comprising GC-
HRMS/TOFMS was applied successfully for screening and confirmation of the key 
anabolic agents in urine at a concentration from 1-3 ng mL-1 [174]. An excellent S/N in full 
scan MS2 mode was supported by the high acquisition rate of TOFMS. The authors 
reported this system to be useful for confirmation, when the signal was close to the 
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detection limit of GC-HRMS, and justified the addition of the extra dimension to the 
detection system.  
 
However, coelution of components which share the same fragment masses (possibly 
produced by the same fragmentation process) may still occur on the chromatographic 
column, especially where the complex matrix comprises components similar in structure 
(sterols/metabolites in urine and blood; PAHs in urban air; PCBs in environmental 
samples, etc.). Measuring a minor amount of analyte in highly complex matrixes is still a 
challenging task even for the most selective detection systems and further 
chromatographic separation is highly desirable. Bowers and Borts [170] stated that none of 
the five tested columns with different selectivity was able to separate all of the tested sterols 
(epimers, isomers, isobaric compounds), and so required the more highly selective 
detection system of tandem mass spectrometry.  
 
3.3.1.4 Four Dimensions: One dimension of separation; three dimensions of 
detection (1SEP-3SEL)  
The group of Bowers and Borts [170] have used GC tandem MS to further fragment the 
unusually stable m/z 545 ion from 3’OH-stanozolol, derived from the fragmentation 
process and selected in MS2. After isolation and storage of this ion, a further CID voltage 
waveform was applied, producing fragmentation of that ion to yield a second generation 
mass spectrum (MS3). In this way an additional dimension is added to the tandem MS to 
obtain (MS/MS/MS) giving a four-dimensional technique. Notwithstanding the potential 
power of such a tool, there appears to be little routine analysis in this area so perhaps 
robustness or broad applicability remains to be proven.  
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3.3.2 Multidimensionality arising from separation (n-SEP)  
 
3.3.2.1 One dimension: One dimension of separation, no detection selectivity 
(1SEP-0SEL)  
Classical one dimensional gas chromatography (1D-GC) still occupies the majority of past 
and present separation methods, although there is both a long history of multidimensional 
separations, with more recently an increased activity in this area. Separation based on a 
single column coupled to a single, or multiple, detector(s) via splitting the effluent at the 
end of the column, may be supplemented for increased separation power by using two 
separate – or parallel – columns of different phase, or longer and/or narrower I.D. 
columns. There is a singular aim in this work – to achieve better resolution of components. 
This usually increases the separation time, but there is a diminishing advantage when 
increasingly complex mixtures have to be analysed, at lower levels, with major component 
interferences. To overcome the many coelutions in the chromatogram, which is 
unavoidable due to the peak capacity limitations of a single column, off-line purification 
and concentration steps can be developed, leading to simpler chromatograms, increased 
resolution, and greater S/N. These extra steps are time-consuming, operator intensive, may 
involve use of toxic solvents or expensive equipment, and can introduce extra 
contaminants or involve critical component losses especially in trace analysis. Ultimately, 
these steps may have little success. A new paradigm may be required. Hyphenated with a 
non-spectroscopic detector, the information content is likely to be incompatible with 
component identification needs, and so for all but the simplest analysis, alternative 
methods must be sought.  
 
3.3.2.2 Two dimensions: Two dimensions of separation, no detection selectivity 
(2SEP-0SEL)  
The obvious question is whether a coupling of two techniques of the same type, like GC to 
GC or LC to LC, can be considered as a multidimensional technique or just a hyphenated 
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technique? Or maybe we have to ask ourselves if the coupling of two techniques of the 
same type is hyphenation? We would argue that the multidimensional realm can include 
the area of coupled column methods, such as comprehensive two-dimensional GC 
(GC×GC), multidimensional GC (MDGC), multidimensional LC (MDLC) etc. If 
“dimensionality” comes from the number of uncorrelated structure-specific signals, than 
the separation of the components on two orthogonal columns will fall well within this 
group. One of the most important criteria for multidimensionality is the availability of the 
reading (signal) in each dimension, and keep it as much as possible uncorrelated to the 
signal from the previous dimensions. Orthogonality of the column sets applied in MDGC 
is responsible for this criterion. 
 
According to this classification, if the separation is based on two distinct mechanisms and 
the method can be applied in a manner that permits a measure of orthogonality or 
independence of these mechanisms, then a 2D separation technique is defined. This 
approach achieves selectivity from separation alone, thus uses non-spectroscopic 
detection, however multidimensionality of detection will be an additional capability to the 
technique (see below).  
 
Several techniques comprise this group: heart-cut GC and GC×GC (explained in detail 
below), coupled to e.g. FID, NPD or ECD detectors. They usually exhibit high separation, 
but low detection confirmation power. Their application is mainly in the field of profiling 
in the petrochemical industry, essential oil analysis, or in method development. If there is 
one advantage, it is probably the price, since these detectors are usually inexpensive.  
 
Neumann et al. [175] have observed that some problems, such as inefficient separation of 
certain parts of the impurity profile of raw processed heroin samples and complete 
masking of important components by interfering matrix compound, remain unsolved 
beside the use of a highly efficient and perfectly deactivated capillary column. He has 
realized that the use of two coupled capillary columns with different polarity, as 
previously used in tobacco smoke separation [176], can solve the problem. As it was 
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expected, the three heart-cuts from the first column (SE-54) giving 6, 5 and 6 components, 
were transferred to the second column coated with a more polar OV-17 stationary phase, 
giving an increase in the number of resolved peaks (17, 13 and 12, respectively). Similarly, 
the important impurity – acetylthebaol, which was completely masked by the huge peak 
of rosin matrix on the first column, was nearly quantitatively separated on the second 
column. However, the extreme complexity of the technology involved in the separation 
has prevented the application of column-switching on a routine base.   
 
3.3.2.3 Three dimensions: Two separation dimensions, one dimension of 
detection (2SEP-1SEL)  
‘Heart-cut’ gas chromatography  
Increased separation of a region of interest in 1D GC can be obtained if the target zone 
(termed a heart-cut; H/C) is redirected to a second column with different separation 
mechanism. Usually, the transferred segment is just a minor part of the first column 
separation, so is limited in both number of H/C and duration of each sampled zone. 
Sample transfer may be achieved by a number of specialty devices – sampling valves, 
storage trapping zones, mechanical switching, and pressure-based microfluidic devices; 
the Deans switch is the most popular of these. This should achieve quantitative and 
reproducible transfer of small, unresolved pre-selected fractions of effluent from the first 
column, to the second column. The extent of separation improvement will be related to the 
magnitude (peak capacity; total number of peaks; mechanism of separation) of the 
sampled zone, to the available peak capacity and capability of the second column to 
separate the transferred components. The process will clearly demand a significant 
increase in peak capacity for the transferred zone, and although there is much application 
of MDGC in the literature of petrochemical, essential oil and environmental analysis, in 
the drugs and doping control area the number of applications do not reflect its potential 
for improved analysis. Generally there is no special requirement placed on detection 
systems in MDGC since the second column tends to be rather ‘classical’, so FID, NPD, 
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ECD, MS and IR can be connected to the MDGC. It should however be appreciated that as 
separation improves, detection methods should work better.  
 
As a demonstration of this principle, the use of heart-cut GC with olfactometry, where 
human ‘sniffers’ are used to detect ‘character-impact odorants’ allows a better correlation 
of resolved peaks with the perception of odour [177]. Human olfaction can be very 
sensitive and selective toward odour-active components, and so this detector constitutes 
an additional dimension for GC analysis. Complex mixtures of essential oils and 
component coelution lead to odour-active component assignment being difficult or 
impossible. Transfer of a narrow H/C fraction of a first dimension (1D) column effluent to 
the second dimension (2D) column allows ‘quantitative’ separation of odour-active 
components. Eyers et al. [177] employed heart-cut GC to determine odours responsible for 
coriander leaf and hop essential oil aromas. Whilst not classified as an instrumental 
technique, the human nose possesses all the hallmarks – with its sensitivity and selectivity 
attributes – of a spectroscopic detector in GC. This example demonstrates the principles of 
accelerated analysis by adding additional dimensions to the analysis. Although the 
separation efficiency of heart-cut MDGC is very high for target separation regions, 
frequent heart-cut events during a single analysis cannot be easily accommodated due to 
the time demand of each 2D analysis. This limits the gain in total peak capacity.  
 
Comprehensive two-dimensional gas chromatography  
In 1991 Phillips and Liu [178] introduced a new approach to expand the peak capacity of 
1DGC and H/C MDGC. The key to this new approach was in the use of a short, fast-
eluting 2D column, combined with a sampling strategy which was faster than the peak 
width of compounds eluting from the 1D column. The technique of comprehensive 2D GC 
(GC×GC) relies on continuous transfer of small time-fractions of effluent from 1D to 2D in a 
pre-defined time (the modulation period; PM), where PM normally ranges from 3 s to 8 s. 
Maximum retention on 2D (= 2tR(max)) should be less than PM so that all the components 
elute prior to launching the next portion of effluent to 2D. Effluent from 1D may be either 
(i) ‘sub-sampled’ with only a small portion of each peak taken via use of a diaphragm 
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valve, (ii) sampled in a differential flow modulator to collect most of the 1D peak before 
flushing it to the 2D column using a high flow rate, or (iii) refocused at the beginning of the 
2D column using a (cryogenic) interface at the column confluence which traps the effluent 
and introduces it to 2D as a narrow band. The first cryogenically driven modulator was the 
longitudinally modulated cryogenic system (LMCS, see Figure 3.3), upon which most 
cryogenic modulators available today are based, with cooling by air, or liquid N2 or CO2.  
 
The efficient trapping and fast releasing of the components is usually achieved by cryo-
focusing (CO2), producing ultra-narrow peaks at the end of the 2D column. The moving 
part of the modulator (mp on Figure 3.3) is continuously cooled down to the optimal 
trapping temperature, condensing the components in the column (going through the 
moving part) at the cooled position 1. At predefined time intervals the modulator moves 
down to position 2, leaving the trapped components at location 1 exposed to the oven 
temperature, which is usually 100-150 °C higher than the TM. This enables fast releasing of 
the trapped components onto the 2D column, followed by increased S/N due to the 
compression effect. Co-eluting components on 1D, where the separation is based on the 
first mechanism, are separated on the orthogonal 2D column, where the separation is based 
on the second mechanism.  
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Figure 3.3 Schematic presentation of GC×GC system with LMCS based modulator 
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The GC×GC format for data collection and transformation is presented schematically in 
Figure 3.4. Each 5 s modulation slice of 1D effluent, represented by the series of vertical 
lines in B, is trapped and released on 2D column and this is represented as a narrow band 
spot in B. Four modulation slices are observed for the first eluting peak in 1D (B) and only 
2 slices for the second peak, which coelutes with the former in 1D (B), but is completely 
separated in GC×GC format (A). The most interesting case is the last eluting component in 
1D, where GC×GC reveals a minor peak completely overlapped by the major peak. This is 
due to the separation of these two components on the 2D column, which is preferably 
orthogonal to the 1D. The signal height is usually described by different colours, each 
representing different response magnitude. Note that the y-scale in A is 5 s only, the same 
as the modulation period.  
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Figure 3.4 1D GC chromatogram peak modulation and GC×GC data format 
transformation and presentation to a so called 2D plot.  
 
Narrow peaks obtained at the end of the separation process (width at half-height ~ 50-150 
ms) require fast detection for adequate quantification. Normally, acquisition rates of 20+ 
Hz is required, and requirements for GC×GC detection have been reviewed [179]. The 
overall separation power will depend on orthogonality exhibited by the two columns, thus 
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their separation mechanism. One common variant is to employ a non-polar (NP) 1D 
column phase, then a polar (P) 2D phase. Thus two co-eluting components on 1D will have 
similar volatility, and provided they sufficiently differ in their ‘polarity’, they will be 
separated by the 2D column. The total analysis time should be similar to that of 
conventional GC, since the 1D column approximates a conventional column; Junge et al. 
[180] demonstrated fast analysis (5 min) for allergen compounds by using GC×GC. It is 
proposed that some off-line sample purification steps applied in 1DGC may no longer be 
required, since peak overlap in 1DGC can be compensated by the greater component 
separation in GC×GC, thus increasing overall sample throughput [181]. The maximum 
overall peak capacity is often reported as 1n × 2n, with components separated over the time 
plane defined by 1D and 2D retention times. This should facilitate sample-to-sample 
comparison or fingerprinting. In addition, since various classes of substances related by 
structural features and/or property (homologues, congeners) are positioned on the plane 
according to their structure, this generates ‘structured chromatograms’ in ways that are 
not possible in 1DGC. Signal-to-noise ratio enhancement arising from cryogenic 
compression of the sample band at the modulator is another benefit, which, when 
considered with resolving power of GC×GC makes the identification of individual 
components more secure.  
 
Quadrupole MS (GC×GC-qMS) and TOFMS (GC×GC-TOFMS) have both been reported 
for detection in GC×GC. More recently, Tobias et al. [182] have applied isotope-ratio MS 
(IRMS) methods to the GC×GC experiment. However, the relatively slow scanning or 
sampling capabilities of qMS when applied in full mass scan mode limit its suitability for 
quantitative data acquisition in GC×GC. Selected ion monitoring (SIM) decreases the MS 
duty cycle, but only for a small number of selected ions. Narrow mass range scanning 
with qMS [183] was used to increase sampling rate for an essential oil, and Song et al. [184] 
employed the same strategy with GC×GC-qMS for separation and detection of 77 drugs 
with reduced mass scan range to obtain greater scan speed. Omitting the molecular ion 
was shown to hinder similarity matching against the MS library. Use of GC×GC-qMS in 
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doping control for horse racing analysis [185] was shown to increase peak height and 
reduce interference ions in the spectrum, when compared to classical GC-qMS.  
 
High data acquisition rates of TOFMS (up to 500 spectra/s) improves compatibility with 
GC×GC [162]. This high ‘data density’ supports peak deconvolution capabilities, where 
coeluting peaks differing in retention maxima by only a few scans can be reliably detected. 
This additional feature is still available in GC×GC analysis, with residual unresolved 
peaks deconvoluted to provide identification. Recent work to assess applicability of 
GC×GC-TOFMS for endogenous sterol analysis and metabolites compared results with 
GC-TOFMS [186]. An increase of 30 fold in signal height arising from signal modulation 
was gained in the GC×GC-TOFMS experiment, when using the same acquisition rate. This 
produced ~ 1 order of magnitude lower limit of detection. Two additional criteria for 
component identification were proposed when compared to 1D GC at the low detection 
limits required: 1) retention time matching in the 2D space, and 2) full mass spectral 
similarity. For example, estrone was detected in the free fraction in urine at a 
concentration of 0.1 ng mL-1 with a similarity of 940 (on a scale from 0-999). At this level, it 
is normally necessary to employ SIM methods, and so conventional library matching is not 
possible. Since GC×GC-TOFMS spectra of sterols differ sufficiently from the commercial 
quadrupole based MS spectra, this justified creation of an in-house TOFMS database. It 
was also concluded that GC×GC offers much higher similarity against in-house TOFMS 
spectra than 1D GC, under the same conditions, due to increased ion abundance. 
However, the most critical benefit of using GC×GC-TOFMS remains the separation of 
components on the 2D plane. The separation of analytes from each other, from the matrix, 
and from column bleed at higher elution temperatures all benefit from the additional 
separation dimension.  
 
In the area of doping control analysis by using GC×GC-TOFMS, Silva et al. [187] showed 
improved signal response and separation compared to GC-MS. Similar conclusions were 
achieved in the work [188], extending the research on separation optimization, mass 
spectral similarity, quantification and compliance to World Anti-Doping Agency (WADA) 
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identification and detection limit criteria. Thus coelution of components with similar 
structure and fragmentation pattern can occur when using 1D GC, while they are 
successfully separated using GC×GC (Figure 3.5). Better separation was obtained by using 
a thicker second dimension column film thickness (0.2 μm). Examples of coelutions on the 
1D column include an endogenous component with clenbuterol for extracted ion m/z 86 
(but not at m/z 335), and the coelution of an endogenous component with 
methyltestosterone metabolites for extracted ion m/z 255. In each case they are baseline 
separated on the 2D column in GC×GC.  
 
Differences noted between TOFMS and quadrupole MS spectra compromises the choice of 
ions for 1D (qMS) and GC×GC (TOFMS) analysis. While the most abundant ions in the 
qMS of the majority of sterols are at the higher masses, the relative abundance of the 
higher mass fragments in TOFMS spectra are often dramatically reduced. Since 
quantification ions are preferably higher mass ions, this reduces the apparent sensitivity of 
TOFMS. However, this observation is compensated by component refocusing on the 2D 
column in GC×GC, giving narrow and tall peaks. Since the quality of mass spectra 
depends on the ratio of ions originating from the component over other ions originating 
from the matrix or column bleed, better differentiation of components is highly desirable. 
 
sep
ara
tion
coelution
 
Figure 3.5 Extracted ion three dimensional plot for 19-norandrosterone, showing its 
coelution on 1D with an endogenous component with similar mass fragments. (A) 405 
m/z and (B) 420 m/z. Note that these two mass fragment are the most characteristic for 
19-norandrosterone [153]. Reproduced with permission of Future Science Ltd. 
 
Song et al. [189] applied GC×GC-TOFMS to drug analysis, where improved separation, 
sensitivity and identification were obtained, compared to GC-qMS. It was shown that the 
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method exhibits a good linearity (R2 in the range 0.978-0.998) and precision. The latter was 
confirmed by quantification of diazepam in a real forensic blood sample, where the same 
indicative concentration was obtained as that with a well established GC-NPD method.  
 
Recently, a comprehensive two-dimensional gas chromatography was applied for 
separation of impurities in heroin samples and pixel-based PCA was used for 
chemometric processing [190]. Twenty-one heroin samples were classified in several 
groups, depending on the cutting level of the dendrogram obtained from the pixel-based 
analysis. The grouping has been found to match the results from the well-established 
comparative studies and/or the forensic background of the samples. In addition, the most 
discriminating components can be selected according the Fisher criteria and subsequently 
can be used as markers for analysis of future illicit drug seizures. Even though the study 
was based on the data of minor component analysis (impurity profiling) only 9 
components were taken for calculations. The authors stated that the rest of the 16 
components used by some criminal police authorities in Europe were not found in the 
samples or there were no spectra accessible. According to the author’s experience in using 
time-of-flight mass spectrometry (TOFMS) as a detector in GC×GC, the missed 
components can be partially contributed to the observed differences in the TOFMS spectra 
when compared to the quadrupole based entries in the commercial MS libraries (NIST05, 
Wiley7) [186]. However, the study represents a new way of improvement of the quality of 
GC data, based on separation of the components on two orthogonal columns. At the 
author’s best knowledge, this is probably the most remarkable step in heroin profiling and 
generally, in drug profiling. The research should be extended to more heroin samples in 
order for the results to be generally applicable.  
 
3.3.2.4 Four dimensions: Three separation dimensions, one dimension of 
detection (3SEP-1SEL)  
Watson et al. [191] have developed a three-dimensional gas chromatographic separation 
system by coupling three columns in series, interfaced by two six-port diaphragm valves. 
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Another example is the work of Edam et al. [192], where LC-GC×GC was applied for 
characterisation of complex petrochemical samples. In both cases an FID detector 
provided identification of separated components, although TOFMS can be applied to form 
a real four dimensional technique. Whether such a system provides improved separation 
power in a procedure that can usefully implemented in practice is still to be demonstrated, 
considering also the novel presentation formats needed of such a system.  
 
3.3.2.5 Four dimensions: Two separation dimensions, two dimensions of 
detection (2SEP-2SEL)  
Improvement in multidimensional methods will continue in future, for instance, the 
combination of multidimensional separation capabilities with multidimensionality in the 
detection system. The use of MDGC with MS/MS would seem logical, but GC×GC coupled 
with MS/MS would present a more technically challenging task. Whilst there is no 
reported case of such a combination, coupling GC×GC or H/C GC to the tandem MS 
experiment seems a likely development. Such a future technique will probably combine 
the relatively high acquisition capabilities of a filter type MS1 (preferable HRMS, but more 
likely qMS) coupled in tandem with full scan MS2 (probably TOFMS) as a detection 
system. In combination with enhanced separation power of GC×GC, this real four-
dimensional technique (GC×GC-HRMS/TOFMS) will represent best detector selectivity 
with best separation power. 
 
 
3.4 CONCLUSIONS 
 
Gas chromatography has a rich and extensive history in the study of drugs, natural 
products, and compounds derived from biological processes. The multidimensional GC 
tools (GC-MS, GC-TOFMS, GC-MS/MS, GC-HRMS, MDGC-MS, GC×GC-TOFMS) that are 
currently available to the analyst for drugs and metabolic profiling are mature and flexible 
enough to allow for their widespread use in the study of biochemical processes. 
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Whilst the emerging GC×GC technique has thus far shown encouraging results, albeit for 
limited applications studies, it should play a major role in future drugs and metabolic 
profiling. Current applications in GC×GC still address basic tasks such as optimization of 
various hardware configurations, development of software tools which provide the 
capacity to handle large data sets produced by high-resolution instrumentation, and MS 
detection protocols.  
 
The availability of a more complete drugs and metabolite complement of isotopically 
labelled standards would assist in quantification. Whilst dedicated MS libraries are 
available, construction of more comprehensive databases continues. This progressive 
development suggests that more work is still required for precise peak identification. 
GC×GC may assist through 3-dimensional correlation of 1tR, 2tR and MS data, along the 
lines of present retention index / MS spectral matching in 1D GC-MS. 
 
Multidimensionality, arising from both detection dimensionality and separation 
dimensionality, leads to more selective determination. Detection selectivity focuses on 
detection precision, usually by making it increasingly ‘blind’ to the matrix, and sensitivity 
by improving signal-to-noise, whilst  method separation focuses on the separation 
efficiency with an aim to resolve more components. This generally increases the method 
accuracy and precision, and the gross number of components separated, detected and 
quantified. The ideal technique should be, as a logical consequence of the above, the most 
powerful separation technique coupled to the most selective and sensitive detection 
system. The search for such a system is still in progress. 
  
 
 
 
 
 
 
 
Chapter 4 
 
4 APPLICATION OF COMPREHENSIVE TWO-
DIMENSIONAL GAS CHROMATOGRAPHY TO 
ENDOGENOUS STEROLS ANALYSIS 
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4.1 INTRODUCTION 
 
The analysis of sterols is challenged by their usually low concentration in samples, and 
complex matrices in which they are found. It requires extraction/pre-concentration, 
followed by a separation technique, normally chromatographic, coupled to a sensitive and 
selective detector, such as mass spectrometry (MS). Complexity of samples, as well as low 
level analytes, and the need for precise results demands best possible identification and 
quantification.  
 
Sterols are important for a number of reasons. The occurrence of estrogenic sterols in 
surface water is environmentally important. Endocrine-disrupting chemicals (EDC) can 
interfere with the function of the endocrine systems in humans and animals, and estrogen 
sterols are one of the most obvious and important of these. Concentrations may be low 
(ng L−1), but can be sufficient to interfere with the normal reproduction and development 
of wildlife [193]. Naturally produced estrogens such as estrone and 17β-estradiol, are 
mainly released in water by inefficient removal from waste-water treatment plants 
(WWTPs), where they are found in humans and livestock excreta [194]. 
 
Many sterols indicated as estrogens, gestagens and androgens (EGAs) are forbidden in 
products of animal origin due to the possible toxicological effect on consumer's health 
[195]. The minimum required performance limit (MRPL) of the methods for analysis of 
these banned hormonal growth promoters is as little as 2 μg L−1, as reported in the Italian 
Monitoring Plan [196]. Plasma or urine levels of some sterols can be used as a marker of 
biosynthesis deficiency [197]. 
 
The desire for maximum athletic performance in sporting arenas, in addition to social 
recognition and financial rewards, leads some competitors to use performance enhancing 
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drugs. Among the most important are anabolic steroids similar in structure and activity to 
the male hormone testosterone. They are used by competitors to improve muscle mass and 
to accelerate recovery times after strenuous exercise [198]. Because of this, they are banned 
in sport competition, and the MRPL for the method of analysis defined by the World Anti-
Doping Agency (WADA) is set at 2 ng mL−1 [133]. 
 
The separation power of gas chromatography (GC) combined with the selectivity offered 
by mass spectrometry (MS) detection, makes GC-MS the method of choice for sterols 
analysis. Methods such as solid phase extraction (SPE) and liquid/liquid extraction (LLE) 
are applied prior to analysis to effect a concentration step since sterol concentration is 
usually very low. Most of the sterols and their metabolites are polar compounds 
containing one or more functional groups (-OH, >C=O, -COOH). In order to decrease 
polarity and to increase volatility and thermal stability of sterols, derivatization can be 
applied. Of the derivatization reagents available, BSTFA [193, 194, 199, 200] and MSTFA 
[139, 194, 195, 200-202] are the most common; trimethylsilyl (TMS) derivatives of sterols 
are stable, giving informative fragmentation ions under positive electron ionization (EI). 
This allows identification and quantification of sterols in complex matrices at a low 
concentration, if sufficient separation from chemical noise is achieved. 
 
Comprehensive two-dimensional gas chromatography (GC×GC) has proved to be 
advantageous over conventional gas chromatography (1D GC) in terms of greatly 
increased peak capacity (separation power), signal-to-noise ratio enhancement, and it also 
offers unique structured chromatograms when structurally related classes of substances 
(analogues, congeners, isomers) are analysed. Principle of operation of this technique is 
given in Chapter 3 (section 3.3.2.3). This technique has been successfully applied in many 
areas, including petrochemicals [179, 201], essential oils [168, 180], food analysis [204, 205], 
environmental [202-204], forensic [189, 205] amongst others. Our pilot study on 
application of GC×GC-FID in endogenous sterol analysis [186] showed an increased 
separation power over 1D GC and signal enhancement of up to 35-fold. A previous study 
of derivatized environmental steroids, including steroids derived from the gut such as 
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coprostanol [206], revealed nine detectable faecal sterols of interest in GC×GC instead of 
five incompletely resolved in 1D GC. 
 
The present study investigates the applicability of GC×GC coupled to both flame 
ionization (GC×GC-FID) and time-of-flight mass spectrometry (GC×GC-TOFMS) detectors 
for analysis of 27 endogenous sterols in human urine. LLE of the free sterols fraction and 
derivatization with N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA) were performed 
prior to analysis. Comparison between 1D GC and GC×GC in terms of separation 
efficiency, sensitivity and identification power of TOFMS detector are reported. 
 
 
4.2 EXPERIMENTAL 
4.2.1 GC×GC-FID 
 
The gas chromatograph, equipped with a flame ionisation detector (GC×GC-FID), used in 
the study was an Agilent 6890 system (Palo Alto, CA, USA) with a Longitudinal 
Modulation Cryogenic System (LMCS, Chromatographic Concepts Pty Ltd., Doncaster, 
Australia). Two column configurations were used with this system, differing only in the 
length of the 1D column: (1) 30 m length of BPX5 phase, 0.25 mm I.D., 0.25 μm film 
thickness (df) as a first dimension column (1D) coupled to a 1 m length of BPX50 phase, 
0.1 mm I.D., 0.1 μm df as a second dimension column (2D); and (2) the same configuration 
as (1) except the column length of 1D was 18 m. These column sets will be abbreviated as 
NP/P and NP(s)/P respectively according to the non-polar, non-polar (short), and polar 
phase nature of the column sets. All columns were from SGE International, Ringwood, 
Australia. Oven program for the first system was from 240 °C to 270 °C at 2 °C min−1, then 
to 320 °C at 4 °C min−1 (hold for 10 min), and for the second system was from 240 °C to 
260 °C at 2 °C min−1, then to 320 °C at 10 °C min−1 (hold for 5 min). The injector and 
detector temperatures were 320 °C and 330 °C, respectively, and the sampling frequency 
was 100 Hz, both for GC and GC×GC. Hydrogen was used as a carrier gas at a flow rate of 
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1.2 mL min−1 for (1) and 1.0 mL min−1 for (2). The modulation period was varied from 3 s to 
6 s, and temperature of the modulator system (TM) from 50 °C to 170 °C, during the 
optimization study. CO2 was used as a coolant in the LMCS and nitrogen as a flush gas at 
a pressure of 15 psi. The modulator in GC×GC operation was commenced at a time from 
2 min to 5 min prior to the elution of first sterol, and turned off after the elution of the last 
sterol. Agilent ChemStation was used for data acquisition and processing. 
 
4.2.2 GC-qMS 
 
The gas chromatography–quadrupole mass spectrometry system (GC-qMS) consisted of 
an Agilent model 6890 GC, coupled to a model 5973 MS detector with fast electronics 
upgrade. A single 30 m long BPX5 column (0.25 mm I.D.; 0.25 μm df) was used for 
separation of sterols. Oven program was from 200 °C to 250 °C at 2 °C min−1, then to 
320 °C at 4 °C min−1 (hold for 15 min). The injector was set at 320 °C, transfer line at 280 °C 
and ion source at 230 °C. The scanning mass range was from 45 m/z to 650 m/z at applied 
electron ionisation voltage of 70 eV. Data acquisition and processing was done by Agilent 
MSD ChemStation software. 
 
4.2.3 GC×GC-TOFMS 
 
A LECO time-of-flight (TOF) mass spectrometer model Pegasus III (LECO Corp., St. 
Joseph, MI, USA) connected to an Agilent 6890 GC was used in GC×GC-TOFMS 
experiments. The modulator was a LMCS system, and subsequent to optimization, the 
cryotrap was operated isothermally at 120 °C and the modulation period was 5 s. Two 
column configurations were used in this experiment: the first was the same as (1) listed for 
GC×GC-FID analysis above, and the second was 30 m BPX50 (0.25 mm I.D.; 0.25 mm df) as 
1D and 1 m BPX5 (0.1 mm I.D.; 0.1 μm df) as 2D column (the latter referred to as a P/NP 
set). Oven program for the first column configuration was from 240 °C for 1 min, increased 
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to 260 °C at 2 °C min−1 then immediately increased to 320 °C at a rate of 10 °C min−1 (hold 
for 10 min). Data collection rate was 100 Hz over the mass range from 45 m/z to 570 m/z. 
 
The oven program for the second column configuration was adjusted for splitless 
injection, so the starting oven temperature was 80 °C, hold for 1 min, increased to 240 °C at 
40 °C min−1, increased to 260 °C at 2 °C min−1, and finally increased to 330 °C at a rate of 
6 °C min−1 (hold for 5 min). Helium was used as a carrier gas in both methods at a flow 
rate of 1.5 mL min−1. The temperature of injector, transfer line and ion source were 300 °C, 
280 °C and 230 °C, respectively. The detector was operated at 1550 V, and applied electron 
ionisation voltage was 70 eV. Data collection rate was 50 Hz over the mass range from 
45 m/z to 570 m/z. A separate GC×GC-TOFMS based library was generated for 
identification purposes. Data acquisition and processing were performed by ChromaTOF 
software (LECO Corp., St. Joseph, MI, USA). 
 
 
4.3 RESULTS AND DISCUSSION 
4.3.1 Derivatization of sterols 
 
The efficacy of the derivatization procedure was checked by running the derivatized 
individual sterols on the GC-qMS system. For their names and annotations see Chapter 2 
(section 2.1.1). All of the estranes (2, 5, 15), cholestanes (14, 16, 18, 19) and androstanes 
(except 8) gave single products with no measurable amount of partially-derivatized or 
underivatized products. 8 gave two products (mono- and di-TMS), with the mono-TMS 
favoured in an approximate 2.5:1 ratio at 80 °C. When temperature and/or time of 
derivatization are increased the ratio is decreased, but mono-TMS was detected in 
measurable amount under all experimental conditions applied. In respect of derivatized 
pregnanes, a single product was obtained only for one sterol (20), with multiple products 
for four (21, 22, 23, 25), and three pregnanes gave low or no signal at all (24, 26, 27). 
Because of this pregnanes were excluded from the experiments dealing with urine. 
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4.3.2 GC×GC-FID separation and identification 
 
The GC×GC separation of the standard mixture of sterols was initially accomplished by 
GC×GC-FID using column configuration NP/P, where modulation period and modulator 
temperature (TM) were optimized. An acceptable separation was achieved in 32 min 
(Figure 4.1a.), at 5 s modulation period, but the best modulation temperature was found to 
be dependent on retention time of the sterols and presumably their boiling points.  
 
 
Figure 4.1 GC×GC-FID separation of (a) 27 BSTFA derivatized sterols on a 30 m BPX5 / 
1 m BPX50 column set. The small dots (minor components) are partially-derivatized 
pregnanes; (b) 19 derivatized sterols on 18 m BPX5 / 1 m BPX50 column set. Good 
separation is achieved in almost 16 min. 
 
Generally, it was found that increasing retention time of sterols accompanies their 
optimum TM being shifted towards higher temperature. Using column configuration 
NP(s)/P, the TM study involved analysing a standard mixture of sterols at isothermal 
modulation temperatures of 50 °C, 80 °C, 110 °C, 130 °C, 150 °C and 170 °C. The curves in 
Figure 4.2 show the influence of TM on peak widths, and their direct effect on the 
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selectivity and sensitivity. The narrowest peak width for the first eluted sterol (1) with a 
retention time of 4 min is obtained at 50 °C, but for the last eluted sterol (19) with a 
retention time of 16 min, the best TM is found to be 170 °C. For the rest of the sterols the TM 
producing narrowest peak widths tends to increment proportionally with retention time 
of sterols. 
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Figure 4.2 The influence of modulator temperature (TM) on peak width for 1 
(androstanol), 6 (DHEA), 21 (pregnatriol) and 19 (cholesteryl butyrate). 
 
By applying a TM program from 80 °C to 160 °C (in four steps incremented by 20 °C), good 
separation for all sterols was achieved in only 16 min (Figure 4.1b), with negligible 
reduction in the separation achieved on the 1D column compared to the separation on the 
30 m BPX5 column (column configuration NP/P). Fine “tuning” of the modulation 
temperature was then tested by running the same sample using a modulation temperature 
program which tracks the oven temperature program, with a differential of −120 °C, 
−140 °C, −160 °C and −180 °C. The best peak shapes were achieved by tracking the oven 
temperature program by about −160 °C. Presently, the only way to set the TM is by tedious 
manual adjustment. From these results, an automated method of tracking the oven 
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temperature at a given differential setting appears desirable, and a method for this is 
presently being evaluated. However, by setting the TM isothermally at 120–130 °C a 
compromise can be achieved for best sterol peak shapes using this column configuration 
(see Figure 4.2). 
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Figure 4.3 2D plot of 12 androstanes separated on a 30 m BPX5 / 1 m BPX50 column set. 
The peaks are presented at only 2 pA from the baseplane, showing almost no peak 
tailing or fronting. Peak 8* is that for the respective mono-TMS sterol. 
 
The GC×GC separation that can be achieved may be compared to conventional 1D GC 
separation, where no modulation is applied. Two completely overlapping pairs of sterols 
predicted to arise in the 1D chromatogram of the 12 androstane standard mixture on a 
30 m BPX5 phase (Figure 4.3) occur at 15.0 min (9 and 11) and 16.8 min (13 and 17). They 
can be successfully separated in GC×GC, under the same chromatographic conditions, 
accompanied by dramatic enhancement of the signal. Here, on average, a 30-fold increase 
of signal height is observed in GC×GC compared to 1D GC, under the same 
chromatographic conditions (see Figure 4.4). Note that the split ratio in GC×GC is 50:1, 
compared to 20:1 in 1D GC. A peak width at half height of 60 ms to 100 ms and nearly 
ideal peak symmetry is obtained when the optimized TM program is applied. The 
androstanes peaks in the 2D plot in Figure 4.3 are presented at only 2 pA response above 
the baseplane, exhibiting almost no peak tailing, nor fronting.  
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Figure 4.4 Chromatograms of 12 derivatized androstanes on (a) 1D GC-FID and (b) 
GC×GC-FID. For GC×GC analysis, the split ratio was increased by 2.5 times. The insets 
show the two pairs of co-eluting broad sterol peaks in 1D (# and *, and $ and &, 
respectively), which are completely resolved in GC×GC analysis. Note that about three 
modulated peaks are obtained for each sterol under GC×GC operation. 
 
Whilst peak tailing may be observed when the temperature of the modulator is too low 
and peak fronting occurs for non-overloaded peaks when the temperature of the 
modulator is too high (Figure 4.5), it was found that, provided TM is optimized, the 
sensitivity of GC×GC-FID approaches the sensitivity of GC-qMS in SIM mode when 
multiple ions are monitored. Where sterols are well resolved from the chemical noise in 
GC×GC, the sensitivity is further improved and does not suffer the sensitivity loss of GC-
qMS (SIM mode) when many ions are selected to monitor many compounds 
simultaneously. However, the lack of identification power of the FID detector limits its 
applicability in sterols analysis in complex mixtures, since the analyte signals may be 
impossible to assign amid the much higher signals from the matrix. The retention time 
window, now locked by 1D and 2D retention times, can give information of the possible 
presence of a particular sterol, but confirmation is still required, or at least, desirable. 
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Figure 4.5 Part of a GC×GC-FID chromatogram showing the separation of 14 sterols 
using non-optimized isothermal modulation temperature (a) at too low TM (−5 °C), (b) at 
too high TM (175 °C) and (c) at optimized TM (programmed from 100 °C to 150 °C). 
 
4.3.3 GC×GC–TOFMS separation and identification of sterols 
 
Knowledge about sterol separation, the 1D and 2D retention times, and optimized 
conditions from the above studies, were used in subsequent GC×GC-TOFMS experiments. 
Conditions were focused on maximising sensitivity, so 3 μL splitless mode injections were 
made in order to establish lower limit of detection. A 50 Hz data collection rate was 
adequate for proper peak shape, identification and for maximum sensitivity, since higher 
sampling rate will decrease S/N magnitude (acquisition rate ∝ N0.5). 
 
Separation of the standard mixture of BSTFA derivatized sterols at a concentration of 
10 μg mL−1 on the NP/P column configuration (BPX5/BPX50) is shown in Figure 4.6a. This 
column configuration showed better separation, with no co-elution, when compared to the 
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separation of sterols on the P/NP column configuration (BPX50/BPX5), shown in Figure 
4.6b, where three co-elutions are observed (4/3, 7/6, 12/11). Whilst better spread of sterols 
is obtained on the former column set, unfortunately it is accompanied by poorer peak 
shape. The average peak width (at half height) on the NP/P configuration is almost 300 ms, 
but for the P/NP column configuration the average is only 120 ms. Because of this, the 
second column configuration was chosen for further experiments, which then focused on 
maximizing sensitivity. Since mass spectral selectivity is determined by choice of the 
proper extracted ion(s) from the full mass spectra offered by TOFMS detection as 
established by spectral information, this parameter is consistent from 1D to 2D operation.  
 
 
Figure 4.6 GC×GC-TOFMS separation of (a) 27 derivatized sterols on BPX5/BPX50 
column set and (b) 19 derivatized sterols on BPX50/BPX5 column set. 
 
For the P/NP column configuration, a peak table (Table 4.1) with the 1D and 2D retention 
times was created, and a GC×GC-TOFMS laboratory-based mass spectral library of all 
BSTFA-derivatized sterols was generated using TOFMS spectra. This in-house library was 
tested for searching and identification purposes in subsequent experiments. Library 
spectra were recorded from an extract of spiked water samples with sterols at a 
concentration of 20 ng mL−1, except for IS (100 ng mL−1) and cholesterol (10 μg mL−1). 
GC×GC of endogenous sterols 
 131 
 
An approximate inversion of position of the sterols within the 2D plot is obtained for the 
two column configurations. For instance 17 has the greatest retention time when BPX50 is 
the 2D column, but has the least retention time when BPX5 is the 2D column. More 
revealing is the relative positions of 10, 13 and 15 when the column configuration is 
inverted. Taking the example of 15, this component is assumed to be more polar since it 
elutes later on the polar BPX50 2D phase. Consequently, in the inverted configuration 
column, it will be more strongly retained when the BPX50 phase is used as the 1D phase, 
being retained to a higher elution temperature. This results in 15 being poorly retained 
when the BPX5 low polarity phase column is used in 2D. To a first approximation, the 
relative position of steroids in the second dimension may be expected to depend upon the 
number of derivatized hydroxyl groups, and the presence of keto functional groups on the 
macrocycle. Since the BPX5/BPX50 column set comprises a more polar second column, the 
more polar steroid should elute later in this dimension. It appears that the number of 
derivatized hydroxyl groups does not affect too greatly the relative 2D position, but as 
more keto functions are added, retentions in 2D increase. In the inverted polarity set, and 
using data from Table 4.1, the average 2D retention for sterols with one hydroxyl and no 
keto group is 1.90 s. For sterols with one hydroxyl and one keto group it is 1.77 s, but 
sterols with two hydroxyl and one keto groups it is 2.05 s, and those with two keto groups 
it is 1.56 s. Results in Figure 4.6 demonstrate that position inversion with functional group 
composition is apparent when the two different column sets are used. 
 
After identification of all derivatized sterols on the 2D plot, creating a peak table and 
recording a TOFMS based library, next experiments involved the separation and 
identification of sterols in urine. The data processed chromatogram of the 100 μL blank 
urine extract from 5 mL urine showed about 2000 peaks (data not shown) at a peak width 
threshold of 50 ms and a minimum signal-to-noise ratio (S/N) threshold of 10. The peaks 
prior to the retention time of the first eluting sterol, and just after the last eluting sterol, are 
excluded in this number of matrix peaks. 
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Table 4.1 Peak table of sterols by using GC×GC-TOFMS on BPX50/BPX5 column 
configuration, with S/N for selected m/z ion value, LOD, match quality and peak width 
at half height indicated. 
LOD 
Sterol 1tR (s) 2tR (s) conc. 
(ng mL-1) 
m/z S/N 
match 
(TOFMS) 
W1/2 
1 690 1.72 0.25 333 20 946 100 
2 750 2.20 0.25 S 29 951 120 
3 945 1.82 0.25 216 14 953 88 
4 950 1.88 PB 75 156 958 90 
5 1040 2.00 0.25 285 24 928 88 
6 1045 1.82 PB 129 (360) 272 (11) 942 92 
7 1050 1.80 0.5 347 26 878 100 
8 1050 2.02 1.0 156 67 978 100 
IS 1055 2.20 - - - - - 
9 1070 1.82 0.5 257 14 978 95 
10 1105 1.98 0.5 214 95 923 100 
12 1120 1.74 PB 232 252 951 79 
11 1125 1.70 1.0 73 254 918 90 
13 1160 1.78 0.5 73 120 974 117 
14 1180 2.06 PB 217 89 927 97 
15 1215 1.56 0.1 342 18 940 77 
17 1355 1.42 PB 368  242  933 120 
16 1360 2.06 0.5 91 77 964 97 
18 1455 2.00 PB 129 243 965 104 
19 1675 2.00 1.0 71 (368) 38 (14) 968 106 
PB: present in the blank; S: sum of 225 masses, chosen by the software. 
* The LOD concentration reported is the lowest concentration of the spiked standard in urine for which the 
match statistic exceeds 800. This ensures that the library match is still adequate to provide reasonable 
certainty of peak identity, at the concentration given. 
 
4.3.3.1 Location of sterol peaks in 2D total ion and extracted ion plots 
The complexity of the endogenous background in the 2D total ion current (TIC) plot of the 
spiked urine extract (2 ng mL−1) obscures most of the sterol peaks, apart from a few that 
are well separated from the matrix (Figure 4.7). The internal standard (IS) alone is clearly 
visible since its concentration (100 ng mL−1) is about 50 times higher than the sterol 
concentration.  
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Figure 4.7 GC×GC-TOFMS separation of spiked urine extract with sterols at 
concentration of 2 ng mL−1 (a) and (b) inset showing the location of 5, 6, 7, 10, 11 and 14 
in the 2D TIC plot. Note that the endogenous compounds are much higher levels than 
the spiked sterols. 
 
Much more specific information can be obtained from extracted ion queries of the full scan 
TOFMS data, facilitated by the strong signal response obtained with prior separation by 
GC×GC. The full mass spectra capability provided by TOFMS allows choice of any ion in 
post-analysis data processing, for example according to the best selectivity and/or the best 
sensitivity. In the extracted ion chromatogram for 5 (416 m/z; M+•), only one peak in the 
spiked urine extract of sterols at a concentration of 2 ng mL−1 appeared, whereas no peaks 
are observed in the blank urine sample (data not shown). However, in the extracted ion 
chromatogram for 360 m/z, characteristic for testosterone (13), epitestosterone (12) and 
dehydroepitestosterone (DHEA) (6), more peaks appeared than those from just these three 
sterols (data not shown). Furthermore, if a more common and abundant ion for most of 
the sterols is chosen, e.g. 129 m/z, even more peaks are observed in the chromatogram.  
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Finally, if 73 m/z ion is chosen, (a diagnostic ion for TMS derivatives) all TMS-derivatized 
sterols and at least all TMS-derivatized endogenous compounds will appear in the 
extracted chromatogram. Usually, the 73 m/z ion is the most abundant ion in the mass 
spectra of BSTFA-derivatized sterols, but at the same time the 73 m/z ion is not such a 
unique ion and so the extracted ion chromatogram of 73 m/z ion is more complex. Figure 
4.8 displays selected extracted ions from the TIC data, to illustrate a particular sterol as 
indicated in the caption. 
 
 
Figure 4.8 Extracted ion chromatogram (a) and extracted ion 2D plot (b) for 347 m/z (5α-
androstan-3β-ol-17-one) of spiked urine sample with sterols at 2 ng mL−1, demonstrating 
the specificity of position of 7 combined with extracted mass in GC×GC. Note that the 
same time window as in Figure 4.7 is used. 
 
4.3.3.2 Identification against NIST05 versus laboratory-created TOFMS library 
In order to compare the identification power of TOFMS when searching against a 
commercial quadrupole-based MS database (NIST05) and a GC×GC-TOFMS-based in-
house laboratory library, the extract of the sterol spiked urine sample at 2 ng mL−1 was 
processed under the two different data processing methods, differing only in the MS 
library against which searching is performed. When a match threshold is set to 800, only 
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four of the sterols are identified as a first match against the NIST05 library, but all 19 
sterols are positively identified against the TOFMS based laboratory library, with an 
average match quality of 950 (Table 4.2). Whilst the mass spectra from qMS and TOFMS 
are visually similar, they differ sufficiently to justify the need for creating a purpose 
constructed TOFMS based library. 
 
Comparison in terms of searching the different MS libraries was made also between 
chromatograms in 1D GC and GC×GC. An extract of urine spiked with sterols at a 
concentration of 10 ng mL−1 was run in 1D GC and GC×GC modes, under the same 
chromatographic conditions, except in the first case the modulator is off. Only three of the 
sterols in the 1D GC chromatogram are identified against NIST05 at a match threshold of 
approximately 800 (on a 0 - 999 scale), but 15 out of 19 are identified against the laboratory 
made TOFMS library at the same match threshold (Table 4.2). The average match quality 
for the identified sterols (n = 15) in 1D GC using the TOFMS library was 867, and 826 for 
the identified sterols (n = 3) in 1D GC versus the NIST05 library. As a comparison, in the 
GC×GC chromatogram all the sterols are identified against the laboratory-generated 
library with an average match of 959. At higher concentration the standard mixture of 
sterols at concentration of 10 μg mL−1, revealed an average match quality of 972. The key to 
this high match is probably in the algorithm of finding the unique masses and apexes of 
each compound, thus making deconvolution easier. It is much easier to differentiate 
sharper peaks from each other and from the matrix, than broader peaks that suffer 
interference, and GC×GC is superior in this respect compared to 1D GC. 
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Table 4.2 Library match of TOFMS spectra obtained from spiked sterols in urine at 
2 ng mL−1 (GC×GC mode) and 10 ng mL−1 (1D GC and GC×GC mode) against TOFMS 
laboratory-based and NIST05 libraries. Comparative data for sterols at 10 μg mL−1 in 
standard solution also shown (BPX5/BPX50 column configuration). 
GC×GC 1D GC 
2 ng mL-1 10 ng mL-1 10 μg mL-1 # 10 ng mL-1 
 
 
sterol 
NIST05 TOFMS TOFMS TOFMS 
rep. 1 
TOFMS 
rep. 2 
NIST05 TOFMS 
1 764* 889 966 997 991 - 819 
2 846 951 951 971 984 - 825 
3 675 (6th match) 968 971 963 956 - 841 
4 750* 958 977 973 965 - 877 
5 712* 928 921 909 904 - 808 
6 773* 980 961 947 942 - 807 
7 642* 914 958 942 958 - - 
8 758* 978 978 996 981 - 831 
9 804* 978 978 945 941 - 882 
10 795* 923 947 976 949 - 908 
11 783* 951 960 959 948 817 928 
12 723 (2nd match) 918 949 984 989 - - 
13 800 974 974 997 993 - 887 
14 784 (2nd match) 958 938 997 994 - 867 
15 869 940 976 980 969 852 926 
16 828 943 918 998 991 809 931 
17 757 (3rd match) 964 967 995 993 - - 
18 749* 965 965 997 996 - - 
19 885* 968 968 957 957 - 870 
* Match quality shown, but for an incorrect compound match. 
# Data for duplicate analyses shown. 
 
4.3.3.3 LOD and the minimum acceptable match (MAM) 
The time window of an individual sterol, locked by 1D time and 2D time, as well as the full 
mass spectra of the deconvoluted compounds in complex matrices such as urine, offers 
unparalleled identification power for compounds. Using GC×GC-TOFMS, we propose a 
minimum acceptable match (MAM) which can be applied as an additional criterion for 
sterols identification at the limit of detection, and at low concentrations usually found in 
sport doping control. Here, the MAM metric is proposed to offer an additional level of 
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specificity to the identification of steroids, especially at low levels. In GC×GC there are two 
unique positions of each sterol in the 1D and 2D. Compared with 1D GC (which usually 
requires SIM mode with one or more ions – one for quantification and one or more for 
diagnostic or confirmatory ions), the proposed MAM uses all the ions and so offers the 
opportunity for routine library matching. Thus in this proposal a given quality match 
comparison between the experimental spectrum and the library spectrum is offered as 
part of the metric, as distinct from the use of a few confirmatory ions and the ratio of these 
ions (within an expressed uncertainty) as the indication of the identity of a steroid. The 
question here is whether a library match metric, as opposed to confirmatory ion(s) and 
their ratio, is a suitable and adequate measure of the identity of the steroid. 
 
Clearly the library match quality will depend on the (proprietary) method employed for 
matching the spectra, and for a routine procedure between laboratories an agreed method 
should be used for this matching algorithm. However in the case of the proposed MAM, it 
should be possible to state with a higher probability that a given steroid is indeed present, 
compared with a SIM experiment. Here, a minimum match of 800 is applied for the library 
match, and to establish a limit of detection that incorporates this metric. Thus if a response 
to a spiked standard in urine is recorded at low concentration (for example S/N of 10), but 
the MAM is <800, then this is not accepted as a suitable match, nor as the limit of 
detection. This will generally lead to an increased LOD, but provides improved certainty 
of positive identification.  
 
GC×GC-TOFMS can offer screening, even for unknown compounds present in a sample 
that only become recognised at some later date through “retro-searching” of full MS data, 
and provides identification and quantification of sterols below the detection limit of 
present analytical methods in GC-qMS. For doping control, GC×GC-TOFMS offers either 
the possibility for manual searching of unexpected compounds in a sample, with the 
chance that a “new” designer drug may be identified (admittedly a tedious task), or if such 
a compound is identified in the future, it should be a relatively straightforward task to 
search data files for this compound, since full mass spectral data are available. 
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In order to obtain the LOD, a series of spiked urine samples were processed as described 
and analysed using the P/NP column set and TOFMS based library for identification. The 
lowest limit of detection, when MAM is set to 800, S/N to 10 and peak width to 50 ms, is 
obtained for estrone (15) at 0.1 ng mL−1, and the highest for 8, 12 and 19 at 1 ng mL−1 (Table 
4.1). Even though S/N for some sterols may be much higher than 10, unless the criterion of 
MAM > 800 is satisfied, the sterol concentration is not taken to represent the LOD. Here, 
the requirement of achieving a minimum in the match statistic (>800) is taken as an 
integral part for defining the LOD. For sterols detected in the blank urine samples (4, 6, 11, 
14, 16, 18) LOD cannot be calculated. The LOD for all analysed sterols, including the 
quantification ions, S/N, match quality and peak width, is given in Table 4.1. The average 
match quality at LOD is 940 and the average peak width at half height is 100 ms. The S/N 
is calculated for the corresponding quantification ion chosen by the software, and this 
automated decision is not always apparent. Thus the S/N value of 29 calculated for 2 is 
obtained from the sum of 225 quantification ions chosen by the software. Any other 
combination of ions gave lower S/N ratio. 
 
4.3.3.4 Linearity 
The linearity was checked by running a series of extracts of spiked urine samples with 
sterols at various concentrations, from 0.1 ng mL−1 to 10 ng mL−1. Linearity equations and 
correlation coefficients for 5, 6 and 9 are given in Table 4.3. The presence of some of the 
sterols in the blank urine is visible from the linearity curve (Figure 4.9), e.g. for DHEA, 
where the intercept is not zero; for sterols absent in the blank urine the intercept is close to 
zero (5 and 9). Using the calibration curve, the calculated concentration of DHEA in the 
blank urine is 0.95 ng mL−1. 
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Table 4.3 Linearity equations and correlation coefficients for selected sterols obtained 
for the given quantification ions.  
sterol Quant. ion equation R2 
androstanol (5) 285 m/z Y = 0.12802x + 0.0079 0.999 
DHEA (6) 360 m/z Y = 0.02102x + 0.0209 0.997 
stanolon (9) 257 m/z Y = 0.12329x - 0.0056 0.999 
Y = A/AIS; x – concentration of sterols in ng mL-1 
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Figure 4.9 Linearity curves for androstanol (5), DHEA (6) and stanolon (9) spiked in 
urine in the concentration range from 0.1 ng mL-1 to 10 ng mL-1 
 
 
4.4 CONCLUSIONS 
 
This study shows that comprehensive two-dimensional gas chromatography can be 
successfully applied to sterols analysis in complex samples, offering better separation and 
signal enhancement when compared to conventional GC. Although GC×GC coupled to 
FID lacks suitable identification power, GC×GC coupled to the TOFMS detector is 
promising for screening, quantification and confirmation of sterols in complex matrices 
such as urine, even at a concentration below 1 ng mL−1. The results show that TOFMS 
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offers greater information content (peak positions and full mass scanning, at lower levels) 
when coupled to GC×GC, compared to 1D GC. Furthermore, it was found that the match 
quality is dramatically improved if searching is performed against a TOFMS laboratory-
created library compared to the commercial qMS-based library. 
 
A new criterion for determination of the limit of detection is introduced here, which 
allows identification of the measured component at a predefined minimum acceptable 
match quality, in conjunction with the signal-to-noise ratio for a particular mass ion. In 
this way, instead of measuring a signal of a predefined mass ion in a predefined 1D time 
window, as in a traditional GC-MS-SIM mode analysis, here the signal of a component is 
identified according its full mass spectrum, with a match quality higher than the defined 
match quality. Once the steroid is confirmed, then a suitable m/z ion of choice, locked by 
predefined 1D and 2D retention times, can be used for quantification. In this case, it is 
relatively easy to confirm that the ion chosen for quantification does not suffer 
interference. The present method contrasts with the conventional GC-MS (SIM) analysis 
method because the latter will require choice of a small number (e.g. two) of confirmation 
ions for identification of the steroids, and then choice of a quantification ion. In this case, 
spectral identification relies solely upon the validity of the confirmation ions to correctly 
represent the target compound, which is not as secure as a full mass spectral match. 
 
The GC×GC-TOFMS method, acquired with full mass scan data, can permit identification 
of unknown compounds in a sample either (i) if the mass spectrum of the compound can 
be interpreted based on spectral interpretation, or (ii) if a new compound (e.g. designer 
steroid) is found in the future and its retention and mass spectrum are then established, 
the acquired GC×GC data can be re-interrogated to determine if a doping offence had been 
committed. Since the limit of detection for the analysed endogenous sterols is 1 ng mL−1 or 
less, this method is in accordance with the MRPL for the anabolic sterols defined by the 
World Anti-Doping Agency (WADA). 
  
 
 
 
 
 
 
 
Chapter 5 
 
5 APPLICATION OF COMPREHENSIVE TWO-
DIMENSIONAL GAS CHROMATOGRAPHY TO  
WADA KEY ANABOLIC AGENTS ANALYSIS 
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5.1 INTRODUCTION 
 
The very low concentrations of anabolic agents (AA), and the complex matrices in which 
they are found (urine, sera, and other biological materials), require a powerful technique 
for separation and unambiguous identification. At present gas chromatography coupled to 
a quadrupole mass analyser (GC-qMS) is a technique of choice which exhibits high 
specificity and sensitivity, especially when selected ion monitoring (SIM) mode is applied. 
The separation is based on using a traditional narrow bore capillary column, and detection 
necessarily relies on monitoring pre-defined diagnostic ions in pre-defined time windows.  
 
The extraction process is generally standardized, comprising of solid-phase extraction 
(SPE), hydrolysis of conjugates (metabolites) with β-glucuronidase and liquid-liquid 
extraction (LLE) by using diethyl ether or methyl tert-butyl ether (MTBE). Prior to GC-MS 
analysis, the AA are derivatized to their corresponding trimethylsilyl (TMS) derivatives 
since they usually contain one or more hydroxyls and/or keto groups and generally show 
poor chromatographic behaviour if not derivatized [207]. The most characteristic and 
preferably the most abundant ion is used for quantification, and 2–3 other ions (qualifiers) 
are used for confirmation purpose.  
 
Most of the current methods in doping analysis, if not all of them, are still “transparent” to 
the potentially new “designer” AA at the lowest level of detection, since they rely on pre-
defined ions to be monitored. Full scan mass spectral techniques coupled to classical one-
dimensional GC (1D GC) with classical injection are not sensitive enough to detect low 
level concentrations down to 1 ng mL−1, as defined by the World Anti-Doping Agency 
(WADA) [133]. In the last few decades many attempts have been made to improve the 
selectivity and the sensitivity of the GC-MS approach. Improvements in the oven 
temperature program [208, 209] in order to obtain better signal-to-noise ratio (S/N), the use 
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of ion-trap tandem mass spectrometry [170, 172], high-resolution mass spectrometry [163, 
165, 208], hybrid mass spectrometry (high-resolution–time-of-flight) [174], and 
combustion/isotope ratio mass spectrometry [139], are amongst the most common.  
 
An attempt was made by Mazzarino et al. [209] to shorten the runtime while retaining the 
resolution and limit of detection by applying fast GC with a 5 m narrow bore column (0.1 
mm I.D.; 0.1 μm film thickness). However, most methods are based on improvements of 
the selectivity, although usually by making the detector increasingly “blind” to the matrix. 
Such an example is the shift from full scan mode to SIM mode in low resolution MS, then 
to high resolution MS (in SIM mode), and finally to tandem MS (MS/MS or MSn). Several 
new approaches are proposed for increasing the sensitivity and selectivity of the methods 
in doping control by using an extra step in purification of the samples. In this manner 
immunoaffinity chromatography (IAC) [210] and high performance liquid 
chromatography (HPLC) fractionation [211] are employed. None of these approaches is 
based on chromatographic separation improvements since the limit of the separation 
efficiency of the 1D GC step has largely been reached. 
 
Recently a new approach for separation improvement has been proposed, by using 
comprehensive two-dimensional gas chromatography (GC×GC) [186, 187] in doping 
analysis. The use of GC×GC is perhaps one of the most significant innovations in terms of 
separation efficiency improvement since the introduction of narrow bore capillary 
columns. GC×GC also reportedly exhibits improved sensitivity, alongside separation 
power, compared to traditional 1D GC [212, 213]. The separation is performed on two 
sequential columns: the first one (1D) approximates a conventional 1D GC separation, 
while the second one (2D) must act as a fast-eluting high-efficiency column, usually 0.5-2 
m in length, with 0.1 mm I.D. and 0.1 μm film thickness (df). The separation mechanisms 
of the stationary phases should be as different as possible in order to maximize their 
orthogonality, giving rise the significant increase in separation power. The interface 
between the two columns (modulator) has to trap/accumulate in the predefined period (3–
8 s) all the components which elute from the 1D column and then release them rapidly as 
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narrow adjacent fractions into the 2D column. The efficient trapping and fast releasing of 
the components is usually achieved by cryo-focusing, producing ultra-narrow peaks at the 
end of the 2D column. Co-eluting components on 1D, where the separation is based on the 
first mechanism, are separated on the orthogonal 2D column, where the separation is based 
on the second mechanism. GC×GC has been successfully applied in petrochemical [201, 
214], food [201, 217], environmental [204], forensic [189, 205], essential oils analysis of 
complex matrices [168, 180], showing for the first time some new features such as 
structured chromatograms. Apart from improved peak capacity and structured 
chromatograms, GC×GC exhibits an increase in the signal height when compared to 
classical GC [186, 215]. 
 
Silva et al. [187] reported analysis of key WADA AA in urine using GC×GC-TOFMS at the 
lowest purported concentration, demonstrating that this technique is highly sensitive and 
specific in screening of these AA. Alternatively, it can be employed as a full spectral 
confirmatory method when coupled to TOFMS as a detector. The separation on a second 
dimension column was based on a 1 m OV-1701 column (0.1 mm×0.1 μm), however, the 
AA were spread in a rather narrow band of approximately 1 s out of the 6 s modulation 
period, along with matrix compounds also within this region. This tends to reduce the 
extent of matrix separation. No data were provided on linearity and TOFMS spectra 
similarity to a commercial or in-house MS library. 
 
The present report describes further improvements in doping analysis, specifically the 
increased peak capacity (separation power) through better spread of AA and matrix 
components over the 2D space, and sensitivity and identification power of the TOFMS as a 
detector coupled to GC×GC. Linearity ranges and limit of detections for the tested 
substances are established, and advantages of GC×GC over 1D GC in term of sensitivity, 
separation and identification power are demonstrated through several examples. The bias 
of TOFMS detector against the higher masses, observed in the results of Silva et al. [187] 
but not reported, has been stressed in respect of the 19-norandrosterone case. 
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The performance of the present proposed method was confirmed using spiked urine 
extracts obtained after SPE, hydrolysis with β-glucuronidase and LLE with MTBE. The 
proposed method is “non-transparent”, since it permits full mass spectral information to 
be retained, both for targets or non-targets. Finally the method was quantified for a urine 
positive control sample (UPC) spiked with the key WADA anabolic agents at a 
concentration of 5 ng mL−1, which was prepared at NDCC (a WADA accredited anti-
doping laboratory in Bangkok, Thailand). 
 
 
5.2 EXPERIMENTAL 
 
5.2.1 GC×GC-FID 
 
The GC equipped with a flame ionization detector (GC×GC-FID) used in the study was an 
Agilent 6890 system (Palo Alto, CA, USA) with a longitudinal modulation cryogenic 
system (LMCS; Chromatography Concepts Pty Ltd., VIC, Australia). The column 
configuration used with this system was 30 m BPX5 (0.25 mm I.D.; 0.25 μm film thickness 
(df)) as a first dimension (1D) column coupled to a 1 m BPX50 (0.1 mm I.D.; 0.1 μm df) as a 
second dimension (2D) column, both columns from SGE Scientific (Ringwood, Australia). 
The oven temperature program was from 140 °C (hold for 1min) to 200 °C at 40 °C min−1, 
then to 240 °C at 4 °C min−1, then to 330 °C at 15 °C min−1 (hold for 5min). The injector and 
detector temperatures were 280 °C and 320 °C, respectively, and the sampling frequency 
was 100 Hz. Hydrogen was used as a carrier gas at a flow rate of 1.1 mL min−1 and 1 μL of 
the sample was injected in split mode at a split ratio of 10:1. The modulation period was 5 
s, and temperature of the modulator system (TM) was varied from 0 °C to 200 °C, during 
the optimization study. CO2 was used as a coolant in the LMCS and nitrogen as a flush gas 
at a pressure of 15 psi. Agilent ChemStation software was used for data acquisition and 
processing. 
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5.2.2 GC×GC-TOFMS 
 
A LECO time-of-flight mass spectrometer (TOFMS) model Pegasus III (LECO Corp., St. 
Joseph, MI, USA) connected to an Agilent 6890 GC was used in GC×GC-TOFMS 
experiments. The TOFMS detector was operated at 1600 V and applied electron ionization 
voltage was 70 eV. Data collection rate was 100 Hz over the mass range from 45 to 700 
m/z. The temperatures of the transfer line and ion source were 280 °C and 230 °C, 
respectively, and data acquisition and processing were performed by ChromaTOF 
software (LECO Corp., St. Joseph, MI, USA). A separate GC×GC-TOFMS-based in-house 
library for improved identification was generated using standard solutions at a 
concentration of 1 μg mL−1 for all AA, in the same manner as in our previous work [186]. 
The National Institute of Standards and Technology algorithm (NIST MS Search 2.0 
Program) was used for mass spectra searching. Two complementary column 
configurations were used for AA separation and identification in this experiment: 
polar/non-polar (P/NP) and non-polar/polar (NP/P). 
 
5.2.2.1 Polar/non-polar column configuration (P/NP) 
P/NP consisted of 30 m BPX50 (0.25 mm I.D.; 0.25 μm df) as 1D and 1 m BPX5 (0.1 mm I.D.; 
0.1 μm df) as 2D column. Oven temperature program was from 80 °C (1 min) to 180 °C at 40 
°C min−1, then to 240 °C at 4 °C min−1 and finally to 330 °C at 15 °C min−1 (hold for 5 min). 
Temperature of the injector was 280 °C and 1 μL of sample was injected in splitless mode 
(1 min purge time) at a carrier gas (helium) flow rate of 1.5 mL min−1. 
 
5.2.2.2 Non-polar/polar column configuration (NP/P) 
Two different 2D columns were applied in NP/P, differing only in df. The first one (NP/P1) 
was the same as listed for GC×GC-FID analysis above and the second one (NP/P2) was of 
the same length and I.D., but with a 0.2 μm df BPX50 phase. Two chromatographic 
methods for each NP/P set were applied, differing only in the oven temperature program 
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and carrier gas flow rate. The oven program for the first (NP/P1S; S: short runtime) was 
from 120 °C (hold for 1min) to 200 °C at 20 °C min−1, then to 230 °C at 3 °C min−1, and 
finally to 320 °C (hold for 5 min) at 8  °C min−1, at a flow rate of 1.5 mL min−1, while the 
oven program for the second one (NP/P1L; L: long runtime) was from 120 °C (hold for 1 
min) to 320 °C (hold for 5 min) at 4 °C min−1, at a flow rate of 1.3 mL min−1. Accordingly, a 
0.2 μm df 2D column film thickness was used in NP/P2S and NP/P2L chromatographic 
methods. 1 μL sample was injected in splitless mode (2.5 min purge open time). 
 
5.2.3 Experiments in 1D GC mode 
 
All experiments using 1D GC were carried out under the same conditions as in GC×GC, 
except the modulator was off and the acquisition rate of TOFMS detector was 20 Hz. Thus 
in this case the 1D system will comprise a long column directly coupled to a short column 
and whilst this can be termed a multichromatography system according to Hinshaw and 
Ettre [216] and discussed elsewhere [217], the second very short column is anticipated to 
lead to negligible variation in peak properties such as width. 
 
 
5.3 RESULTS AND DISCUSSION  
 
5.3.1 GC×GC-FID separation of anabolic agents 
 
It was found in the previous work [186] that the peak shape of steroids on the 2D depends 
on the modulator temperature (TM). The GC×GC separation of the standard mixture of 
anabolic agents was initially accomplished by GC×GC-FID, where TM was optimized for 
the best separation and narrowest peak width. An acceptable separation was achieved in 
21 min, except for 4 and 5 which co-elute (Figure 5.1), at 5 s modulation period but the best 
modulation temperature was found to be dependent on the retention time of the anabolic 
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agents, and presumably their boiling point. The peak width at half height (W1/2) of each 
anabolic agent was constant over a TM range from 0 °C until a characteristic (steroid-
dependant) temperature, at which stage the peak width of the anabolic agent starts to 
increase. For instance, the peak of clenbuterol (first eluted compound) started to broaden 
at 60 °C TM (Figure 5.2), but the peak of 3’OH-stanozolol maintained its W1/2 of ~45 ms up 
to 160 °C. Onset of peak broadening for the rest of the anabolic agents was observed 
between these two temperatures.  
 
 
Figure 5.1 GC×GC-FID contour plot of the TMS derivatized WADA key AA on 
BPX5/BPX50 column configuration: clenbuterol (1), 19-norandrosteron (2), 
epimethendiol (3), M1 metabolite (4), M2 metabolite (5), and 3’OH-stanozolol (6) 
 
In contrast to the previous work [186], here an increase of the peak width towards lower 
temperatures (down to 0 °C except for 6 where the minimum achieved TM at its elution 
temperature was 60 °C) was not observed. This is probably due to the different nature of 
some of the anabolic agents, and the use of a different derivatization reagent capable of 
derivatising keto-enol groups also, and not just the hydroxyls. In order to maximize the 
separation efficiency (narrowest peaks) and to minimize the CO2 consumption, we 
decided to perform all further experiments by holding the TM at 80 °C. The 2D plot in 
Figure 5.1 shows the separation of the 6 anabolic agents in a standard mixture at a 
concentration of 10 μg mL-1 (split ratio 1:10), at 80 °C TM.         
 
The anabolic agents were detected at a concentration down to 0.2 μg mL-1 in a standard 
mixture (splitless mode), which theoretically corresponds to 4 ng mL-1 spiked in urine (at a 
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concentration factor of 50), but the lack of identification power of the FID detector limits 
its applicability in complex mixtures, since the analyte signals may be poorly recognized 
in the presence of much higher signals from the matrix.  
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Figure 5.2 The influence of modulator temperature (TM) on peak width (W1/2) for the key 
WADA anabolic agents 
 
5.3.2 GC×GC-TOFMS separation and identification of anabolic agents  
 
Since BPX50/BPX5 (P/NP) has been successfully applied in endogenous sterols separation 
[186] this column configuration has also been used for AA separation. Despite the good 
peak shapes (data not shown) of 1, 2, 3, 4 and 5, with an average W1/2 of 90 ms, it was not 
possible to elute 3’OH-stanozolol at a concentration lower than 0.5 μg mL-1. This 
concentration corresponds to a concentration of 10 ng mL-1 of AA spiked in urine at a 
concentration factor of 50. The injector temperature was varied from 260 °C to 320 °C, 
initial oven temperature from 80 °C to 180 °C, and the flow rate from 0.8 mL min-1 to 1.5 
mL min-1, and 6 could not be eluted at concentrations below 0.5 μg mL-1. This is probably 
because of the length (30 m) and the polarity of the 1D column (BPX50) and its activity 
towards polar components. 3’OH-stanozolol is known as the most problematic steroid in 
anti doping control when GC is applied [136, 218]. Because of this, experiments were 
continued on the non-polar/polar (NP/P) column configuration BPX5/BPX50. 
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5.3.2.1 Short runtime vs. long runtime 
Since the focus of this work was the separation and identification of the key WADA 
anabolic agents in a urine matrix, and not on the extraction efficiency, they were directly 
spiked to the blank urine extracts. A 2D plot of a blank urine extract spiked with the 
anabolic agents at a concentration of 2 ng mL-1 and IS at a concentration of 50 ng mL-1, by 
using the method NP/P1S, is shown in Figure 5.3A. As the result of the poor spread of the 
components on the 2D column, unsatisfactory separation from the matrix and 
identification of the key anabolic agents are obtained. For instance, 2, 3, 4 and 5 were 
detected with a similarity below 600, and 1 and 6 were not detected at all. In order to 
improve the separation efficiency, especially the spread of the components on the 2D, a 
slower oven temperature program was applied (NP/P1L). The obtained separation and 
identification of anabolic agents were better, but at an overall runtime of 50 min (Figure 
5.3B). 
 
5.3.2.2 0.2 µm df 2D column vs. 0.1 µm df 2D column 
In order to further improve the spreading of components on the 2D plot, a 2D column with 
0.2 μm df instead of the original 0.1 μm was applied, keeping other conditions the same as 
in NP/P1L. The 2D plot of the blank urine extract spiked with AA at 2 ng mL-1 is shown in 
Figure 5.3C, where the improvement of the peak separation is apparent. A peak table with 
1D retention times (1tR), 2D retention times (2tR), W1/2, S/N for selected quantification ions 
and the similarity to the in-house created TOFMS library for the WADA key anabolic 
agents at 0.1 μg mL-1 in standard solution was created (Table 5.1) under these conditions 
(NP/P2L). The concentration of 0.1 μg mL-1 in the standard solution theoretically 
corresponds to a concentration of 2 ng mL-1 of anabolic agents when spiked in an original 
urine sample, at the concentration factor of 50 (2.5 mL urine to 50 μL final volume of the 
urine extract). The improvement of the separation on the 0.2 μm df 2D column over 0.1 μm 
df is clearly seen from the example of 19-norandrosterone, given in Figure 5.4. The 
increased retention of 2 and the coeluting endogenous component provided by the thicker 
film produces a better separation, followed by a better deconvolution of their MS spectra.      
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Figure 5.3 2D plots of spiked urine extracts with the WADA key anabolic agents at a 
concentration of 2 ng mL−1, analysed under NP/P1S (A), NP/P1L (B) and NP/P2L (C) 
chromatographic conditions. 
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Figure 5.4 Extracted ion chromatogram at 405 m/z for 19-norandrosterone (2), showing 
the achieved separation from the co-eluting endogenous component on 0.1 µm (A) and 
0.2 µm (B) df 2D column. 
 
5.3.3 Linearity and Limit of Detection (LOD) 
 
The method linearity was recorded by obtaining data over the concentration range from 
0.5 ng mL-1 to 20 ng mL-1 and the limit of detection (LOD) was established under these 
conditions (NP/P2L). The correlation coefficients were in the range from 0.995 (for 3’OH-
stanozolol) to 0.999 (for epimethendiol). LOD was defined as the lowest concentration 
which gave S/N above 10 for the quantification ion (see Table 5.1) and the minimum 
acceptable match (MAM) criterion [186] to the in-house library of 700 or higher. This is a 
rigorous criterion when defining LOD for steroids in anti doping control, and only 
possible by using GC×GC-TOFMS at the lowest limit required for reporting the WADA 
check solution. The obtained LOD was from 1 ng mL-1 (for 1, 2, 4 and 5) to 2 ng mL-1 (for 3 
and 6).  
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Table 5.1 Peak data table of the WADA key anabolic agents, including retention time on 
each dimension and peak width at a half height. TOFMS similarity against the in-house 
TOFMS-based library, selected quantification ions and corresponding signal-to-noise 
ratios were reported for a concentration of 0.1 µg mL−1 in standard solution. Linearity 
data are for a concentration range of 2-20 ng mL−1. 
Anabolic agent 1tR 
(s) 
2tR 
(s) 
W1/2 
(ms) 
TOFMS 
similarity 
Quant. 
ion 
S/N R2 Equationb 
Clen-2TMSa 1670 2.48 108 963 335(86) 51(542) 0.996 Y = 0.0138x + 0.0102 
19-Nor-2TMS 2125 2.58 103 986 405 51 0.996 Y = 0.0058x + 0.0098 
EMD-2TMSa 2165 2.64 110 970 358(143) 18(398) 0.999 Y = 0.0086x + 0.0076 
M1-2TMS (4) 2340 2.44 117 984 255 36   
M2-2TMS (5) 2345 2.45 119 982 255 30 0.995 Y = 0.0143x + 0.0109 
IS 2500 2.91 115 981 301 1808   
3’OH-Stan-3TMSc 2920 3.08 128 840 143 34 0.996 Y = 0.0043x + 0.0002 
a For clenbuterol and EMD two ions of each are shown with their respective S/N. The former ions are more   
unique, but are of lower abundance.  
b Y = AAarea / ISarea; x = AA concentration in ng mL-1 
c Equation obtained for 254 m/z 
 
5.3.4 GC×GC-TOFMS vs. GC-TOFMS 
 
The high acquisition rate of TOFMS as a detector in GC allows full scan mass spectral 
information to be acquired not only for the target components, but also for non-targets and 
the matrix. The similarity matching of each compound’s MS spectrum against the MS 
libraries, even at the LOD, is another benefit of TOFMS. In addition, it allows choosing the 
best ion for quantification from the full mass spectrum, whether it be the most abundant 
and/or the ion that has least interferences from the matrix. The sensitivity, separation and 
identification efficiency of the present method (NP/P2L) were checked on a UPC sample 
(Figure 5.5) and a spiked urine extract with WADA key anabolic agents at a concentration 
of 20 ng mL-1 (data not shown), in GC×GC and 1D GC mode. In the latter case the 
modulator was turned off and the acquisition rate was reduced to 20 Hz (in order to 
closely match the data acquisition conditions in classical 1D GC-MS), while the rest of the 
conditions were kept the same.  
GC×GC of anabolic agents 
 154 
 
The results of a comparison (see Table 5.2) showed that not one anabolic agent in the UPC 
sample was detected in 1D GC, except 2 with a very low similarity (match 520 on a scale 
from 0 - 999). Furthermore, at the highest concentration level tested in urine (20 ng mL-1), 
only 2 and 5 were properly detected in 1D GC (matches 854 and 817). 3 was poorly 
identified (match 591) and 4 was recognized with a higher similarity (match 761) but at a 
low S/N (14). Clenbuterol and 3’OH-stanozolol were not detected at all under the defined 
criteria. In comparison, all the anabolic agents in both samples were identified in GC×GC 
mode with an average match quality of 890 (UPC sample) and 910 (20 ng mL-1). The results 
of the comparison are given in Table 5.2.  
 
Table 5.2 Comparison of similarities to the in-house created TOFMS library between 
1D GC-TOFMS and GC×GC-TOFMS obtained spectra for the WADA key anabolic 
agents spiked in urine at two levels of concentration. 
5 ng mL-1 
(UPC sample) 
20 ng mL-1 
 
1D GC GC×GC 1D GC GC×GC 
clen-2TMS - 875 - 897 
19-nor-2TMS 520 928 854 828 
EMD-2TMS - 822 591 936 
M1-2TMS* - - 761 938 
M2-2TMS - 932 817 957 
3’OH-stan-3TMS - 870 - 894 
* M1 was not spiked in the UPC sample, since this epimer is not monitored at the MRPL of 2 ng mL-1 [133]. 
 
As can be seen from the 2D plot of the UPC sample in Figure 5.5, the extract prepared at 
NDCC is significantly cleaner than the extracts prepared at the ACROSS laboratory, 
presumably because of the experience of NDCC and optimized conditions applied in the 
sample preparation. The extraction conditions applied at the ACROSS laboratory were not 
optimized since the focus of the research was the separation efficiency. The separation and 
improved dispersion of the components on the 2D plot by using 0.2 μm df column is even 
more apparent on this sample.    
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Figure 5.5 2D plot of the UPC sample, analysed under NP/P2L conditions 
 
Here a number of advantages of GC×GC over the classical 1D GC method were observed: 
 
In the extracted ion chromatogram (data not shown) and 3D plot at 86 m/z for clenbuterol 
(Figure 5.6), an endogenous component co-elutes with 1 on 1D, making quantification 
difficult in 1D GC if this ion is used. For the 335 m/z extracted ion chromatogram (Figure 
5.6B) there is no interference (co-elution), but this ion is much less abundant compared to 
86 m/z under these conditions, thus this drastically reduces the sensitivity. As a 
comparison, S/N of 239 is obtained at the concentration of 0.5 ng mL-1 in urine if 86 m/z is 
selected, with no background interference for GC×GC. However, the match quality was 
not satisfactory to confirm the presence of clenbuterol at this level of concentration, using 
the applied criteria.           
 
In the extracted ion chromatogram and 3D plot at 405 m/z, 420 m/z and 315 m/z for 2 
(Figure 5.6C-E), an endogenous component co-elutes with 2, with some common mass 
fragments (405 m/z, 420 m/z) as in 2. The extracted ion area ratio is in favour of the 
endogenous component at lower concentrations (see Figure 5.4, at 2 ng mL-1), and can not 
be ignored in 1D GC. It is obvious from Figure 5.6E that 315 m/z will give the least 
interference in 1D GC if chosen for quantification, with some loss of sensitivity compared 
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to 405 m/z. However, GC×GC offers in this case choice of any ion for quantification, since 
full mass spectra are obtained even at the lowest detectable concentrations. The same 
sensitivity as for 405 m/z can be obtained if 225 m/z were chosen, with no interfering 
component (data not shown). 
 
In the extracted ion chromatogram (data not shown) and 3D plot at 255 m/z for M2 
metabolite (Figure 5.6F) an endogenous component co-elutes on 1D, making the 
quantification in 1D GC difficult if this ion is selected. GC×GC overcomes this problem 
since M2 and the interfering component are separated on the 2D column. However, in the 
435 m/z, and especially in the 345 m/z extracted ion chromatograms (data not shown), 
there is no interference, but these two ions are less abundant under these conditions when 
compared to 255 m/z, thus reducing the sensitivity by approximately 2 fold.  
 
On the other hand, the extracted ion chromatogram and 3D plot at 143 m/z (Figure 5.6G) 
lacks interference and can be used as a quantification ion for sensitive determination since 
143 m/z is the base ion in the mass spectra of M2. From Table 5.2, the similarity of the mass 
spectrum of M2 at this level of concentration to the in-house TOFMS library is 932. A 
similar sensitivity as for 255 m/z was obtained by selecting 270 m/z ion (Figure 5.6H), with 
no coelution on the 1D column. All these ions (255 m/z, 143 m/z, 345 m/z, 435 m/z and 270 
m/z) are common for both M1 and M2 metabolites, but at different relative abundances, 
which helps to differentiate them even though they are separated by only one modulation 
period (5 s) on 1D column. Deconvolution of their mass spectra is possible if their 
retentions differ on the 2D column. Figure 5.7 shows the two metabolites present in a 
standard solution. The ion abundance for 255 m/z is higher for M1, and that of 270 m/z is 
higher for M2. Since the ratio of ions 255 m/z and 270 m/z are not constant in the two peak 
pulses in Figure 5.7, this shows that M1 and M2 are partially resolved on the 1D column. 
The retention of each compound on the first column can be predicted by a recently 
proposed metric based on modulated peak distribution [219]. The peaks almost 
completely overlap on the 2D column. 
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Figure 5.6 Extracted 3D plots for clenbuterol at 86 m/z (A) and 335 m/z (B); 19-
norandrosterone at 405 m/z (C), 420 m/z (D) and 315 m/z (E); M2 metabolite at 255 m/z 
(F), 143 m/z (G) and 270 m/z (H), obtained from the UPC sample. 
 
Cryo-focusing and releasing of components on the 2D column permits an elegant 
integration of the peak area of 6, even though it showed a high degree of tailing on 1D. The 
expanded extracted ion chromatogram at 254 m/z in Figure 5.8 shows 9 modulation slices 
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of 6 (due to the tailing on 1D) at a concentration of 0.5 μg mL-1 in standard solution, 
automatically integrated and summed up by ChromaTOF software. At a concentration of 
5 ng mL-1 in urine (UPC sample) 4 slices are detected, integrated and summed up. The 
identification and integration of tailing peaks is a great problem in 1D GC.  
 
 
Figure 5.7 Mass spectral deconvoluted modulated peaks for ions 255 m/z and 270 m/z, 
corresponding to M1 and M2 metabolites in a standard solution, showing that the peaks 
strongly overlap on both the first and second columns. 
 
 
Figure 5.8 Extracted ion chromatogram at 254 m/z of 3’OH-stanozolol at 10 ng mL−1 in 
standard solution showing the 1tR range in which 9 modulations were detected and 
integrated automatically by ChromaTOF software. The extracted 3D plot in the inset 
shows the integrated surface. 
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Among the full spectral information of the target components, GC×GC-TOFMS also offers 
the complete spectral information of the matrix (e.g. endogenous sterols) and non-target 
components, allowing post-run search and even quantification if reference material is 
available, without the need for re-analysis of the samples. The UPC sample was post-run 
processed against the in-house created library of 19 endogenous sterols, which were 
investigated in our previous work [186]. 10 of them were detected and identified with an 
average similarity of 922. The corrected T/E ratio (testosterone/epitestosterone) for the 
UPC sample was 0.85, which is within the expected window for normal athlete’s urine 
[207, 220, 221].  
 
Forty to seventy other endogenous compounds, generally low molecular mass, were 
usually identified with a match quality much higher than 900. Higher molecular mass 
compounds exhibiting higher molecular mass fragments in the mass spectra showed 
lower similarity to the commercial (quadrupole based) MS libraries, since bigger 
difference is observed in the ion intensities to the TOFMS obtained spectra. However, if a 
more comprehensive TOFMS-based library of identified endogenous compound was 
created, the average similarity would be expected to be much higher.           
 
The main drawback of using TOFMS as a detector for GC×GC in sterol analysis is some 
loss of sensitivity when higher mass fragments are chosen for quantification. For instance, 
405 m/z is the base ion in the MS spectrum of 2 in NIST05 (quadrupole based) library, and 
73 m/z is 73% abundant compared to the base ion, but in the TOFMS spectrum of 2 
(recorded at 1 µg mL-1 in standard solution), the base ion is 73 m/z and the ion 405 m/z is 
2.8% abundant only (Figure 5.9). This is the main reason for the low similarity of TOFMS 
spectra against the quadrupole based MS library, and why best library matching is with a 
laboratory generated TOFMS library, as observed in the previous work [186]. It is worth to 
point out that the TOFMS was properly tuned according the producer’s recommendation. 
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Figure 5.9 The comparison of TOFMS spectrum of 19-norandrosterone-2TMS recorded 
at 1 µg mL−1 in standard solution (A) to its entry in the commercial NIST05 quadrupole 
MS-based library (B). 
 
 
5.4 CONCLUSIONS 
 
The applicability of GC×GC coupled to TOFMS has been demonstrated in this study. The 
main advantages of GC×GC over 1D GC, as the increased peak capacity, enhanced 
sensitivity and improved identification power, were proved through the analysis of the 
key WADA anabolic agents spiked in urine extracts.   
 
In contrast to the traditional GC-MS method in SIM mode, the proposed method offers 
some unique features. The 2D retention times, the full mass spectra of target and non-
target components, as well as the retained full mass spectral information of the matrix, are 
the benefits of the proposed method. Additionally, the MAM criterion, introduced in the 
previous work [186], was successfully applied along the established WADA rigorous 
criteria for identification and quantification of anabolic agents in urine. Furthermore, the 
method provides a retro-search (post-run) in a case new “designer” drug is present in the 
sample, but not detected at the time of analysis due to the lack of its spectral information. 
In this case the search is performed only on the acquired data, with no need of re-analysis. 
GC×GC of anabolic agents 
 161 
Moreover, GC×GC revealed its real power through a few examples of component 
coelution on 1D column in extracted ion mode. The extreme case, where the co-eluted 
components share the same m/z masses originating from the same structure fragments, 
can not be solved even by using high resolution or tandem mass spectrometry. Separation 
of co-eluted components in this case is the only solution. We have shown in our 
experiment a coelution of 19-norandrosterone with an endogenous component, sharing 
some of the most characteristic m/z fragments in their spectra.        
 
A new dimension in doping control analysis has been implemented in this study, this time 
on the separation side. Instead of increasing the method performance by making the 
detector more “blind” (like in SIM mode, HRMS, tandem MS) this study proposes an 
improvement in method capabilities by adding a new “separation” dimension, while 
retaining the full mass spectral information. Further coupling of the best in separation 
(GC×GC) to the best in detection (MS/MS) will be probably just a matter of time.  
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6 EVALUATION OF WORLD ANTI-DOPING AGENCY 
CRITERIA FOR ANABOLIC AGENT ANALYSIS BY 
USING COMPREHENSIVE TWO-DIMENSIONAL GAS 
CHROMATOGRAPHY‒MASS SPECTROMETRY 
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6.1 INTRODUCTION 
 
The following work represents a logical continuation of the first two studies on sterols and 
anabolic agents. While general applicability of comprehensive two-dimensional gas 
chromatography has been demonstrated on endogenous sterols, with the limit of detection 
established at reasonably high concentrations of up to 100 ng mL-1, the real applicability 
has been confirmed on the WADA key anabolic agents. Their low required limits of 
detection and strict identification criteria are established by WADA and described in its 
two technical documents: TD2003IDCR [164] and TD2004MRPL [133]. In this chapter a 
point-by-point assessment of data in GC×GC-TOFMS format against each criterion is 
presented. 
 
Anabolic steroids (AS) and β2-agonists with anabolic effect are the pharmacological 
substances most frequently abused in doping control. The International Olympic 
Committee (IOC) and other organizations responsible for anti-doping control (i.e. WADA) 
have banned these substances because of their effect on athlete’s performance and 
consequently on the results of competitions. More details about the importance of these 
substances in doping control, the matrix of choice and the current methodology for 
analysis are given in the introduction part of Chapter 4 and Chapter 5. Here the focus is 
given to the compliance of the GC×GC results to the present WADA criteria [164]. 
 
 
6.2 EXPERIMENTAL 
 
The same sample preparation method used for WADA key anabolic agents analysis by 
GC×GC-TOFMS (Chapter 5) has been applied also in this study. Since the focus of the 
study was the separation and identification of AA, and not the extraction efficiency, the 
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AA were spiked in urine extracts and not directly to the urine samples. In this way the 
eventually encountered problems and/or limitations can be easily associated to the 
GC×GC technology and not to the extraction step. All the results used for method 
performance assessment were generated by using GC×GC-TOFMS method described in 
Chapter 5.     
 
 
6.3 RESULTS AND DISCUSSION 
6.3.1 Retention time tolerance criteria 
 
Present WADA criterion:  
- The retention time of the analyte shall not differ by more than 1% or ±0.2 minutes 
(whichever is smaller) from that of the same substance in a spiked urine sample or reference 
material analysed contemporaneously [164]. 
 
The relative standard deviation (RSD) of the first dimension (1tR) and second dimension 
(2tR) retention times of the proposed method has been calculated from a series of spiked 
urine samples with anabolic agents at different levels of concentration and the results are 
given in Table 6.1. A representative 2D plot of urine extract spiked with sterols at a 
concentration of 10 ng mL-1 is given in Figure 6.1. The reproducibility (RSD) of 1tR has been 
found to range from 0% for clenbuterol-2TMS and 19-norandrosterone-2TMS to 0.18% for 
EMD-2TMS, which agrees with the previous findings for GC×GC reproducibility [222].  
 
The relative error of the retention times of the reference compounds are well within the 
tolerance window of 1% [164]. The lowest deviation (Table 6.1) has been obtained for 
clenbuterol-2TMS and 19-norandrosterone-2TMS (0%), and the highest for EMD-2TMS 
(0.23%). The 0% RSD values for clenbuterol-2TMS and 19-norandrosterone-2TMS are due 
to the “quantised” values of the 1tR derived from the modulation process and data 
processing software. 
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Figure 6.1 A representative 2D plot of urine extract spiked with anabolic agents at a 
concentration of 10 ng mL-1. Note that the 2tR is shifted vertically by -1 s to provide a 
better presentation format. 
 
Specifically, ChromaTOF assigns the same 1tR for all components in the same modulation 
period, regardless of their 2tR values. In addition, since each component generates more 
than one modulation peak, the 1tR of the component is assigned the retention time of the 
highest modulated peak. Obviously, the highest modulated peak for clenbuterol-2TMS has 
been found in the same modulation event at 1670 s in each run, and likewise for the 19-
norandrosterone-2TMS peak at 2125 s to give an ‘arbitrary’ 1tR variation evaluated to be 
0%. Thus it is not necessarily true that each replicate of each of these compounds has 
exactly the same 1tR, but rather is an artefact of the data presentation. This group has 
proposed an algorithm for exact 1tR determination in GC×GC [219].     
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Table 6.1 1tR and 2tR retention time reproducibility and the relative error to the reference 
compounds 
Clen-2TMS 19-nor-2TMS EMD-2TMS M2-2TMS 
3’OH-stan-
3TMS 
 1tR (s) 2tR (s) 1tR (s) 2tR (s) 1tR (s) 2tR (s) 1tR (s) 2tR (s) 1tR (s) 2tR (s) 
AA average 
(n=13) 
1670 2.498 2125 2.577 2170 2.627 2343 3.071 2918 3.075 
RSD (%) 0.00 0.65 0.00 0.75 0.18 0.83 0.10 0.64 0.09 0.57 
ref. average 
(n=2) 
1670 2.480 2125 2.565 2165 2.605 2340 3.045 2920 3.055 
rel. error (%) 0.00 0.72 0.00 0.47 0.23 0.84 0.13 0.85 0.07 0.65 
 
The 2tR relative error of the reference compounds, even though not defined as part of the 
established WADA criteria, fall within the tolerance window of 1%. The reproducibility is 
in good agreement with the previous results [222], and the relative error is from 0.47% (for 
19-norandrosterone-2TMS) to 0.85% (for M2-2TMS metabolite). Reproducibility in 2tR 
values is found to depend on maintaining constant CO2 cryogen supply, since the 
temperature of the modulator can influence the 2tR; clearly the values found here, being 
less than 1% RSD, are acceptable for purposes of this criterion. The high reproducibility of 
1tR produces very reproducible elution temperature for all anabolic agents, which in turn 
means constant and stable 2tR. If the modulation process is properly conducted the 2tR is 
very robust so the same criteria (1% relative error) can be applied also for this additional 
parameter. The retention time reproducibility was carried out on spiked urine samples at 
different concentration levels, over the range from the limit of detection (2 ng mL-1) to the 
highest tested concentration level (20 ng mL-1), which demonstrates a rugged 
reproducibility assessment of 1tR. In the event that WADA adopts GC×GC technology, then 
a new criterion specific for 2tR will need to be considered. 
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6.3.2 Relative abundance tolerance window criteria 
 
Present WADA criteria [164]:  
- All diagnostic ions with relative abundance greater than 10% in the reference spectrum 
must be present in the spectrum of the unknown peak, and 
 
- The relative abundance of three diagnostic ions shall not differ by more than the amount 
shown in Table 6.2 from the relative intensities of the same ions from that of a spiked urine 
or reference material.  
 
Table 6.2 Maximum tolerance windows for relative ion intensities to ensure appropriate 
uncertainty in identification [164] 
rel. abundance 
(% of base peak) 
(EI)GC-MS 
> 50 ± 10% (absolute) 
25 to 50 ± 20% (relative) 
< 25 ± 5% (absolute) 
 
The mass spectrometric detection and identification in selected ion monitoring (SIM) 
mode is usually based on monitoring of one quantification ion (for estimation of 
concentration) and two or more qualification ions (qualifiers, for identification criteria). 
The relative abundance of these diagnostic ions in unknown samples compared to the 
relative abundances of the same ions from the reference compounds is used as criteria for 
positive identification. The graphical view of the maximum tolerance window of relative 
difference (MTWRD) against the relative abundance of the ions, based on WADA criteria 
[164], is given in Figure 6.2.    
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Figure 6.2 Graphical view of the maximum tolerance window of the relative difference 
(MTWRD) against the relative abundance, according to the WADA criteria [164] 
 
Several diagnostic ions and ion ratios for each anabolic agent have been tested against 
their compliance with the WADA relative abundance criteria. The results are summarized 
in Table 6.3.  
 
The results in Table 6.3 demonstrate that all ions and ion combinations for clenbuterol-
2TMS, except for 86 m/z alone, comply with the WADA criteria. The low reproducibility of 
the relative abundance of 86 m/z is due to two main factors: 
 
1. The low uniqueness of the base ion 73 m/z in TOFMS spectra. This ion is present in 
all trimethylsilyl (TMS) derivatized compounds - endogenous or exogenous - since 
it is a fragment pertaining to derivatizing agent. In contrast, the base ion in 
quadrupole based MS spectra (NIST05) is 86 m/z, which is more characteristic than 
73 m/z. 
2. The narrower permitted tolerance window of the relative difference for ions with 
higher relative abundance (see Figure 6.2).  
 
However 335 m/z, 337 m/z and their combinations, including the combinations with 86 
m/z, have complied with the criteria. The relative abundance ratio has shown higher 
reproducibility than the relative abundances itself. All ion combinations fell well within 
the tolerance window.  
Evaluation of WADA criteria in GC×GC format 
 170 
 
Table 6.3 Relative abundances of diagnostic ions and their combinations for AA spiked 
in urine extract over the concentration range from 2 ng mL-1 to 20 ng mL-1  
ion (m/z) 86 335 337 335/86 337/86 337/335 
average (%) 65.7 10.2 8.2 12.2 9.0 74.6 
STD 27.1 3.1 2.3 0.6 0.6 2.6 
Clen-2TMS 
(n=12) 
out of rangea 8 - - - - - 
ion (m/z) 405 420 315 420/405 315/405 315/420 
average (%) 35.4 14.9 13.4 41.9 36.6 81.0 
STD 20.4 9.7 8.7 3.5 5.1 13.5 
19-nor-2TMS 
(n=11) 
out of rangea 8 6 4 - 1 2 
ion (m/z) 358 143 216 358/143 216/143 358/216 
average (%) 1.9 67.1 3.4 2.9 5.0 57.6 
STD 0.3 9.0 0.7 0.4 0.7 9.0 
EMD-2TMS 
(n=12) 
out of rangea - 4 - - - 1 
ion (m/z) 255 143 435 255/143 435/143 255/435 
average (%) 2.7 86.9 2.8 3.3 3.5 94.7 
STD 0.4 19.0 1.3 0.4 1.3 29 
M2-2TMS 
(n=10) 
out of rangea - 4 - - - 3 
ion (m/z) 254 143 545 254/143 545/143 545/254 
average (%) 15.1 51.6 6.1 29.5 12.7 44.6 
STD 6.5 23.3 2.8 3.1 3.3 12.9 
3’OH-stan-
3TMS 
(n=9) 
out of rangea 1 6 1 1 - 1 
a Number of spiked urine samples (out of the total number of analysed samples) which do not comply with 
the WADA relative abundance criteria 
 
The relative abundance of the diagnostic ions and their combinations for EMD-2TMS fell 
within the tolerance window except the 143 m/z ion. Again, the main reasons for this are 
the same as for clenbuterol-2TMS: the low uniqueness of 73 m/z as a base ion in TOFMS 
spectra of EMD-2TMS, and the narrower tolerance window for ions with higher 
abundances. Any tested combination, except 143 m/z alone, can be used as a qualifier.   
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Methyltestosterone metabolite M2-2TMS gives similar results to EMD-2TMS. 143 m/z 
alone cannot be used as a diagnostic ion since it shows low reproducibility and does not 
comply with the established identification criteria. Another combination which cannot be 
used is the relative ratio of the 255 m/z and 435 m/z relative abundance; because they are 
both of low abundance (less than 3% of the base ion), their ratio can therefore vary greatly. 
All other ions and ion combinations (255 m/z, 435 m/z, 255/143 m/z and 435/143 m/z) can 
be used as qualifiers.  
 
The 143 m/z ion alone, as well as 254 m/z alone, did not pass the test as qualifiers for 
3’OH-stan-3TMS. However, 545 m/z, 545/143 m/z and 254/143 m/z gave results within the 
tolerance window. 560 m/z cannot be used as a diagnostic ion in samples with a 
concentration of 3’OH-stanozolol-3TMS lower than 4 ng mL-1, because of the observed bias 
of TOFMS towards higher masses [186]. The comparison of TOFMS and quadrupole MS 
spectra of 3’OH-stanozolol-3TMS is given in Figure 6.3. The relative abundance of 560 m/z 
in TOFMS spectrum of 3’OH-stan-3TMS acquired at 0.5 µg mL-1 concentration in standard 
solution (Figure 6.3a) shows approximately 20 times lower relative abundance when 
compared to the quadrupole based MS spectra (Figure 6.3b) [188]. However, the TOF mass 
spectra similarity of 3’OH-stan-3TMS to the in-house created TOFMS library ensures 
positive identification of this sterol even at the lowest level of concentration spiked in 
urine extracts.  
 
Each of the diagnostic ions alone for 19-nor-2TMS (405 m/z, 420 m/z and 315 m/z) have 
failed the criteria despite the good similarity of TOFMS spectra to the entries in the in-
house library. One of the reasons could be the coelution of 19-nor-2TMS with the 
endogenous component which shares some of the diagnostic ions [188], but most probably 
the reasons are the same as for the other anabolic agents. However, their combinations 
(with few exceptions at the lower levels of concentration) gave results within the tolerance 
window (Table 6.3). 
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Figure 6.3 Comparison of (a) TOFMS spectra of 3’OH-stan-3TMS acquired at 0.5 µg mL-1 
in standard solutions and (b) its entry from the NIST05 MS database. Note that the 
abundance of several consecutive mass intervals in TOFMS spectrum is enhanced by 
factors given above the intervals.   
 
Furthermore, the spectral similarity even at the lowest level of concentration is high 
enough to ensure unambiguous identification. The similarity of 19-nor-2TMS spiked in 
urine extract at different concentrations is given in Table 6.4. The general trend of 
increased similarity for higher concentrations has been observed, even though the 
variation of similarity has been found to be quite large (within ±10%). 
 
 
 
 
 
 
a) 
b) 
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Table 6.4 TOFMS similarity of 19-norandrosterone-2TMS spiked in urine extracts at 
different levels of concentration against the in-house TOFMS library  
conc. level 
(ng mL-1) 
similarity 
(n = 2) 
500 (std) 945 
20 926 
10 867 
8 891 
6 888 
4 799 
2 784 
 
The lower relative abundance of higher masses observed in TOFMS spectra of anabolic 
agents can be seen as an advantage over GC-qMS identification since the maximum 
tolerance window of the relative difference for lower abundance diagnostic ions is wider 
(see Figure 6.2), and the reproducibility of TOFMS spectra even at the lowest levels of 
concentration is good. On the other hand, the diagnostic ion ratio, which is not 
implemented in the WADA criteria, gave reproducible and consistent results allowing this 
to be used as a criterion in anabolic agent identification.  
 
6.3.3 Other criteria 
 
6.3.3.1 Presence of diagnostic ions 
Present WADA criteria: 
- Diagnostic ion with relative abundance of less than 5% in the reference must be present in 
the unknown. 
All the diagnostic ions with abundance above 10% which were present in the reference 
spectra of the anabolic agents have been detected also in the spiked urine samples. When 
ions with abundance lower than 5% were chosen as the qualifier, these ions were also 
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detected in spiked samples, even at the lowest concentration tested. As stated previously, 
the commonly used 560 m/z ion for 3’OH-stan-3TMS was not chosen as a qualifier because 
of the decreased sensitivity of TOFMS at higher masses. Figure 6.3 shows the comparison 
of TOFMS spectra of 3’OH-stan-3TMS and its entry in NIST05 MS database (qMS based 
spectrum). For the same reason the ion 448 m/z is not considered in EMD-2TMS 
identification criteria.  
 
This creates the biggest challenge in strictly applying the WADA criteria in GC×GC-
TOFMS: the lack of three diagnostic ions with abundance above 5%. As can be seen from 
Table 6.3, the abundances of 358 m/z and 216 m/z for EMD-2TMS, and 255 m/z and 435 
m/z for M2-2TMS metabolite, are below 5%. As a comparison, the abundance of these ions 
in NIST05 library entries of the same sterols is between 10% (216 m/z) and 30% (435 m/z). 
However, the high similarity of TOFMS spectra from spiked urine samples to the TOFMS 
spectra of the reference compounds permits unambiguous identification based on all ions 
in the spectrum. This has a range of ramifications for establishing a new criterion based on 
adequacy of library matches to sterol spectra as opposed to simply comparing ion ratios in 
SIM spectra [188].  
 
6.3.3.2 Isotope ratio criteria 
Present WADA criteria:  
- A second ion belonging to the same isotopic cluster may also be used as diagnostic only 
when the peculiarity of the atomic composition of the fragment so justifies (e.g. presence of 
Cl, Br, or other elements with abundant isotopic ions).   
The clenbuterol molecule contains two chlorine atoms and its isotope pattern can be 
another useful criterion in identification of this anabolic agent. The ion abundance ratios of 
337/335 m/z and 339/335 m/z have been compared against the theoretical values calculated 
by the isotope calculator from the NIST MS Search software package (ver. 2.0). The 
average ion abundance ratios were calculated from 12 spiked urine samples with anabolic 
agents over the concentration range from 2 ng mL-1 to 20 ng mL-1. The results are given in 
Table 6.5.    
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Table 6.5 Experimental and calculated isotope ratio patterns for clenbuterol-2TMS 
analysed in GC×GC-TOFMS format 
ion abundance ratio area ratio  
337/335 m/z 339/335 m/z 337/335 m/z 339/335 m/z 
average (%, n=12) 74.6 17.8 76.5 21.1 
RSD (%) 3.4 11.7 2.6 11.8 
calculated (%) 73.7 16.7 - - 
 
Good agreement has been obtained between the experimental and the calculated values 
for both ion ratios: 337/335 m/z and 339/335 m/z (Table 6.5). The 337/335 m/z and 339/335 
m/z ratios, when the peak area was used instead of ion abundances, were slightly higher. 
However, the reproducibility of the 337/335 m/z ion abundance and area ratio was better 
than the 339/335 m/z ratios.  
 
The good agreement between the experimental results obtained from clenbuterol-2TMS 
spiked at different concentration in urine extract to the theoretical values is a result of the 
deconvolution capabilities of the ChromaTOF software. The high acquisition rate (100 Hz) 
contributes to the correct deconvolution. A series of deconvoluted MS spectra of 
clenbuterol-2TMS spiked in urine extract at different concentrations, showing the chlorine 
isotope pattern, are given in Figure 6.4. 
 
Furthermore, the appearance of 334 m/z in the experimental results (but not in the 
calculated isotope pattern) and the differences arising in the isotope pattern at 336 m/z and 
338 m/z between experimental and calculated results (Figure 6.5) may be explained by 
presuming the formation of a species with A-1 m/z (that is, the 334 m/z ion). The isotope 
pattern of the dominant fragment ion at m/z 335 is shown in Figure 6.5. The experimental 
spectrum in this region extends from 334 – 341 m/z. Note that ion 334 m/z will not arise 
from fragment mass loss from the parent ion, but arises from an A-1 ion species. 
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Figure 6.4 Deconvoluted TOFMS spectra of clenbuterol-2TMS spiked in urine extracts 
at different concentrations, expanded over the 334-339 m/z cluster and normalized to 335 
m/z as the base ion 
 
Taking the predicted isotope pattern for the 335 m/z ion, including the Cl isotopes, gives 
the pattern labelled as ‘calculated without A-1 ion’. This is a very poor match with the 
experimental pattern. In order to calculate the isotope pattern correctly, the presence of the 
A-1 ion has been presumed, and since it contains 2 × Cl atoms (in the ratio 9 : 6 : 1), it will 
have a strong isotope contribution at 336 m/z. This leads to the large discrepancy between 
the experimental pattern and the calculated pattern in the absence of the A-1 species. Once 
the A-1 species is included as an overlapping ion pattern, very good agreement between 
experimental and calculated patterns arises.  
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Figure 6.5 Cluster isotope pattern of clenbuterol-2TMS in standard solution at a 
concentration of 0.5 µg mL-1 for  experimental data, calculated data by assuming the A-1 
fragment has been formed in a ratio 1:2 against A, and calculated data without taking 
the A-1 fragment formation into account 
 
6.3.3.3 Linearity 
The linearity of the proposed method has been calculated from spiked urine extracts with 
anabolic agents at different concentrations from 0.5 ng mL-1 to 20 ng mL-1. The correlation 
coefficients and the linearity curve equations are given in Table 6.6. The highest 
correlation (R2) was obtained for EMD-2TMS and 19-nor-2TMS (0.996) and the lowest for 
M2-2TMS metabolite (0.992). Please note than even though the quantification ions of the 
anabolic agents are detected down to the lowest tested concentration (except for EMD-
2TMS at 0.5 ng mL-1), unambiguous identification is obtained only at 1 ng mL-1 and above 
for clenbuterol-2TMS, 19-norandrosterone-2TMS and M2-2TMS, and at 2 ng mL-1 and 
above for EMD-2TMS and 3’OH-stanozolol-3TMS [188]. The good correlation coefficients 
are the result of the temporal deconvolution of the anabolic agents’ mass spectra from the 
background components, and this is a direct result of the separation of the components in 
the 2D space. The high acquisition rate of the TOFMS detector (100 Hz) further facilitates 
the deconvolution in the mass spectral domain. As previously shown [188], the poorer 
separation of the components on the 0.1 µm df 2D column gave lower similarity which is 
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based on the poorer deconvolution. Furthermore, the low acquisition rate of the TOFMS 
detector (20 Hz) in 1D GC experiments, and the separation based on classical 1D GC, gave 
even lower mass spectra similarity against TOFMS entries in the in-house library.        
 
Table 6.6 Linearity parameters for the anabolic agents spiked in urine extracts at 
different concentrations from 0.5 ng mL-1 to 20 ng mL-1 
anabolic agent quant. ion linearity equation* R2 
EMD-2TMS 358 m/z Y = 0.0081x + 0.0074 0.996 
19-nor-2TMS 405 m/z Y = 0.0061x + 0.0094 0.996 
M2-2TMS 255 m/z Y = 0.0144x + 0.0070 0.992 
clen-2TMS 335 m/z Y = 0.0143x + 0.0050 0.994 
3’OH-stan-3TMS 254 m/z Y = 0.0043x + 0.0003 0.994 
* Y=Area(AA) / Area(IS); x=concentration of AA (ng mL-1) 
 
6.3.3.4 Testosterone/epitestosterone (T/E) ratio 
Testosterone/epitestosterone ratio (T/E) values can be calculated from the same run with 
unambiguous identification of both sterols. The average similarity of testosterone and 
epitestosterone TOFMS spectra against the in-house library, across the concentration range 
of AA from 0.5 ng mL-1 to 20 ng mL-1 in urine samples, was 915 and 820, respectively.  
 
6.3.3.5 Signal-to-noise (S/N) ratio 
Present WADA criteria:  
- The signal-to-noise ratio of the least intense diagnostic ion must be greater than 3:1. 
 
The final criterion which must be complied with is the signal-to-noise (S/N) ratio for the 
least intense diagnostic ions. The lowest S/N permitted in WADA criteria is 3:1. S/N ratio 
for quantification ions obtained at 0.1 µg mL-1 in standard solution (which corresponds to 
2 ng mL-1 in spiked urine samples at a concentration factor of 50) has been found to be 
above 18 [188]. The lowest S/N (4) has been obtained for EMD-2TMS (358 m/z) spiked in 
urine extracts at 2 ng mL-1. This is again due to the bias of TOFMS towards the higher 
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masses, combined with the low relative abundance of 358 m/z. The lack of potential 
diagnostic ions in the TOFMS spectra of EMD-2TMS limits the choice.  
 
19-nor-2TMS and 3’OH-stan-3TMS are the only anabolic agents which completely comply 
with defined WADA criteria, since all others do not contain at least 3 diagnostic ions with 
abundance higher than 5% relative to the base ion. However, WADA permits a laboratory 
to establish its own identification criteria which can be based on minimum MS similarity 
against the reference compounds. A minimum acceptable match (MAM) has been defined 
[186] as a criteria for identification of minor components in a complex matrices such as 
urine, where a library match is required to be above a certain match quality in order to 
provide satisfactory identification of the component. The MAM in doping control depends 
on the reproducibility of the MS similarity and probably is best to be set at the average MS 
similarity of anabolic agents at the positive urine control level, corrected for the standard 
deviation of the reproducibility. It has been found that for unambiguous identification the 
MAM can be set at 800 when analysing free sterols in non-hydrolysed urine samples [186], 
and to 700 in hydrolysed urine samples [188]. The main reason is the more complex urine 
extract from hydrolysed samples. Obviously, MS similarity is just a confirmation of the 
other identification parameters, such as relative abundance ratio and retention time 
tolerance windows. In this case the MAM serves the purpose of providing a minimum 
value for the quality of full mass spectral similarity matching against, here, the in-house 
library for sterols. By all measures this should represent a sound basis for confirmation 
(subject to the metric by which library searches are performed). The compounds can still 
be quantified based on a selected single quantification ion if so desired.  
 
6.3.4 Other benefits of the GC×GC-TOFMS method 
 
Amongst T and E, another 8 sterols which were investigated in a previous work [186] were 
detected in the urine extract with an average similarity above 900. Once full MS data are 
available, the presence of sterols can be confirmed in post-run processing, allowing retro-
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searching for newly designed sterols, should the analyst become aware of such sterols or 
any other illicit compounds in the future.  
 
Another advantage of having access to the full mass spectral information is 
characterisation of the interfering components and the matrix. Just as the deconvolution 
works for the target anabolic sterols, so it works also for matrix components, and their 
spectra are likewise deconvoluted. This is a simple and inexpensive way to characterize 
trace components in urine matrix by their full deconvoluted mass spectra, and not just a 
limited suite of sterols defined by selected SIM ions and retention windows. 
 
Finally, as previously stated, several tens of other non-target components were identified 
with high similarity. Most of them are low molecular mass components, because lower 
mass components have higher similarity against the NIST05 database than high mass 
counterparts. At present only sterols are included in the custom in-house library. A 
dedicated comprehensive TOFMS library is needed for proper identification of higher 
molecular mass components because of the previously stated bias of TOFMS against the 
higher masses, and consequent larger differences between qMS (used for most library 
entries) and TOFMS spectra. 
     
 
6.4 CONCLUSIONS 
 
The results presented here confirm that GC×GC-TOFMS of anabolic agents largely 
complies with the established WADA identification criteria. This technique has been 
shown to be a powerful tool for detection and unambiguous identification of trace 
amounts of anabolic agents in complex matrix as urine, so proved to be a promising choice 
for doping control in sport competition.  
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Retention time reproducibility on both columns has been found to be below 0.83%, 
allowing relative error to the reference components to be within the WADA tolerance 
window of 1%. The second dimension retention time relative error also complies with 
these criteria, although it is not explicitly required in the WADA criteria. 
 
The relative abundance tolerance criteria have been complied with by most of the 
diagnostic ions selected, except for the high abundance ions or the ratio between two low 
abundance ions. Spectral deconvolution has been demonstrated in the case of clenbuterol-
2TMS, where very good agreement has been obtained between experimental and 
theoretical calculations for the isotope cluster from 334-339 m/z.     
 
Other general criteria complied with include the linearity and minimum spectral match 
quality for positive identification. The deconvoluted full mass spectral information of the 
non-target components and the matrix are other benefits from this method. The least-
complied criterion of the proposed method is the presence of at least three diagnostic ions 
in the TOFMS spectra with abundance above 5% of the base peak. This appears to be due 
to the predominance of the 73 m/z in sterol spectra, and if scans were to exclude the 73 m/z 
ion by presenting data at > 73 m/z, then the WADA criteria may be complied with. 
Because of the observed bias towards the higher masses, only 19-norandrosterone-2TMS 
and 3’OH-stanozolol-3TMS comply with the criteria. However, the high similarity based 
on the full mass spectra offers an unambiguous identification even at the lowest tested 
concentrations. This latter benefit of using full scan TOFMS data is not available for most 
classical methods used in doping control that rely on SIM analysis. 
 
The present work suggests that the GC×GC-TOFMS method can play an important role in 
doping control and drug testing in the future. Separation of components on 2D space 
relaxes the eventually coelutions with the matrix components and deconvoluted full mass 
TOFMS spectra offers unambiguous identification. This makes the method a good 
alternative for anti-doping screening and if sensitivity is improved and confirmed when 
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recovery is taken into consideration, the method can be a promising option for AA 
confirmation. 
 
 
 
  
 
 
 
 
 
 
 
Chapter 7 
 
7 PROFILING OF ECSTASY TABLETS BY USING 
COMPREHENSIVE TWO-DIMENSIONAL GAS 
CHROMATOGRAPHY 
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7.1 INTRODUCTION 
 
Amphetamines are the second most commonly used illicit drug type in Australia, after 
cannabis [223]. Ecstasy, a term referring to tablets containing 3,4-methylenedioxy-
methamphetamine as an active component, are very popular among young party-goers 
for their short-term effects, which include a heightened sense of well-being, reduced 
inhibitions, increased energy levels and self-confidence. According to the World Drug 
Report 2008 [1], at 4.4% Australia has the highest  rate of ecstasy users in the world for 
those aged 15-64. The composition of these illicit preparations can vary significantly under 
the influence of synthetic route, purification methods, source materials and the presence of 
cutting agents and tabletting excipients. As clandestine laboratories rarely adopt good 
manufacturing practices or standard preparation procedures, the presence and relative 
concentrations of trace impurities and additives may serve as chemical ‘fingerprints’ that 
are unique to a particular manufacturer, ‘cook’ or batch of drugs.   
 
In the last 2 decades considerable international effort has been made in the fight against 
illicit production and distribution of amphetamine-type stimulants (ATS), including 
ecstasy. In addition to cataloguing the physical characteristics (colour, shape, logo, 
dimension and mass) of seized samples [224, 225], other chemical features including the 
presence of major components, trace organics [106, 118, 230, 231], metals [116, 117] and the 
isotopic ratio of 15N/14N [111-114, 226] have been profiled. Several laboratories have 
harmonised their methods of analysis in the interests of efficient data sharing across 
jurisdictions [7, 106]. 
 
Impurity profiling in this sense is understood to be the chemical analysis, collection of 
data and its use for evidential or intelligence purposes [7, 10, 106, 233]. As in any type of 
profiling, the more information that is gathered during the analytical phase, the greater 
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the opportunity to derive some useful information from the relationship between the 
seized specimen and the database [7]. Trace organic component analysis is most often 
used for profiling or developing a sample ‘signature’ because it has the capacity to provide 
higher information content than other forms of analysis.  
 
Many reported methods for organic impurity analysis involve liquid-liquid extraction 
(LLE) [104, 106, 230, 231] and subsequent analysis by gas chromatography coupled to a 
flame-ionisation detector (GC-FID) [118, 234] or mass spectrometer (GC-MS) [104, 106, 
229]. More recently, solid phase micro extraction (SPME) of volatile components [227, 228] 
in ecstasy samples was found to give comparable results to LLE for the detection of the 
most discriminative components. The attraction to SPME was reported to be a simpler and 
shorter sample preparation and a reduction in the sources of error.  
 
The analysis of chemical ‘signature’ has been reported in a variety of ways. Principal 
component analysis (PCA) [112, 231] and hierarchical cluster analysis (HCA) [112, 113, 
116, 117] have been used for classifying samples according their similarities (intelligence) 
while Pearson correlation coefficients [106, 227, 229-231] and cosine functions [104, 231] 
have been employed for differential comparisons or evidential purposes. Most of the 
reported drug profiling methods have used single-column (or one-dimensional, 1D) 
chromatographic techniques. Due to the very large number of trace components found in 
the majority of illicit drug samples, most of these 1D chromatographic methods have had 
insufficient separating power to map important regions in the chromatogram. Co-elution 
can mask the presence of trace impurities that are definitive to the chemical signature and 
therefore reduce the informing power of the analysis. While mass spectrometry provides a 
tool that can be used for deconvolution of coeluting peaks, this method is only useful 
where there is either sufficient mass spectral power or where the coeluants are well 
resolved in the mass domain. In most cases, coeluant resolution to evidential standard 
relies on either a reduction in the informing power of the mass spectrum or the application 
of a tandem technique.   
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Conventional approaches to increasing informing power when employing 1D-techniques 
include multiple analyses on different columns or the use of complementary methods that 
are able to increase the information content of the total analysis. Typically for a single 
technique, increasing the informing power for one aspect of the analysis results in either 
reduced throughput and increased reporting times (larger data set) or a decrease in the 
sample cross-section and therefore a loss of information peripheral to the identity of the 
key components (increased specificity or selectivity). While both approaches are valid, 
neither is ideal for the efficient chemical fingerprinting of samples. These strategies not 
only limit the throughput in the laboratory but also risk the loss of important components 
that could have contributed to the unique signature of a sample.  
 
Recent advances in multidimensional chromatographic technologies provide a facile 
means of achieving high separation efficiency with a single injection and acceptable 
analysis times. One reported example from Neumann and Meyer [175] used “heart-cut” 
multidimensional  GC (GC-GC) for the analysis of illicit heroin. In their experimental 
setup, two GC columns of highly different selectivity were connected by a pneumatic 
Deans switch at the confluence of the two columns. The role of the switching device was to 
direct specific (co-eluting) bands from the first column (1D) to the second column (2D) for 
further analysis. This approach is particularly useful when specific parts of a 1D 
chromatogram contain severely overlapping analytes. The different selectivity of the 2D 
GC column affords enhanced resolution power to reveal trace impurities, which might 
otherwise be obscured.  Depending on the routing of the two outlet columns to detectors, 
the technique can provide an additive increases in the information content.  
 
In comprehensive two-dimensional gas chromatography (GC×GC), instead of sampling 
only subsections of the 1D column chromatogram, the entire eluted volume from the first 
column is subjected to further analysis on the 2D column. With only one detector, the 
increase in separation power is multiplied within the same analysis time as that of a single 
column GC experiment.  
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The opportunity to maximise the separating power of the two column set is reliant on 
selecting phases that have orthogonality in their selectivity towards the analytes of interest 
and so it is to be expected that column sets will be tuned to particular tasks. The 2D 
column in GC×GC must act as a fast-eluting high-efficiency column and is typically 0.5–2 
m in length and 0.1 mm I.D. with a 0.1 μm film thickness (df). The interface between the 
two columns (modulator) has to trap/accumulate all the components which elute from the 
1D column for a predefined period (typically 3–8 s) and then release the ‘focussed’ band in 
narrow fractions to the 2D column. The efficient trapping and fast release of components is 
usually achieved by cryo-focusing, which yields ultra-narrow peak widths at the end of 
the 2D column.  
 
GC×GC has been successfully applied in the analysis of petrochemical [201, 214], food 
[201, 229], environmental [204], forensic [189, 190, 205, 230, 231], doping [186, 187], and 
essential oil [168, 180] samples in complex matrices. In addition to improved peak 
capacity, GC×GC yielded highly structured chromatograms and improved sensitivity from 
increased signal height when compared to classical GC [185, 221].     
 
Although GC is an important technique for ATS profiling, to the author’s knowledge, no 
reports have been made describing the application of GC×GC in this area. GC×GC has 
characteristics that make it ideally suited for drug profiling purposes [21]. In this chapter, 
chemical profiling of 24 ecstasy tablets by GC×GC has been described and its potential as a 
new chemical profiling tool has been explored.  
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7.2 EXPERIMENTAL 
 
An Agilent 7890 GC was used in both GC-accurate time-of-flight mass spectrometry (GC-
accTOFMS) and GC-flame photometric detection (GC-FPD) experiments and an Agilent 
6890 GC fitted with a longitudinal modulation cryogenic system (LMCS) modulator 
(Chromatography Concepts, Doncaster, Victoria, Australia) was used in all other 1D GC 
and GC×GC experiments. A LECO Pegasus III MS instrument was used in fast acquisition 
TOFMS (fastTOFMS) experiments, an Agilent 5973 MSD in quadrupole MS (qMS) and 
Waters GCT Premier in accTOFMS experiments. 1D GC experiments were carried out 
either on a single column (qMS and accTOFMS) or under the same conditions as in 
GC×GC, except the modulator was off and the acquisition rate of fastTOFMS detection 
was reduced to 20 Hz. Thus in this case the 1D system will comprise a long column 
directly coupled to a short column. Whilst this can be termed a multi-chromatography 
system according to Hinshaw and Ettre [216] and discussed elsewhere [217], the second 
very short column is anticipated to lead to negligible variation in peak properties such as 
width. 
 
The GC conditions were kept the same for each column configuration, except the column 
head pressure which depends on the column dimensions and outlets. Column sets used 
for separation are listed in Table 7.1. Columns denoted BP were from SGE Analytical 
Science (Ringwood, Victoria, Australia), and the HP column was from Agilent (Folsom, 
CA, USA). Conditions are given below, unless otherwise specified. Injector and detector 
temperatures were both 250 °C and oven temperature program was from 40 °C (hold for 2 
min) to 250 °C at 10 °C min-1 (hold for 7 min). Hydrogen was used as a carrier gas at a flow 
rate of 1 mL min-1 in all FID/FPD and helium at 1.3 mL min-1 in all MS experiments. 
Splitless mode was applied for injection (SPME desorption) with a purge off time of 2 min. 
The modulation period (PM) was varied from 3 s to 6 s and modulation temperature (TM) 
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was set at -30 °C, 0 °C, 40 °C and 80 °C during the optimization stage. Temperature 
tracking was applied in all GC×GC-TOFMS experiments by keeping a constant 
temperature difference between the oven and modulator temperature of 130 °C, starting at 
0 °C for the LMCS cryotrap.   
 
Table 7.1 Column sets used in all 1D GC and GC×GC experiments 
system 1D column* 2D column** 
BP20 DB-1 
BPX50 BPX5 
BPX5 BPX50 
GC×GC-FID             
BPX5 BP20*** 
GC×GC-FPD BPX5 BP20 
GC×GC-fastTOFMS BPX5 BP20 
GC-accTOFMS HP5  
GC-qMS BPX5  
* 30 m x 0.25 mm; 0.25 μm 
** 1 m x 0.1 mm; 0.1 μm, except otherwise stated 
*** 1.4 m x 0.1 mm; 0.1 μm 
 
MS detectors were operated at ionisation energy of 70 eV over the mass range from 45 m/z 
to 500 m/z. One scan per second acquisition rate was used with all single column 
experiments (qMS and accTOFMS), 20 Hz in all 1D GC and 50 Hz in all GC×GC 
experiments with two-column sets (FID, FPD and fastTOFMS). Components were 
tentatively identified against NIST05 (National Institute of Standards and Technology, 
Gaithersburg, USA) and Wiley 7 (John Wiley & Sons, New York, USA) commercial MS 
databases by using PBM (qMS only) or NIST algorithm. When in doubt, accTOFMS was 
used for component confirmation. Automated spectra deconvolution and peak finding 
features of ChromaTOF (LECO Corp.) acquisition and data processing software have been 
applied in all fastTOFMS experiments. Signal-to-noise ratio (S/N) threshold of 100 was set 
for peak detection (except otherwise stated) and minimum acceptable match threshold 
[186] of 800 (on 0 – 999 scale) for component identification. All 2D plots are presented with 
50 contour levels from 10±2 pA to 50 pA (FID) or 180k – 680k counts (TOFMS).       
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7.2.1 Statistical analysis 
 
Data were processed using the Statistica Software release 8.1 package (Statsoft, Maison- 
Alfort, France). The 24 ecstasy tablets were gathered in eight groups by their post-
tabletting (post-TB) physical characteristics (logo, colour, diameter and thickness) and 
intelligence information. The raw dataset (53 observations x 16 variables) consisted of the 
abundance of the targeted compounds determined by GC×GC-TOFMS for each replication 
of each tablet sample plus 5 replicates of one sample (XTC5). The data were normalized 
according to the procedure described by Bonadio et al. [227, 228]. The procedure involves 
calculation of the 4th square root of the ratio between the abundance of the targeted 
compound and the sum of the abundance of all compounds selected for the profiling. To 
determine which compounds distinguished between the eight groups, a one-way analysis 
of variance (ANOVA) was performed on raw and normalized datasets according to the 
model: abundance of the compound : group of tablets, p<0.05. Principal component 
analysis was performed on raw and normalized data sets to visualize the structure of the 
data. In order to confirm the ability of some compounds to differentiate the samples 
according to their country of seizure, a one-way ANOVA was performed on the 
normalized data set according to the model : country, p<0.05.   
 
In order to determine a set of “orthogonal” compounds enabling discrimination of the 
eight groups of ecstasy tablets, a linear discriminant analysis (LDA) was carried out on the 
normalized dataset. For processing the LDA, the dataset was divided into two 
independent subsets: (i) a “learning” dataset (n=35) for the generation of candidate 
discriminative models and (ii) a “test” dataset (n=18) for the assessment of the robustness 
of the model. For the DA, only the three most relevant variables were selected according to 
the “best subset” algorithm. The best subset of three variables was selected from the 
learning dataset according to the best subset algorithm where the misclassification rate 
was chosen as the criterion of ranking between all the models constructed on three 
variables. 
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7.3 RESULTS AND DISCUSSION 
7.3.1 Separation of volatile components in ecstasy on different column sets 
 
The concept of orthogonality in GC×GC aims to maximise the utility of the 2D separation 
space by having minimum correlation between the retention mechanisms of 1D and 2D 
[232]. In cases where this extreme is desirable and can actually be achieved, the GC×GC 
approach is capable of generating a large number of points of reference and so is effective 
for profiling complex mixtures. In the case of chemico-legal profiling of illicit substances, 
differential analyses of this type permits ideally results in the derivation of relationships 
such as batch-to-batch association, supply chain tracking and mapping of synthetic and 
geographic origins.   
 
The selection of column sets that have demonstrable orthogonality is sample dependent 
and must be derived from either a detailed understanding of the sample composition or 
by empirical methods.  As the former is rarely achieved without first completing the 
orthogonal analysis, phase polarity is usually deduced using the ad hoc application of 
solvation parameter models such as that derived by Abraham et al. [233].  In practice, the 
phase polarity is more commonly interpreted in terms of a simplified polarity scale, such 
as that developed by Wynne et al. [234], in which spatial restriction to interaction are 
normalised and bonding considered according to the π- or n-type character in the analyte-
phase interactions.   
 
In the case of ecstasy and its likely precursors, by-products and contaminants, predictive 
analyte chemistry suggests that orthogonality to a simple van der Waals type retention is 
likely to be found by using an aromatic chemistry (on the basis of the 3,4-
methylenedioxybenzyl moiety) or a hydrogen bonding or n-electron chemistry (on the 
basis of the amine moiety) [234].  Accordingly, these polar chemistries (P) have been 
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coupled with less polar phases (NP) in two dimensional sets to test for separation of 
components in the ecstasy samples. 
 
7.3.1.1 BP20 / DB-1 
A BP20 / DB-1 column combination was used as a P – NP column set to test the separation 
of volatiles in ecstasy samples. Despite the reasonably good spread of the components on 
the 2D plot and their very good peak shape (Figure 7.1), the lowest number of components 
has been detected with this column set (proved when all column sets were tested). This 
fact together with the strongly tailed MDMA peak on the 1D column, which is most likely 
due to the strong H-bonding and weak n-π* interaction with the stationary phase, has 
limited the applicability of this column set in ecstasy volatiles profiling.  
 
 
Figure 7.1 2D plot of ecstasy sample XTC4 analysed by SPME GC×GC-FID on BP20 / 
DB-1 column set. The highly tailed MDMA peak on 1D column is annotated. 
 
7.3.1.2 BPX50 / BPX5 
The second P – NP column set applied for separation of volatiles in ecstasy tablets was 
BPX50 / BPX5 (Figure 7.2). Similarly to the separation on the opposite phase column set 
(BPX5 / BPX50, see Figure 4 later), increased peak signal was obtained due to the very 
narrow peaks on the 2D column, with the components spread in a narrow band on the 2D 
plot along the 1D time. Three different ecstasy samples (which were later proved to be 
different) showed similar GC×GC profiles here, but this is due to the poor separation on 
the 2D column which compresses the volatile components into the narrow band noted 
MDMA 
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above. The separation mechanism in BPX5 based on the weak H-bonding and stronger π-
π* interaction is not enough to separate the ecstasy constituents on 2D. This makes the 
column set unsuitable for GC×GC profile comparison since it does not offer much 
advantage over classical 1D GC separation. The major feature of this column set was the 
clear separation of highly NP components, i.e. alkanes and siloxanes, from the rest of the 
ecstasy constituents, which have the longest retention on BPX5. However, peaks as narrow 
as 50 ms peak width at half height (W1/2) on 2D column have been obtained.   
 
 
Figure 7.2 Representative 2D plots of ecstasy samples XTC3 (A), XTC4 (B), XTC5 (C) and 
a blank (D) analysed on BPX50 / BPX5 column set. Note the similarity of the profiles, 
even though the samples proved to be different. 
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7.3.1.3 BPX5 / BPX50 
The separation of volatiles in ecstasy tablets on a NP – P column set was first conducted 
using BPX5 / BPX50. While increased peak signal was obtained when compared to the 
other column set (BP20 / DB-1), the components are located in a narrow band in the 2D axis 
on the 2D plot along the 1D time, showing poor spread in 2D space (Figure 7.3). This 
makes the column set unsuitable for analysis of volatiles since it does not offer much 
advantage over classical 1D separation. However, good peak shape (narrow and 
symmetrical) has been obtained. The separation on this and the previous column set 
incorporating the BPX50 polar column suggests that the selectivity of the BPX50 phase is 
relatively poor towards chemical constituents of the sample. However, this phase is 
known to be more selective (retaining) towards aromatic compounds. It seems that all 
sample constituents show similar “aromaticity” and the selectivity towards BPX50 is in 
some way “normalized” to give only a narrow separation band. The separation appears to 
be superficially the same as a boiling point elution, thus reducing the orthogonality of this 
column set. 
  
 
Figure 7.3 2D plot of sample XTC4 analysed by SPME on BPX5 / BPX50 column set 
 
7.3.1.4 BPX5 / BP20 
The second NP – P column set tested was BPX5 / BP20. This column set showed a good 
spread of components over the 2D space, as well as having good peak shape (Figure 7.4). 
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Despite the unresolved cluster of components at the lower right side region of the 2D 
plots, which is partially contributed by siloxanes from the SPME fibre and column bleed, 
most of the components are well separated and spread within 2D space. It seems the 
spread of the components on the 2D column (BP20) is mainly due to the column selectivity 
towards the aliphatic hydrocarbon chain in sample constituents rather than the selectivity 
towards the aromatic moiety. 
 
This column set reveals a high number of volatiles in ecstasy samples, offering complex 
sample profiles for easier sample comparison. Three different volatile ecstasy profiles are 
shown in Figure 7.4, along with a representative blank. Closer examination of the profiles 
reveals some easily noticeable differences in component ratios between samples, and some 
differences in presence/absence of other components. Because of this, all further 
experiments were conducted on this column set. However, unambigious identification of 
the components is necessary in order to avoid comparison of samples based on non drug-
origin related markers. Whilst a large number of reference components is required for 
identification of components based on GC×GC-FID, availability of MS detection provides 
valuable molecular information of sample composition. 
 
Flame photometric detection (FPD) is a highly sensitive and selective detection system 
toward P- and S-containing components. Its potential in GC×GC format for ecstasy 
profiling has been investigated by using this column set. However, only a few components 
(data not shown) have been detected on both the P- and S-channel. Although some 
infrequent and unusual components can be of great value in sample-to-sample 
comparison, the few detected components with similar ratio in the analysed ecstasy 
samples has been shown to be of little value in ecstasy volatile profiling by using FPD. 
 
On the basis of the good separation found for the present NP – P column set, it was 
decided that a subset of 16 compounds would be selected as representative of different 
ecstasy samples, to demonstrate sample similarity and heterogeneity. 
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Figure 7.4 Representative 2D plots of three different ecstasy samples analysed by SPME 
on BPX5 / BP20 column set, at -30 °C modulation temperature and 6 s modulation 
period: sample XTC3 (A); sample XTC4 (B); sample XTC5 (C) and a blank (D). Note the 
differences between profiles, especially as suggested by the circled regions. The 
annotated components in sample XTC3 are selected for 2tR and area reproducibility. 
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7.3.2 Optimization of some GC×GC parameters 
 
Modulation period, PM. It has been shown in subsequent experiments that 5-6 s modulation 
period is necessary in order to elute some polar components from the highly polar 2D 
column, under the proposed conditions, within one PM value. The most retained 
components from the selected 16, along with various fatty acids, were the most polar 1,3-
benzodioxole-5-MeOH and benzyl alcohol. Although they showed a high level of tailing 
on the 1D column, they were well modulated on the 2D column which makes identification 
and integration much easier [188].     
 
Modulation temperature, TM. Not surprisingly, it has been found that lower modulation 
temperature offers better peak shape. However, consistent with conclusions in previous 
work on sterols [186], experience reveals that higher modulation temperature favours 
better elution of some of the higher boiling point components (data not shown). Whilst a 
modulation temperature of -30 °C offers the best overall peak shapes, modulation at 0 °C 
gave acceptable results since none of the early eluting components were selected for 
profiling. All subsequent experiments, unless otherwise stated, were carried out at this TM.    
 
7.3.3 Reproducibility of peak area and 2D retention time in GC×GC 
 
The reproducibility of the GC×GC method was confirmed by running five fresh aliquots of 
the same sample on the above column set. Very reproducible profiles were obtained, even 
in terms of the minor components usually not seen in 1D GC chromatograms. The 2D 
plots of five replicates of ecstasy sample XTC3 are given in Figure 7.5. 
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Figure 7.5 2D plots of five replicates of ecstasy sample XTC3 obtained by GC×GC-FID 
on BPX5 / BP20 column set. The three components selected for 2tR and peak area 
reproducibility are circled in the top plot.  
 
The 2tR and the peak area reproducibility of three selected components (shown in Figure 
7.4A, and in the top plot of Figure 7.5) are given in Table 7.2. Relative standard deviation 
1 
2 
3 
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(RSD) of ~1% was obtained for 2tR reproducibility and 6-7% RSD for peak area 
reproducibility of the selected components. The results for 2tR reproducibility here are in 
good agreement with the previous findings in GC×GC format [188, 222].  
 
Table 7.2 Reproducibility of 2D retention time and peak area of three selected 
components obtained from five replicates of ecstasy sample XTC3, analysed by SPME 
GC×GC-FID. Selected components are annotated in Figure 7.4A. 
 component 1 component 2 component 3 
Average (s) 2.736 3.228 2.328 
2tR 
RSD (%) 1.20 0.83 1.15 
Average (pA s) 13.19 14.56 48.05 
Area 
RSD (%) 6.2 7.0 6.1 
 
7.3.4 Ecstasy volatiles profiling on GC×GC-TOFMS 
 
The two column sets incorporating BPX50 and BPX5 were eliminated from further 
experiments due to the low components spread over the 2D separation space. This is 
greatly contributed by the poorer orthogonality of these column sets towards sample 
constituents compared to the orthogonality of BPX5 / BP20 and BP20 / DB-1. The phase 
selectivity of BP20 based on H-bonding interactions apparently plays a key role in the 
orthogonality of these column sets for this kind on components. 
  
Both, BP20 / DB-1 and BPX5 / BP20, gave good spread of the ecstasy volatiles in the 2D 
plots. However, because of the strong tailing of the large MDMA peak on the 1D BP20 
column, all further experiments were proceed on the BPX5 / BP20 column set. One method 
difference involved replacing the 1.4 m 2D column with a 1.0 m long 2D column of the 
same type, to avoid any wraparound (ensuring 2tR < PM) whilst still keeping good spread of 
the components on the 2D plots.  
 
 
 
Ecstasy profiling by GC×GC 
 
 200 
 
7.3.4.1 Identification of components on GC×GC-TOFMS 
Automated deconvolution and peak finding data processing of GC×GC-TOFMS 
chromatograms on this column set revealed the identity of most of the higher abundance 
components with high match quality. The high match quality of TOFMS spectra against 
commercial MS databases (NIST05 and Wiley7) agreed with our previous conclusions 
[186, 188] that match quality decreases as molecular mass and higher mass ion 
fragmentations in the mass spectra increase. The highest molecular mass components 
which were detected and identified in HS-SPME sampling were N-formyl- (RMM 221) and 
N-acetyl-MDMA (RMM 235), compared to as high as RMM 560 for derivatized 
components in the previous study of sterols (see Chapter 5 and Chapter 6).     
 
Through use of ChromaTOF software automated detection and identification, an extensive 
number of components in ecstasy volatile profiles have been recorded. In some ecstasy 
samples up to 450 components out of a total of 1200 have been tentatively identified at a 
S/N threshold of 100 and minimum acceptable match threshold of 800, of which several 
tens were replicates and background components (mainly siloxanes, see Figure 7.4D). In 
comparison, only 50 out of 200 detected peaks in total were identified against MS 
databases by using PBM algorithm in GC-qMS experiments under similar 
chromatographic and integration conditions (data not shown). This demonstrates that 
ecstasy volatile profiles in GC×GC format are complex, that many more peaks can be 
positively identified, and that GC×GC approaches should be appropriate for sample-to-
sample comparison and grouping. Representative GC×GC-TOFMS 2D plot of an ecstasy 
sample analysed on BPX5 / BP20 column set is given in Figure 7.6.   
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Figure 7.6 Representative SPME GC×GC-TOFMS 2D plot of an Australian ecstasy 
sample analysed on BPX5 / BP20 column set. The location of selected 16 components for 
profiling, along with the identified fatty acids, is shown on the plot. 
 
7.3.4.2 Selection of components for profiling and their location on the 2D plot 
Selection of components for profiling was firstly based on previous work [104, 106, 227, 
235], according to components that have been previously employed for profiling in 1D GC 
methods. Among several precursors (safrole, isosafrole, piperonal), intermediates (PMK) 
and by-products (piperonyl alcohol, PMK-OH, N-formyl- and N-acetyl-MDMA) with 
known origin, several unknown or known components with unexplained origin have also 
been selected. The structures of the 16 selected components which showed good 
reproducibility and were present in all tested samples in reasonable but variable 
concentrations are given in Figure 7.7. Their location on a representative 2D plot of an 
ecstasy sample is given in Figure 7.6, and the peak table with their names, 1tR, 2tR, and 
quantification ions for peak area calculation is given in Table 7.3.  
 
 
 
Ecstasy profiling by GC×GC 
 
 202 
 
O
O
   O
O
   O
O
   O
O O
 
1                                  2                                    3                                    4 
O
O OH
    O
O
O
   O
O
OH
    O
O
O
 
5                                  6                                    7                                    8 
O
O
N O
  
O
O
N O
   O
O O
 
OH
 
9                                     10                                   11                      12 
O
O
    
O
    N
S
    O
O Cl
 
13                           14                        15                        16 
Figure 7.7 Structures of the selected 16 components selected for profiling. Note that 
most compounds incorporate similar aromatic functionality; this choice of compounds 
was not a deliberate strategy, but rather was completely fortuitous.  
 
Peak area reproducibility of the selected components for profiling has been confirmed on 
the BPX5 / BP20 column set also in GC×GC-TOFMS format, similarly to the procedure 
where GC×GC-FID had been applied. An average of 9.1% RSD has been obtained with the 
lowest being for 1,3-benzodioxole-5-MeOH (6.0%) and N-acetyl-MDMA (5.8%) and the 
highest for benzyl alcohol (15.7%) and benzothiazole (15.5%). The average RSD has 
reduced on 7.9% when the three least discriminative components (3,4-MD-benzyl-Cl, 
benzyl alcohol and benzothiazole) were excluded from the calculation. The last two 
components do not contain the 3,4-methylenedioxyphenyl bridge. The higher RSD in 
GC×GC-TOFMS format over GC×GC-FID format is likely related to the lower mass 
spectrometry reproducibility over FID reproducibility. Peak area reproducibility is a key 
issue when the aim is to discriminate samples according to their similar profiles. A poor 
reproducibility is a source of unexplained variability and contributes to lower the 
discrimination power of the distinctive compounds.     
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Even though the number of selected components for profiling is quite large (16), only one 
component (5) in only one sample (XTC3) was not detected at a defined S/N threshold of 
100, but was detected at S/N ratio of 20. This is partially contributed by the strong tailing 
of 5 on the 1D column, where up to 6 modulation slices were automatically detected, 
integrated and summed up. Adequate integration was facilitated by the excellent trapping 
and releasing of 5 on the 2D column, giving narrow peaks with an average W1/2 of ~200 ms. 
It has been shown latter that this tailing and low abundant component could be one of the 
most discriminative in the proposed statistical approach.   
 
On the other hand, the TOFMS detector was saturated with some of the components listed 
in the literature at their characteristic ions, i.e. N,N-dimethyl-3,4-methylenedioxy-
amphetamine at 72 m/z. Because of this, the component was rejected from selection. An 
inconvenience due to the overloading has been encountered also with other higher 
abundance components in the profiles such as PMK, piperonal and PMK-OH. Sometimes 
different modulation slices of the same component have been identified and integrated as 
different species, so manual inspection and proper data processing method (match 
similarity threshold for combining modulation slices, peak width on 2D, S/N threshold) are 
required. This problem was not observed with lower abundance components in the 
profiles.      
 
Many production-specific components, generally those containing a 3,4-methylene-
dioxyphenyl bridge, co-elute on the 1D column with some matrix components or cutting 
agents, but they then are subsequently separated on the 2D column. Figure 7.8 shows co-
elution of benzodioxole-5-MeOH (5) with two other matrix components, with which they 
share the two most characteristic mass fragments of 5: 135 m/z with component x and 152 
m/z with component y. Note that the Macedonian ecstasy sample presented in Figure 7.8 
(sample XTC3) contains minor amount of 5, in contrast to the Australian ecstasy sample 
presented in Figure 7.6. 
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Table 7.3 Peak table of the 16 selected components chosen for profiling with their 
retention times and quantification ions used for area calculation 
 Compound 1D time 
(s) 
2D time 
(s) 
Quant. ion 
(m/z) 
1 safrole 960 1.58 162 
2 isosafrole-2 995 1.78 162 
3 3,4-methylenedioxyphenylpropane 
(3,4-MD propane) 
920 1.48 164 
4 piperonal 970 2.86 149 
5 1,3-benzodioxole-5-MeOH 
(benzodioxiole-5-MeOH, piperonyl alcohol) 
1005 4.54 152 
6 3,4-methylenedioxyphenyl-2-propanone 
(Piperonylmethylketone, PMK) 
1080 2.58 178 
7 3,4-methylenedioxyphenyl-2-propanol  
(PMK-OH) 
1085 2.88 180 
8 unknown 147 1150 2.420 147 
9 N-formyl-MDMA 1400 3.080 162 
10 N-acetyl-MDMA 1415 2.78 162 
11 3,4-methylenedioxyacetophenone 
(3,4-MDAcPh) 
1050 2.62 164 
12 Benzyl alcohol 670 4.24 108 
13 3,4-methylenedioxytoluene 
(3,4-MD toluene) 
740 1.68 135 
14 benzylmethylketone (BMK) 760 1.98 134 
15 benzothiazole 870 2.28 135 
16 3,4-methylenedioxybenzylchloride 
(3,4-MD-benz-Cl) 
990 2.30 170 
 
The highly abundant and strongly tailing peaks of polar organic acids on the 1D column 
can strongly interfere with some of the co-eluting components in the profiles. For example, 
Figure 7.6 shows that 13 co-elutes with heptanoic acid, 1 with decanoic acid and 8 with 
several matrix components on the 1D column. However, they are all well resolved on the 
2D column and this, facilitated by the deconvolution and automated peak finding features 
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of ChromaTOF software, resulted in high similarity to the commercial MS database 
entries.  
 
   
Figure 7.8 Extracted ion 2D plot of Macedonian ecstasy sample XTC3 showing the co-
elution of 5 on the 1D column with two other components which share some common 
mass fragments: component x and component y have abundant 135 m/z and 152 m/z 
daughter ions, respectively. Note that these two ions are the two most characteristic for 
5. 1D GC will have difficulty in identifying these peaks.    
 
Two out of four of the most discriminative components listed in the work of Weyermann 
et al. [235] elute after N-formyl- and N-acetyl-MDMA, and they were not detected in the 
samples due to their poor sorption on SPME fibre at the applied temperature (80 °C). 
Several other higher boiling point components listed in the literature were not detected in 
the samples due to the SPME sampling limitation. However, many lower molecular 
weight components are detected in the profiles which could represent minor by-products, 
intermediates or impurities present in precursors used in ecstasy production and the list of 
the components selected for profiling can be further extended.    
 
The average match quality of the 15 selected components listed in Table 7.3 (there is no 
entry for Unknown 147 in the MS databases) against NIST05 and Wiley7 was 920, the 
lowest being for N-formyl-MDMA (813) and N-acetyl-MDMA (901) and the highest for 
isosafrole-2 (957) and 3,4-MDAcPh (965). The mass spectrum of Unknown 147, in a latter 
stage confirmed as 3-(3,4-methylenedioxyphenyl)-3-buten-2-one by accTOFMS at 3 ppm 
   y  
    x 
5 
  152+135x0.1 m/z 
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error, showed high similarity to the literature spectra [106] of Unknown 44. The high 
match quality for low RMM compounds, facilitated also by the deconvolution capabilities 
offered by ChromaTOF software, precludes the need for generation of a TOFMS dedicated 
in-house library, which was necessary in the previous study on higher molar mass sterols  
[186] and anabolic agents [188]. 
 
GC×GC has demonstrated its improved separation and enhanced sensitivity over 1D GC 
through more separated and detected components in the profiles. The fastTOFMS detector 
performance (high speed in full mass spectra mode, non-skewed spectra across the peak, 
spectral deconvolution and peak finding features) fits perfectly with the GC×GC 
performance and simply testifies to its superior identification power over 1D GC when 
coupled to this detector. However, the larger number of separated and detected 
components requires an extensive study on relationship between the newly detected 
components and their significance in ecstasy profiling. 
 
7.3.5 Authentication of ecstasy tablets based on GC×GC-TOFMS profiling 
 
The 24 tablets were initially classified in eight groups by their post-TB characteristics, even 
though samples from Macedonia (XTC1, XTC2 and XTC3) were all from different seizures 
and samples from Australia (ECS1 to ECS5) were from a single seizure. In order to 
determine whether the sixteen variables chosen for profiling enable to discriminate these 
groups (supposing they all have different profiles), one-way ANOVA was performed on 
the raw dataset and confirmed the relevance of each of the sixteen selected volatile 
compounds (p<0.05). The first map of the PCA performed on the dataset (53 analysed 
samples x 16 compounds) shows that it was possible to make a clear distinction between 6 
of these groups based on the raw data (peak area) provided by the GC×GC-TOFMS 
analysis (Figure 7.9A). In contrast, ECS3 and ECS5 or ECS2 and ECS4 can not be clearly 
distinguished. Figure 7.9B shows the first map of the PCA performed on the same dataset 
after its normalization by the procedure proposed by Bonadio et al. [229, 230]. Whereas the 
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percentage of variation explained by the first map was roughly the same, Figure 7.9B 
shows a clear separation of the 8 groups after normalisation and confirms both the 
relevance of this data treatment and the suitability of the sixteen selected compounds for 
authentication purpose.  
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Figure 7.9 First map PCA differentiation of 24 ecstasy tablets carried out from the raw 
(A) and normalized (B) abundances of the 16 selected components. The eight groups are 
annotated by their names beside each group and the country of seizure is annotated by 
empty circles (Macedonia) or empty squares (Australia). 
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In addition to the clustering of tablets from different seizures with the same post-TB (XTC 
samples) and differentiation between the eight groups, Figure 7.9B also evidenced a 
clustering of Australian and Macedonian samples. The examination of the variable 
projection on the PCA first map (data not shown) shows that Macedonian samples were 
found to be rich in N-formyl-MDMA and N-acetyl-MDMA and poor in 3,4-MD-propane 
and 3,4-MD-acetophenone as compared to Australian samples. One-way ANOVA 
confirmed this significant country effect (p<0.05) for the four variables with Fisher-F 
values ranging from 57 to 386.  
 
In order to determine the best subsets of variables enabling the discrimination of the eight 
groups, a linear discriminant analysis (LDA) was applied on the normalized data matrix. 
Several combinations of three compounds chosen out of the sixteen were shown to be 
suitable to classify 100% of the samples in both learning and test subsets of the dataset. 
Figure 7.10 shows the discrimination obtained in the 3D orthogonal space generated by 
3,4-methylenedioxyacetophenone, 1,3-benzodioxole-5-MeOH and Unknown 147.  
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Figure 7.10 3D score plot of normalized abundances of three components selected by 
LDA, showing clear discrimination of the eight groups of ecstasy tablets  
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Even though synthesis route elucidation was not the focus of the present thesis, several 
components specific for country of seizure have been detected. 2-(dimethylamino)-2-
methyl-3-(3,4-methylenedioxyphenyl)-propanenitrile, shown to be a marker for reductive 
amination by using cyanoborohydride (NaBH3CN) [103], has been detected in different 
proportions only in samples from Macedonia. Its GC×GC-TOFMS spectrum is given in 
Figure 7.11. The difference in the reduction pathway could be one of the reasons for 
obtaining different profiles between samples according the country of seizure. 
Interestingly, the presence of this component in samples from Macedonia could not be 
confirmed with accTOFMS even though the relative location on 1D GC chromatogram and 
accurate mass were available. The reason is probably the presence of this component at 
low levels, where the compression effect of the modulator and the relatively low m/z of 
the base mass fragment (97 m/z) favour its detection and identification in GC×GC format. 
As a reminder, the sensitivity of fastTOFMS is biased against higher masses [186, 188, 236]. 
 
50 100 150 200 250 3000
25
50
75
100
51 77
70
232
97
135
2-(dimethylamino)-2-methyl-3-(3,4-
-methylenedioxyphenyl)-propanenitrile
re
l. 
a
bu
n
da
n
ce
 
(%
)
m/z  
Figure 7.11 Mass spectra of 2-(dimethylamino)-2-methyl-3-(3,4-methylene-dioxyphenyl)-
propanenitrile, a marker for cyanoborohydride reduction of PMK, found only in 
samples from Macedonia.  
 
Two other unknown components, whose mass spectra are given in Figure 7.12, have been 
detected only in samples from Australia. This could be another reason for the difference in 
the profiles between samples from the two countries. Even though the initially annotated 
Unknown 166 has not been identified against MS databases, the mass spectrum (Figure 
7.12A) resembles the mass spectrum of piperonyl methyl ether, a component previously 
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reported as an impurity in ecstasy samples [106]. The identity of initially annotated 
Unknown 208 is still unknown but the presence of 135 m/z ion fragment in its mass 
spectrum (Figure 7.12B) suggests it could be a 3,4-methylenedioxyphenyl derivative. 
Many more components are detected in extracted 135 m/z GC×GC chromatograms (data 
not shown) which suggest that the number of potential markers could be much higher 
than the selected 16 components.       
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Figure 7.12 Mass spectra of Unknown 166 (A) and Unknown 208 (B), two components 
detected only in samples from Australia 
 
 
7.4 CONCLUSIONS 
 
The purpose of this work is to show the enhanced separation efficiency of GC×GC over 
classical 1D GC, and to prove its applicability in ecstasy impurity profiling. Different 
column set combinations gave different profiles with components spread over 2D space in 
a different pattern. The BPX5 / BP20 column set has shown the best separation with 
maximum use of the 2D separation space among the tested column sets.    
 
General advantages of GC×GC over 1D GC applies also in ecstasy volatiles profiling. The 
modulation process, combined with SPME concentration and sampling, leads to almost all 
selected components being detected at S/N threshold of 100 and tentatively identified with 
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an average MS similarity of 920. Some components previously reported in the literature as 
being relevant to ecstasy profiling are rejected due to the TOFMS saturation at its 
characteristic mass fragment. The incorporation of highly tailed components on the 1D 
column in the presented metric, which is always problematic in classical 1D GC and limits 
the selection of these components for profiling purposes, is facilitated due to the 
modulation process involved in GC×GC which captures a larger area proportion of such 
peaks. Combined with the increased separation efficiency, enhanced sensitivity and 
retaining the full mass spectra information content of targets, non-targets and the matrix, 
extends the possibility of detecting more markers and route-specific components, 
especially low abundance polar components (i.e. component 5). However, the work 
should include a larger sample set in order to construct robust and generic models for 
sample classification and discrimination. 
 
PCA has clearly classified the 24 analysed ecstasy tablets into 8 groups, which corresponds 
to their post-tabletting features. PCA score plot has also shown distinction between 
Macedonian and Australian samples based on the relative abundance of the selected 16 
components for profiling purpose. In a latter stage, several components characteristic 
either for Macedonian or Australian samples only have been detected, which makes 
differentiation between countries of seizure trivial.     
 
GC×GC-TOFMS can be successfully applied to ecstasy impurity profiling. The main 
drawback of the method is its high investment cost. Peak integration, even facilitated by 
the compression effect of the modulator, can be an issue since more “slices” have to be 
integrated, properly identified, and combined in one total peak area. This is especially true 
for highly abundant components such as PMK, piperonal and PMK-OH. This makes the 
method more operator-dependent than the current GC-MS profiling methods. On the 
other hand, automation in data processing (detection, identification and integration) with 
low abundance components appears to work better than in GC-qMS.     
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Chapter 8 
 
8 APPLICATION OF COMPREHENSIVE TWO-
DIMENSIONAL GAS CHROMATOGRAPHY IN 
HEROIN AND COCAINE PROFILING  
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8.1 INTRODUCTION 
 
Cocaine is a purely natural component derived from coca leaves (Erythroxilym coca). Its 
illegal production involves several consecutive extraction and purification steps, leaving 
the main component unchanged from its source to the final product. However, many 
naturally occuring components in coca leaves are co-extracted and so are present in the 
final product, giving rise to its total profile. Tropacocaine (TPC), ecgonine methyl ester 
(EME), cis- and trans-cinnamoylcocaine (CCC and TCC, respectively), cuscohygrine are the 
most frequently encountered in cocaine samples. Others i.e. hygrine, trimethoxycocaines, 
trimethoxy-tropacocaines, are present in minor amounts in coca leaves or are largely 
removed during the extraction process; they are less frequently found in cocaine samples 
[84, 85]. Special extraction methods such an ion-pairing and column fractionation [84] have 
been developed in order to effectively quantify the presence of natural impurities. Some of 
them i.e. truxillines show poor chromatographic behaviour so reduction to simpler 
molecules and their derivatization is required for their detection [75, 86]. 
 
The process of purification usually involves an oxidation step by potassium 
permanganate, where many by-products are generated. The bulk of them are intentionally 
removed, i.e. cis- and trans-cinnamoylcocaine, but many more are unintentionally formed 
during the poorly controlled oxidation step. N-norcocaine, N-benzoylnorecgonine methyl 
ester and N-formylcocaine have been formed in over-oxidized cocaine samples [74]. Four 
diastereomeric of 2,3-dihydroxy-3-phenylpropionylecgonine methyl esters from 
incomplete oxidation of cis- and trans-cinnamoylcocaine have been detected in cocaine 
samples [78]. Due to their highly polar character, derivatization prior to GC analysis is 
required. Another group of by-products has been detected in Peruvian cocaine base 
samples purified by using ethanol instead of permanganate oxidation. Several ethyl 
homologues of natural tropane alkaloids have been detected in these samples due to the 
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transesterification [77], after ion-pair chromatography fractionation and concentration. 
Finally, many hydrolysis products are formed during the production steps or during 
prolonged storage under  inappropriate conditions. Hydrolysis usually occurs at the ester 
linkage so cocaine yields benzoylecgonine, ecgonine methyl ester, ecgonine and benzoic 
acid. Trace amounts of other hydrolysis products are formed from minor tropane 
alkaloids.         
    
Heroin on the other hand is a semi-synthetic drug obtained by acetylation of morphine, a 
purely plant-derived alkaloid isolated from the latex of opium poppy (Papaver 
somniferum). Many naturally ocuring alkaloids in opium poppy (codeine, thebaine, 
noscapine, papaverine etc.) are co-extracted with morphine and undergo acetylation 
giving many by-products. This is especially true for the raw processed morphine, where 
the variety in the impurities, their acetylation products and degradation by-products, and 
variety in their concentrations give rise to the total heroin profile. At least nine 
degradation products of thebaine [16] and eighteen of papaverine [17] have been detected 
when these components had been boiled in acetic anhydride. On the other hand, 
acetylation of highly purified morphine samples results in heroin which lacks these trace 
components, leading to simpler profiles.    
 
The level of different manufacturing by-products and naturally occuring alkaloids in 
cocaine and heroin samples vary significantly, about 2-3 orders of magnitude [75]. The 
concentration range of the impurities as well as the variety in their chemistry require 
various methods for extraction, concentration, derivatization and detection. This is 
especially true for cocaine where many different cocaine profiling methodologies have 
been applied.  
 
The generic approach to major component profiling of cocaine and heroin [27, 29, 38, 94, 
140, 243] is based on sample dissolution, optional prior derivatization and injection into 
the GC port. Sample comparison is based on the normalized area of each of the selected 
analytes against the peak area of cocaine, the peak area of whole morphine (sum of 
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morphine, 6-monoacetyl morphine and diacetylmorphine), or the peak area ratio against 
an internal standard. The chromatograms do not appear complex because of the very few 
target components at relatively high concentrations in the profiles. Cocaine, CCC, TCC, 
tropacocaine, ecgonine, benzoyl ecgonine, EME are mainly used in cocaine profiling; 
meconine, acetyl codeine, 6-monoacetyl morphine (6-MAM), papaverine and noscapine 
are often used in heroin profiling.  
 
A separate cocaine and heroin profiling method based on solvents occluded in their 
crystals have been applied as a complementary technique by using head space (HS) [47, 
48, 93] or solid-phase microextraction (SPME) [92] sampling. The information content has 
been limited to several solvents detected in the samples, originating from the purification 
and base-to-salt conversion process applied. The most frequently encountered solvents are 
toluene, acetone, diethyl ether, methyl ethyl ketone and methylene chloride in cocaine 
samples [93] and acetic acid, acetone and diethyl ether in heroin samples [46, 47]. 
Additional methods for sample-to-sample comparison and geographic origin 
determination are based on isotope ratio [56, 58, 60, 62, 95] or trace metal contaminants 
[51-53, 55, 96].  
 
Advanced heroin profiling methodology has been generally based on acidic and neutral 
organic impurity extraction [19], concentration and subsequent analysis on GC coupled to 
FID [19, 33] or MS detector [17, 34]. Sixteen impurities have been selected in the most 
comprehensive study aimed at harmonizing the method for retrospective comparison and 
data exchange between three well-equipped and experienced forensic laboratories [31]. 
Various limitations of the GC technique have been identified as the main reason for the poor inter-
laboratory reproducibility. Recently, comprehensive two-dimensional gas chromatography 
has been applied in heroin and cannabis impurity profiling with pixel-based chemometric 
processing [190]. Even though only 9 out of 16 componets reported in the literature have 
been detected in a relatively simple 2D profile, the group classification has matched the 
results found by well-established 1D GC impurity profiling methods and/or the forensic 
background of the samples. However, the applicability of GC×GC is poorly justified for 
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samples where no coelutions on 2D column have been observed and the problem could be 
solved by using well established 1D GC.       
 
The most comprehensive cocaine profiling approach so far has been developed and used 
by the Special Testing and Research Laboratory (STRL) at the Drug Enforcement 
Administration (DEA) in USA. The approach is based on six independent cocaine profiling 
methods for sample comparison analyses, geographic origin studies and solvent 
determinations [142]. It combines different and separate preparation steps, from simple 
derivatization, through head space sampling of volatiles, to component reduction and 
column chromatography fractionation. Furthermore, different detection systems have 
been used for each class of the components (FID, ECD, MSD).     
 
However, none of the profiling methods available offers high information content and 
simplicity at the same time. Either the methods are complex and time consuming but 
offering high amount of data, or they are simple but offering limited information content. 
 
In this chapter an application of comprehensive two-dimensional gas chromatography as 
an alternative simple and reasonably high information content method for cocaine and 
heroin sample discrimination is presented. The method is based on SPME sampling of 
volatiles and semi-volatiles in cocaine and heroin samples, subsequent separation on a 
non-polar / polar column set and TOFMS detection. Even though many components 
currently used in profiling methods, especially those which require reduction and 
derivatization (truxillines), and higher molecular mass components (i.e. CCC, TCC, 
papaverine, noscapine, thebaine acetylation by-products) are not detected, the method 
offers a complex profile composed of many other sample constituents. Several potential 
markers have also been detected in highly purified heroin samples from SEA. To author’s 
best knowledge, this is the first ever application of GC×GC in cocaine profiling and the 
second one in heroin profiling, but this time focused on more complex profiles of heroin 
volatile and semi-volatile components.       
 
Cocaine and heroin profiling by GC×GC 
 
 218 
 
 
8.2 EXPERIMENTAL 
 
Gas chromatography and mass spectrometry conditions for profiling of volatiles in heroin 
and cocaine samples were generally the same (unless otherwise sated) as the conditions 
applied in ecstasy profiling in Chapter 7.  
 
Analysis of impurities in heroin samples extracted by LLE was performed in 1D and 
GC×GC mode by using BPX5 / BPX50 and BPX50 / BPX5 column sets. For column 
dimension details see Experimental section for ecstasy profiling (Chapter 7). 1D GC 
experiments were carried out either on 1) a single column (qMS and accTOFMS) or 2) on 
coupled columns under the same conditions as in GC×GC, except the modulator was off 
and the acquisition rate of fastTOFMS and FID detectors was reduced to 20 Hz. Thus in 
this case the 1D GC system will comprise a long column directly coupled to a short 
column and whilst this can be termed a multi-chromatography system according to 
Hinshaw and Ettre [216] and discussed elsewhere [217], the second very short column is 
anticipated to lead to negligible variation in peak properties such as width. The applied 
temperature program [31] was from 160 °C to 320 °C at 6 °C min-1 (hold 6 min) at a flow 
rate of 1.3 mL min-1 (He). Splitless injection with a purge time of 1 min was applied.  
   
Comparison between major component analysis of cocaine samples in 1D GC and GC×GC 
mode has been done on the same column set, under different oven temperature program 
[141]. The following conditions in 1D GC analysis were applied: isothermal temperature at 
180 °C was kept for 1 min, then increased to 275 °C at 4 °C min-1 rate, and finally hold at 
this temperature for 2.25 min. One µL of the MSTFA derivatized sample was injected in 
split mode at 20:1 split ratio.  
 
 
Cocaine and heroin profiling by GC×GC 
 
 219 
 
8.2.1 Statistical analysis 
 
Several pre-treatment methods on the raw data followed by PCA analysis have been 
tested in order to find the best statistical approach for separation of linked (subsamples) 
and non-linked (different seizures) samples. Applied pre-treatment methods are given in 
Table 8.1.  
 
Table 8.1 Applied pre-treatment methods on the raw data (peak area) of the selected 
heroin and cocaine volatile components  
 Description abbreviation 
1 Normalization N 
2 Normalization + square root N + SQR 
3 Normalization + 4th square root N + 4SQR 
4 Logarithm Log 
5 Normalization + logarithm N + Log 
 
20 volatiles in 21 heroin and 23 volatiles in 18 cocaine samples have been selected for 
profiling purposes. The raw dataset of heroin/cocaine samples consisted of the abundance 
of the targeted components determined by GC×GC-TOFMS. Each sample was run in 
duplicate, unless otherwise stated. However, some components were absent in some 
samples (i.e. heroin samples seized in Australia) either because the actual components 
were absent from the samples, thus representing characteristic of the sample profile, or 
they were below the limit of detection of the instrument [94]. In such a case an arbitrary 
area has been assigned to the component, which corresponds to the concentration of that 
component at the limit of detection under the given conditions. Data were processed by 
using the Minitab 15 software package (Minitab Inc., State College, PA, USA).  
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8.3 RESULTS AND DISCUSSION 
8.3.1 1D GC vs. GC×GC in major component analysis of cocaine and heroin 
 
Based on author’s previous results and experience in illicit drug analysis, GC×GC was not 
expected to offer much advantage over 1D GC in term of major components analysis. The 
only advantage expected was seen in some increase of sensitivity for low abundant 
components. A comparison of GC×GC-FID and 1D GC-FID chromatograms of the same 
cocaine sample is presented in Figure 8.1. 
 
 
Figure 8.1 Comparison of (A) GC×GC-FID and (B) GC-FID results for cocaine major 
component analysis. BPX5 has been used in 1D GC and BPX5 / BP20 column set in 
GC×GC format. Note the difference in the peak width of cocaine on 1D column.    
 
Despite the two well separated pairs of coeluting components in 1D GC at 11 min and 19 
min, there is not much improvement in the GC×GC 2D plot. In contrast, several 
components eluting immediately after the cocaine in 1D GC (Figure 8.1B) are overlapped 
by its huge and tailing spot on 1D column in GC×GC format (Figure 8.1A). Peak tailing on 
1D of overloaded components in GC×GC is mainly contributed by the inefficiency of the 
co
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modulator to effectively remobilize the trapped (overloaded) portion onto the 2D column. 
The spot width on 1D can be minimized either by increasing the temperature of the 
modulator (to ease the remobilization), or by decreasing the modulation period (less 
component cryotrapped per cycle). However, both can significantly alter the overall 2D 
plot, either by inefficient trapping of other components (at higher TM) or by increasing the 
chances of wraparound (shorter PM). In general, the example confirmed the proposition 
that GC×GC has no advantages over 1D GC when dealing with simple component 
mixtures. Similar results for comparison between 1D GC and GC×GC analysis of main 
components have been obtained for heroin samples (data not shown).   
 
8.3.2 1D GC vs. GC×GC in impurity profiling of heroin  
 
Heroin organic impurities have been analysed on both, BPX5 / BPX50 and BPX50 / BPX5 
column sets, the second one being similar to the column configuration used in [190]. The 
first column configuration gave good spread of components on 1D BPX5 column with 
relatively strong retention and almost no coelution revealed on 2D BPX50 column (Figure 
8.2A). The retention on BPX50 is probably contributed by the high aromaticity content of 
the impurities. Despite the expected enhancement in sensitivity, there was not much 
improvement in separation compared to the well established 1D GC heroin profiling 
methods (Figure 8.2B).  
 
Since the column choice for separation of high boiling point components in GC×GC is 
limited to the few high temperature limit columns, the logical step was to check the 
separation on BPX50 / BPX5 column configuration. As expected (Figure 8.3), most of the 
aromatic impurities have shown strong retention on the 1D BPX50 column, with some 
better spread of components on 2D BPX5 column, and few coelutions of minor components 
revealed on 1D BPX5 column. However, the strong tailing of the major polar components 
on 1D column, especially the latter eluting, has rejected this column set as an appropriate 
for heroin impurity profiling. The major benefit of using this column set, among the good 
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spread and peak shape of early eluting components, was the clear separation of straight 
chain hydrocarbons and siloxanes from other components (Figure 8.3). Less tailing on 1D 
and more on 2D column has been obtained in the results of Groger et al. [190].    
     
 
 
Figure 8.2 Comparison of a heroin impurity profile in (A) GC×GC-FID with the profile 
in (B) GC-FID   
 
 
Figure 8.3 A representative heroin impurity profile on BPX50 / BPX5 column set. Note 
the significant tailing of components on 2D column, and especially on 1D column for 
late eluting components. Siloxanes and n-alkanes homologues are denoted.    
 
8.3.3 Cocaine and heroin volatile profiles in 1D GC 
 
A sampling procedure similar to the one explained in the previous chapter on ecstasy 
profiling (see Chapter 7) has been applied to cocaine and heroin samples in order to check 
if their volatile and semi-volatile profiles are complex enough for profiling in GC×GC 
format. Generally, heavier molecules and consequently less volatile components were 
siloxanes 
n-alkanes 
B 
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expected in cocaine and heroin samples, so prolonged equilibration and absorption time 
was applied in the SPME sampling procedure. Chromatograms of three different cocaine 
samples analysed on GC-qMS are given in Figure 8.4. Reasonably complex profiles were 
obtained, showing many coelutions. However, only a small number of components were 
identified with a similarity above 800 (out of 999). The number of identified components 
was improved by applying the AMDIS32 (NIST), an automated deconvolution and 
identification software, but still the number was far below the number of components 
identified by GC×GC-TOFMS in a later stage. Similar results were obtained also for three 
different heroin samples. In author’s opinion, the profiles looked complex enough and 
promising for the next step - comprehensive two-dimensional gas chromatography. 
 
 
Figure 8.4 Comparison of GC-qMS volatile profiles of three different cocaine samples: 
sample Ca (A), sample Cb (B) and sample Cc (C)  
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8.3.4 Separation of volatiles in cocaine and heroin samples on different column 
sets in GC×GC format 
 
Comprehensive two-dimensional gas chromatography offers more choices in term of 
column selection over 1D GC because two-column combinations are in play in each 
system. As stated previously, the choice for higher molecular weight components is 
limited due to the temperature limitation of highly polar columns. On the other hand, the 
choice is much wider for volatiles and semi-volatile components eluting up to 260 °C. The 
separation of volatiles in cocaine and heroin samples has been tested on four different 
column sets: two non-polar (NP) – polar (P) and two P – NP. Different profiles for each 
column set have been obtained, each offering advantages and disadvantages over the 
other column sets. 
  
8.3.4.1 BPX50 / BPX5 
The first column set applied in cocaine volatiles separation was BPX50 / BPX5. Three 
different cocaine samples (proved to be different in a later stage) have shown different 
profiles, but the components were spread on a rather narrow band along the 1D column 
(Figure 8.5). It seems that the separation mechanism in BPX5 based on the weak H-
bonding and moderate π-π* interaction is not enough to separate the cocaine constituents 
on 2D column. This makes the column set unsuitable for GC×GC profiles comparison since 
it does not offer much advantage over classical 1D GC separation. 
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Figure 8.5 Representative 2D plots of volatiles in cocaine samples Ca (A), Cb (B), Cc (C) 
and a blank (D) analysed by SPME on BPX50 / BPX5 column set. 
 
The major feature of this column set was the clear separation of highly non-polar n-
alkanes from the rest of the matrix, having the longest retention time on 2D column 
(BPX5). However, narrow peaks on 2D column have been obtained. Interestingly, very 
similar dispersion on 2D column has been obtained also for volatiles in heroin samples, 
which were spread rather in a narrow band along the 1D column. Similar profiles have 
been obtained for samples Ha and Hb and slightly different for sample Hc (Figure 8.6), 
even though all three samples proved to be different. 
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Figure 8.6 Representative 2D plots of volatiles in heroin samples Ha (A), Hb (B), Hc (C) 
and a blank (D) analysed by SPME on BPX50 / BPX5 column set. Note the similarity of 
the profiles in (A) and (B), even the samples have proved to be different. 
 
8.3.4.2 BP20 / DB-1 
A BP20 / DB-1 column combination was used as a second P – NP column set to test the 
separation of volatiles in cocaine and heroin samples. Very few components in sample Cc 
(Figure 8.7) have been detected in contrast to the 2D plot of the same sample obtained on 
BPX50 / BPX5 column set (Figure 8.5C). Please note that the same contour level has been 
used in all FID 2D plots. However, good spread on 2D space and good peak shape have 
been obtained, excluding some components showing tailing on 1D column, (most probably 
the polar ones). Similar results have been obtained on 15 m FFAP as a 1D column, showing 
similar profiles; however at a shorter total runtime (due to the reduced 1D column length).  
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Figure 8.7 2D plot of volatiles in cocaine sample Cc analysed by SPME on BP20 / DB-1 
column set 
 
Chromatographic behaviour of volatiles in heroin on this column set (Figure 8.8) has been 
found similar to the cocaine volatiles, not because of their same identity, but simply 
because the spread over 2D space. Compared to separation on BPX50 / BPX5, smaller 
number of components has been detected; however they showed good peak shape and 
they were better spread on the 2D plot. It seems the separation mechanism of DB-1, based 
on weaker aromatic and hydrogen bonding but strong van der Waals interaction, shows 
higher discrimination of cocaine and heroin constituents on 2D column, thus better spread 
over the 2D space. 
 
 
Figure 8.8 2D plot of volatiles in sample Ha analysed on BP20 / DB-1 column set 
 
8.3.4.3 BPX5 / BPX50 
The separation of volatiles in cocaine samples on NP – P column sets was initially 
conducted on the BPX5 / BPX50 column set (Figure 8.9A). While slightly increased peak 
signal for components was obtained when compared to BPX50 / BPX5 column set, and 
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significantly more components detected than in the case of BP20 / DB-1, the components 
are rather located in a narrow band on the 2D plot along the 1D retention time, showing 
poor spread on 2D space. The “orthogonality” of this column set based on the different 
aromaticity content of the two phases (5% vs. 50%) does not work well for cocaine 
constituents. The poor spread on 2D plot is undesirable in GC×GC, which makes the 
column set unsuitable for analysis of volatiles since it does not offer much advantage over 
classical 1D GC separation. Similarly to the separation on BPX50 / BPX5, good peak shape 
has been obtained. Again, similar results for spread of components on 2D plots have been 
obtained also for volatiles in heroin samples (Figure 8.9B).  
 
 
 
Figure 8.9 2D plots of cocaine sample Cc (A) and heroin sample Ha (B) analysed by 
SPME on BPX5 / BPX50 column set. Note that the same contour levels are used in all 
FID 2D plots.  
 
8.3.4.4 BPX5 / BP20 
BPX5 / BP20 was the second NP – P column set tested for volatiles in cocaine and heroin 
samples. It has shown better spread of components on the 2D space, as well as good peak 
shape This column set revealed the highest number of separated volatiles in cocaine 
(Figure 8.10) and heroin (Figure 8.11) samples compared to the other column sets, offering 
complex sample profiles for easier (or reliable) sample discrimination. The “orthogonality” 
of this column set, based on strong van der Waals and weak aromatic interactions of BPX5 
A 
B 
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phase vs. strong H-bonding and weak π- and van der Waals bondings of the BP20 column, 
is more discriminative towards heroin and cocaine volatile constituents. A representative 
GC×GC-FID profile of volatiles and semi-volatiles in cocaine is shown in Figure 8.10 along 
with a 2D plot of a blank, where only a few siloxanes are detected as background 
components. 
 
 
Figure 8.10 Representative 2D plots of (A) cocaine sample Cc and (B) a blank, analysed 
by SPME on BPX5 / BP20 column set at 0 °C modulation temperature and 5 s 
modulation period. 
 
In contrast to heroin volatile profiles of samples Ha, Hb and Hc obtained on BPX50 / BPX5 
column set (given in Figure 8.6), profiles on BPX5 / BP20 showed more individual 
components and could serve reliable sample comparison based on much more 
individually separated components. However, unambigious identification of the 
components is necessary in order to avoid comparison of samples based on non-origin 
related markers. Unfortunately, a high number of reference components is required with 
GC×GC-FID to identify all components. A closer look at the heroin profiles in Figure 8.11 
can distinguish sample Ha from sample Hb and the differences are easily noticeable at the 
circled regions. Because of this, all further experiments were conducted on this column set, 
including the application employing a flame photometric detector (FPD). Differentiation 
of these two samples on the other column set was almost impossible. The largest spot in 
A 
B 
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sample Hb at 1tR of 20-23 min is due to the high abundance peak of caffeine, which in fact 
is not a good component for sample comparison.     
 
 
Figure 8.11 Representative 2D plots of heroin samples Ha (A), Hb (B) and Hc (C) 
analysed by SPME on BPX5 / BP20 column set at 0 °C modulation temperature and 5 s 
modulation period, along with a 2D plot of a blank (D), analysed under the same 
conditions. Note the difference in the Ha and Hb profiles at circled regions.  
 
8.3.4.5 Heroin and cocaine profiling on BPX5 / BP20 with FPD detection 
The findings for presence of S- and P-containing components in heroin and cocaine 
volatiles are similar to the findings for ecstasy profiling. Very few components at similar 
ratio have been detected on both S- and P-channels, which makes this highly selective and 
sensitive detector not suitable for profiling purposes.    
caffeine 
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8.3.5 Cocaine and heroin volatiles profiling by GC×GC-TOFMS 
 
GC×GC-TOFMS separation and identification were conducted on the BPX5 / BP20 column 
set under the same conditions as in GC×GC-FID experiments, but with two differences: 1.4 
m 2D column was replaced with 1 m long 2D column of the same type and helium was 
used as a carrier gas instead of hydrogen.  
 
8.3.5.1 Identification and location of components in GC×GC-TOFMS 
As expected, most of the higher molecular weight components usually used in cocaine and 
heroin profiling have not been detected in profiles by SPME sampling. The main reason, 
beside the low concentration of some of them, is the sampling technique. Some are not 
amenable for direct detection without prior reduction and/or derivatization (i.e. 
truxillines). Head space SPME is generally not efficient in sampling higher molecular 
weight components, components which show low vapour pressure and polar components 
on PDMS/DVB. However, GC×GC-TOFMS chromatograms of volatiles and semi-volatiles 
in four different cocaine samples (Figure 8.12) have revealed a large number of 
components, with some of them as potentially good markers for profiling purpose.  
 
Good spread of the volatiles on this column set has also been obtained for heroin samples. 
Figure 8.13 shows different profiles of different heroin samples seized in Australia. It is 
well known that highly purified heroin samples from SEA (the majority of heroin samples 
seized in Australia come from this region) have simple organic impurity profiles making 
them less suited for sample-to-sample comparison by using current profiling 1D GC 
methods. However, volatile profiles of these samples are still of reasonable complexity and 
represent a good base for selecting many markers for sample discrimination. The huge 
peak at 1tR of 1350 s in Figure 8.13A and Figure 8.13C is due to the heavy sample 
adulteration with caffeine.  
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Figure 8.12 Representative GC×GC-TOFMS 2D plots of cocaine samples Ca (A), Cb (B), 
Cc (C) and a cocaine sample seized in Australia (D), analysed by SPME on BPX5 / BP20 
column set. Visually different profiles have been obtained for different samples. 
 
In contrast to the previous methods for cocaine volatile profiling [93, 244], where 
components eluting up to acetophenone (RMM 120) have been detected and selected for 
profiling, in the present method components with a molecular weight up to 289 
(norcocaine) have been detected. The list of components preliminarily selected for cocaine 
profiling purposes consisted of 23 components (Table 8.2) and the list of selected 
components for heroin profiling consisted of 20 components (Table 8.3).  
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Figure 8.13 Representative GC×GC-TOFMS 2D plots of heroin samples H6 (A), H7 (B), 
H8 (C) and H9 (D) seized in Australia, analysed by SPME on BPX5 / BP20 column set. 
Visually different profiles have been obtained for different samples. 
 
Some of them are well known as constituents of cocaine (tropanone, ecgonidine ME, EME, 
tropacocaine and norcocaine) and heroin samples (meconine, hydroxycotarnine, acetyl 
codeine), some of them are structurally similar to cocaine-related (methyl benzoate, 
trimethoxybenzaldehyde, methyl- and ethyl cinnamate) and heroin- or opium-related 
components (cresol acetate isomers, 4-methoxy quinoline) and are related or possibly 
related to them, but many of them apparently have not been previously reported as 
cocaine (methyl nicotinate, 1-methyl pyrrole, 2,5-pyrrole-dione) or heroin sample 
constituents (1,2,4-trimethoxy benzene, 3,4- and 3,5-dimethoxy benzaldehyde, xanthene 
isomers) and therefore their origin is unknown. An extensive study on a larger number of 
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samples is required in order to establish a strong relation between these components and 
their origin. However, most of them are prevalent in all analysed cocaine samples, with 
few exceptions where some selected components are unique for Macedonian or Australian 
samples. The latter makes classification according to the country of seizure trivial.  
 
Highly purified heroin samples from SEA (i.e. samples seized in Australia) lack many of 
the components selected for profiling making differentiation between SEA and SWA 
samples trivial. However, the lack of markers in these samples makes differentiation 
within a region difficult and probably an increase of extraction temperature and sample 
amount are a possible solution to reveal more components for reliable sample 
discrimination. 
 
The list of components for cocaine profiling can be further extended with components 
frequently encountered in cocaine samples but originating from solvents (or impurities in 
solvents) used in cocaine extraction and purification. Toluene, xylene isomers, ethyl 
benzene, trimethylbenzenes, straight-chain hydrocarbons, benzyl alcohol, benzoic acid etc. 
are detected in many cocaine samples, but they are not taken into consideration. In the 
same manner, acetic acid, toluene, n-alkanes, xylene isomers, phenyl acetate, 
benzaldehyde etc. are detected in heroin samples but not taken for profiling purpose.  
 
The lowest boiling point solvents such as diethyl ether, acetone, methanol, ethanol, 
methylene chloride etc. are not determined because of their poor trapping at the operating 
temperature of the modulator (-30 °C to 0 °C). Formation of some degradation products 
due to the long equilibration and absorption time (80 min in total), even though unlikely, 
is not excluded. However, such a confirmation requires an extensive research undertaking.  
 
A number of pyridine and quinoline derivatives have been detected in some cocaine 
samples from Macedonia only, which probably represent a unique profile of samples 
originated from that batch or particular supply chain. Two pesticides have been detected 
at different levels in some drug samples. γ-lindane has been detected in some cocaine 
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samples from Macedonia and in one sample from Australia, and trifluraline has been 
detected in all heroin samples from Macedonia and in one sample from Australia.  
 
Table 8.2 Selected 23 components for cocaine profiling with their retention times, ions 
used for area calculation and similarity against NIST05 and Wiley7 MS libraries 
 
Component 
1tR 
(s) 
2tR 
(s) 
similaritya 
quant. ion 
(m/z) 
RMMb 
1 1-methyl pyrrole 340 1.64 946 81 81 
2 phenyl methyl ketone 700 2.04 961 120 120 
3 methyl benzoate 725 1.76 938 136 136 
4 2,5-pyrrole-dione 750 3.22 947 113 113 
5 methyl nicotinate 775 2.12 943 137 137 
6 1-phenyl-1,2-propanedione 800 2.06 952 105 148 
7 tropanone 835 1.92 905 139 139 
8 6-caprolactam 905 3.34 940 113 113 
9 α-oxo-benzeneacetic acid methyl 
ester 915 2.40 966 105 164 
10 2-chloroacetophenone 915 2.66 956 105 154 
11 ecgonidine methyl ester 1010 1.56 809 181 181 
12 ecgonine methyl ester 1085 1.80 899 199 199 
13 4-ethoxybenzoic acid ethyl ester 1100 1.68 930 194 194 
14 Unknown-1 1110 2.18 - 199 - 
15 3,4,5-trimethoxybenzaldehyde  1165 2.38 925 196 196 
16 phenyl benzoate 1210 1.64 972 105 198 
17 2-ethylhexyl benzoate 1260 1.02 888 105 234 
18 (4-chlorophenyl)phenyl methanone 1355 1.56 907 216 216 
19 tropacocaine 1430 1.76 909 245 245 
20 Unknown-2 1445 1.30 - 182 - 
21 1,3-diphenyl-1,3-propanedione 1505 3.42 904 223 224 
22 norcocaine 1600 3.52 928 168 289 
23 Unknown-3 1755 2.96 - 105 - 
a Calculated from duplicate analysis obtained from samples where the component has been detected at S/N  
of 100 or above.  
b RMM: relative molecular mass. 
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The trace amount of pesticides could be good batch markers if they originate from the coca 
and opium crops treatment. Their presence in the samples (only when present in higher 
amount) has been confirmed by GC-accTOFMS with an average mass accuracy of less than 
5 ppm. It is worth to mention that GC-accTOFMS was not able to detect and confirm the 
presence of pesticides in samples with lower abundance even though they were detected 
and tentatively identified by using GC×GC-TOFMS. The sample carry-over was excluded 
as an option for this discrepancy, since none of the pesticides were detected in the blanks.  
 
Table 8.3 Selected 17 components for heroin profiling with their retention times, ions 
used for area calculation and similarity against NIST05 and Wiley7 MS libraries  
 Name 1tR (s) 2tR (s) similarity quant. ion (m/z) 
1 4-cresol acetate 770 1.76 940 150 
2 3-cresol acetate 805 1.76 905 150 
3 naphthalene 825 1.74 940 128 
4 Unknown 129 isomer1 905 2.12 - 129 
5 Unknown 129 isomer2 930 2.74 - 129 
6 1,2,4-trimethoxybenzene 975 2.02 945 168 
7 3,5-dimethoxybenzaldehyde 1060 2.18 920 166 
8 3,4-dimethoxybenzaldehyde 1090 2.44 925 166 
9 4-methoxyquinoline 1135 2.34 850 159 
10 3,4-dimethoxybenzyl acetate 1165 2.14 835 210 
11 xanthene isomer 1 1195 1.64 - 181 
12 xanthene isomer 2 1205 1.74 - 181 
13 xanthene isomer 3 1215 1.76 - 181 
14 Unknown 197 isomer 1 1210 1.20 - 197 
15 Unknown 197 isomer 2 1215 1.26 - 197 
16 Unknown 197 isomer 3 1250 1.32 - 197 
17 meconine 1275 3.78 885 194 
18 hydrocotarnine 1320 1.92 840 220 
19 acetyl codeine 1395 3.44 830 341 
20 trifluraline 1200 1.26 810 306 
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Once the full mass spectra of the components of the matrix are retained, cutting agents 
and other non-target components can be easily included in the list if such is needed. On 
average 400 components out of 1400-1700 detected in total have been tentatively identified 
in the samples with MS similarity above 800 and S/N threshold of 10. Although several 
tens are background components (mainly siloxanes from the SPME fibre and column 
phase bleeding) the majority are still cocaine and heroin related components.  
 
The large number of components detected in heroin and cocaine volatile profiles in this 
experiment is mainly contributed by three factors:  
 
i. The extraction and concentration capabilities of SPME sampling method, where the 
whole sorbed extract to the SPME fibre is introduced directly into the GC system. In 
contrast, in liquid injection methods only small part of the extract is injected (usually 
1 µL out of 100-500 µL).  
 
ii. The compression effect of the modulator, where the whole effluent in the time 
interval of 5-6 s has been condensed and released to generate sharp bands (~200 ms) 
on the 2D column. 
 
iii. The separation of the complex profiles based on two different mechanisms results in 
increased number of components resolved and detected as unique compounds.  
 
While the first factor is purely due to the sample preparation step, the last two are 
exclusively contributed by the comprehensive two-dimensional gas chromatography. Full 
mass spectral data recorded at high acquisition rate, combined with the automated 
deconvolution capabilities of ChromaTOF software, have also contributed to the total 
number of detected components.  
 
One of the drawbacks in GC×GC-TOFMS is the “artificial” increase in the number of 
detected components due to the modulation process. Namely, each “slice” of the same 
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component is first deconvoluted, detected, integrated and identified, and then all the slices 
with MS similarity above the pre-defined value are combined as a unique component with 
common retention times on 1D and 2D columns, area and MS identity for all combined 
slices. In cases where the MS similarity between different slices is below the pre-defined 
value, or the difference in their retention times on the 2D column is above the tolerance 
window, each different slice is identified as a different component, which “artificially” 
increases the number of detected unique components, which then requires manual 
adjustment. Some of the reasons for this include inability to accommodate proper S/N and 
peak width thresholds in samples with large variability of component abundance, 
multiple slicing of high abundance components, MS similarity threshold too high, high 
fluctuation in the modulation temperature etc. However, this can be minimized with 
proper tuning of the data processing method or can be completely eliminated by manual 
inspection and correction of the results. Approximately several tens of components are 
“artificially” added to the real number of unique components in both heroin and cocaine 
volatile profiles.        
 
While the number of components detected in Macedonian samples in GC×GC format was 
around 2000 (several tens were replicates and background components), the number of 
components in the corresponding samples in 1D GC mode was 3-4 times less. Some of the 
lower abundance selected components for profiling of heroin and cocaine samples have 
not been detected in 1D GC mode analysis of the same samples. Six out of the 20 selected 
heroin volatiles (1, 4, 7, 11, 13 and 19 in Table 8.2) and eight out of the 23 selected cocaine 
volatiles (1, 5, 7, 15, 19-22 in Table 8.3) have not been detected or identified with a 
minimum MS similarity of 800 in corresponding samples analysed on GC-fastTOFMS. The 
two main reasons are the lack of the compression effect of the modulator and the lack of 
the second separation mechanism in 1D GC, which reduces the sensitivity and leaves the 
eventual coelutions on 1D column unresolved. Reduced acquisition rate of TOFMS in 1D 
GC mode (20 Hz) is another reason for worse deconvolution and identification of lower 
abundance components in complex matrixes.  
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GC×GC-TOFMS offers unprecedented information content for volatiles and semi-volatiles 
in cocaine and heroin samples. The high match quality of TOFMS spectra against 
commercial MS databases (NIST05 and Wiley7) agreed with previous conclusions [186, 
188] that match quality decreases as molecular weight and thus mass fragments in the 
mass spectra increases. The general trend of similarity decreasing as molecular weight 
increases (R2 = 0.60), as calculated for the components given in Table 8.2, is shown in 
Figure 8.14. The average similarity of selected cocaine profiling components (excluding 
two outliers) was 925 and the average similarity for the identified heroin components was 
880. The lower average similarity for heroin components is probably contributed by their 
higher average molecular mass (data not given) when compared to cocaine components. 
The high similarity of TOFMS spectra to the commercial library entries excludes the need 
of a TOFMS dedicated in-house library, one which was necessary in the studies on sterols 
and anabolic agents [186, 188, 236].           
 
800
850
900
950
1000
50 100 150 200 250
mol. weight
s
im
ila
rit
y
 
Figure 8.14 The average similarity of TOFMS spectra of selected volatiles in cocaine 
samples against NIST05 and Wiley7, versus their molecular weight.  
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8.3.6 PCA discrimination and classification of samples 
 
The best PCA discrimination of different heroin samples (non-linked) and the best 
grouping of the subsamples to the corresponding samples (linked) was obtained by 
applying the N + SQR pre-treatment (Table 8.1). Four different groups were obtained from 
Macedonian heroin samples (including the blend sample), and five groups from 
Australian heroin samples. Although all 9 Australian samples were (presumably) 
originated from SEA region, 5 groups have been observed. The five Australian samples in 
the same group (H1-H5, Figure 8.15) were samples from the same seizure, and the rest of 
the samples were discriminated between each. The PCA result for heroin samples is given 
in Figure 8.15. Similar differentiation into five groups has been obtained also by using 
Australian samples only, and by selecting components which were present in at least one 
of the samples.  
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Figure 8.15. Principal component analysis of 21 heroin samples based on the selected 
volatiles (samples Hb and Hc in triplicate). N + SQR pre-treatment was applied on raw 
data. The first two components account for 66% of the variability.   
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When blend samples (B1-B3) were plotted against the original samples only (Ha, Hb and 
Hc), the PCA score plot showed they are located at the gravity center of the three clusters 
(Figure 8.16). It was expected since the variability set of the blend samples is composed of 
the variables from the three original samples used to make the blends. This observation 
confirms the reliability of the analysis and strenghthen the confidence in the selected set of 
variables (the components selected for profiling).    
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Figure 8.16 The location of blend samples B1-B3 on the PCA score plot when plotted 
against the original samples only 
 
Similarly to the statistical analysis applied on heroin data, the same approach has been 
applied also for discrimination of cocaine samples. The best sample discrimination has 
been obtained by applying the Log pre-treatment on the raw data. PCA has clearly 
distinguished the three Macedonian samples (Ca, Cb and Cc) while all subsamples (Ca1, 
Ca2, Ca3, Cb1 etc.) have been well grouped into their corresponding sample origin (Ca, Cb 
etc.). Six Australian cocaine samples originated from the same seizure (C1-C6) have been 
classified in one group according to the PCA analysis of their volatile profiles. The rest of 
the Australian samples represent separate groups. The score plot of all selected volatiles in 
Ha 
Hb 
Hc 
B1-B3 
Cocaine and heroin profiling by GC×GC 
 
 242 
18 cocaine samples is shown in Figure 8.17. The first two principal components account for 
71% of the variation, slightly higher than in the case of heroin.   
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Figure 8.17. Principal component analysis of 18 cocaine samples based on the selected 
volatiles (each sample in replicate). Log pre-treatment was applied on raw data. The 
first two components account for 71% of the variation. 
 
 
8.4 CONCLUSIONS 
 
The method presented here represents a compromise between the complex and time 
consuming profiling methods offering high information content and much simpler 
methods based on major components profiling which offer limited information content. 
Even though the method lacks some components usually used in profiling of cocaine and 
heroin, mainly higher molecular mass components, the method offers clear and trivial 
discrimination between samples from different countries, and more important – 
discrimination between samples from the same country (region). This is especially 
valuable for highly purified heroin samples usually originating from SEA region, where 
the low abundance of impurities in the profiles prevents their discrimination using 1D GC 
methods.   
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Volatile and semi-volatile component profiles are complex, containing a great number of 
compounds for reliable comparison. However, the number of resolved components is 
strongly related to the column configuration applied for separation, and BPX5 / BP20 has 
been shown to offer maximum spread on the 2D plots for both, heroin and cocaine 
volatiles. It seems the orthogonal separation mechanisms of BPX5 phase based on 
moderate π-π* interaction and BP20 phase based on strong hydrogen bonding are best 
suited for volatiles in cocaine and heroin samples. This gives different profile patterns of 
samples with maximum number of individually separated components, which in turn 
offers most reliable sample comparison and differentiation.         
 
The lists of cocaine and heroin selected components for profiling can be further extended 
with new components from profiles once a good relationship is established between them 
and their origin in the samples. Solvents used in the preparation of drugs, as well as their 
impurities, are good markers for sample-to-sample comparison and can be easily added to 
the list. Exceptions are lowest boiling point solvents such as diethyl ether, ethanol, 
methanol, acetone etc. which are not amenable for proper modulation in GC×GC format at 
the operating temperature of LMCS.  
 
Although heroin samples originated from SEA region usually exhibit poor impurity 
profiles, around 1000 components have been detected in GC×GC-TOFMS at S/N threshold 
of 10 in samples from Australia which presumably come from the same region. On the 
other hand approximately double the peaks in SEA samples have been detected in 
samples from Macedonia, which presumably come from SWA region. In any case the 
number of components detected in GC×GC format is much higher than in any current 
profiling method based on 1D GC separation. The success of this study can be attributed 
to the improved separation based on two “orthogonal” separation mechanisms, to the 
enhanced sensitivity due to the compression effect of the modulator, and to the powerful 
deconvolution capabilities of the LECO ChromaTOF software facilitated by the high 
acquisition rate. 
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PCA followed by Log pre-treatment of raw data for cocaine and N + SQR pre-treatment of 
raw data for heroin samples has shown best discrimination between different samples 
(non-linked) and good grouping of all subsamples to the corresponding samples (linked). 
While discrimination between heroin samples from different countries and presumably 
from different production regions is trivial even with the current 1D GC profiling 
methods, the differentiation between samples within regions is greatly facilitated by the 
large number of peaks detected and selected for profiling purpose when GC×GC is 
employed. 
 
The full mass spectral data of non-targets and matrix components, retained due to the 
TOFMS detector capabilities, permit many more components to be tested and used as 
markers. Some of them could be very unique for particular group of samples or 
geographic origin determination if strong relationships are established. Pesticides used in 
crop treatment could be potentially good geographic origin markers once strong 
relationships are established between their presence in samples and known regions of 
their specific use.          
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The infamous Marion Jones had never been caught by anti-doping authorities, not because 
she was “negative”, nor had she avoided the frequent testing that all elite athletes must 
submit themselves to, but simply because of the “transparency” of the screening methods 
applied at that time – the inadequacy of the analytical method! This thesis proposes a new 
approach for screening in doping control, which overcomes the “transparency” of the 
current screening methods; by having significantly more separation performance, then full 
scan MS can be applied to better characterise separated components. The work in this area, 
presented in this thesis, is far from complete, but it offers a fertile ground for further 
improvement and tightening the screw on sports-drug cheating. There is a long way to go 
through performance testing on larger numbers of real samples, and further validation 
against current and hopefully new established criteria in GC×GC format in the future. 
Hopefully, the scope of the work presented here, will direct sports drug analysts along the 
path that has been illuminated by this study.  
 
Mass selective detectors are well established in analysis of complex matrixes, and very 
often is the only way to identify minor amount of analytes in presence of high abundance 
background components. However, as lower detection is mandated, mass interference 
becomes prominent due to matrix coelutions. Selected ion monitoring (SIM) can 
significantly increase the sensitivity but at the price of lower net information content. 
Further sample separation without losing the full mass spectral capability is highly 
desirable in analysis of such a complex matrix. Comprehensive two-dimensional GC 
coupled to fast time-of-flight MS has been proved advantageous over classical GC in 
doping control. As a result, the minimum acceptable match (MAM) has been proposed as 
an additional criterion when defining limit of detection. The new criterion proposes that 
the LOD be taken as the lowest concentration of analyte which gives S/N of a pre-defined 
value or greater (the same is in current methods), plus a further metric of MS similarity of 
the measured signal equal to or above a pre-defined value. The metric slightly 
compromises the LOD but it greatly improves the reliability of the detection and 
identification, at the lowest concentrations.  
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The criterion has been successfully applied in endogenous sterol analysis, and in the 
proposed GC×GC-TOFMS method for analysis of anabolic agents. The ultimate result 
reported in this thesis is the detection of the free fraction of estrone at a concentration of 
0.1 ng mL-1 spiked in blank urine, with a MS similarity of 94%.  
 
Furthermore, full mass spectral information of non-targets and the matrix are retained and 
can be used for future retro-searching – re-examining the data alone in the light of newly 
identified compounds, to identify if a doping offence has been committed. The biggest 
issue identified in this study was the poor similarity of TOFMS spectra to the entries in the 
commercial MS libraries. The bias of the TOFMS detector towards higher masses has been 
identified as the cause of the problem. Further work needs to be done in order to find the 
law (if there is) which relates TOFMS and quadrupole MS sensitivity across the mass 
range. In that case the reliability of searching of “altered” TOFMS spectra against well 
established and huge commercial MS libraries (mainly based on quadrupole MS spectra), 
will be enhanced. Note that this appears to be a limitation of the LECO Pegasus system, 
since TOFMS should ideally be able to generate an unbiased spectrum. 
 
GC×GC-TOFMS has been proven advantageous over one dimensional GC when coupled 
to the same detector in analysis of anabolic agents in urine. More anabolic agents, with 
higher similarity, have been detected in GC×GC format. The bias of TOFMS towards 
higher masses has been addressed again. Another field of further research in this area can 
be coupling of GC×GC with another type of TOFMS, namely accurate mass TOFMS. 
Preliminary results have shown this detector lacks the bias towards higher masses 
reported above, which makes it a perfect detector for minor amount of anabolic agents in 
such a complex matrix as urine. Furthermore, accurate mass will give another dimension 
in mass selectivity which will further increase reliability of the method. However, the 
acquisition rate of this detector will need to be improved from the currently 20 Hz to at 
least 50 Hz, in order to be applied in GC×GC format. Knowing the development of 
technology, it seems it is just a matter of time.      
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The proposed GC×GC-TOFMS method has been evaluated against strict WADA criteria 
for identification and minimum required performance limits. It has been shown that 
proposed methods largely comply with the criteria. The lack of at least three diagnostic 
ions with abundance above 5% has been compensated by the high MS similarity. Among 
the MAM criterion, an additional criterion has been proposed, namely second dimension 
retention time tolerance window. It adds weight to the total reliability of the method, and 
it seems the present criterion for retention time tolerance window defined by WADA can 
be freely applied also for the second dimension retention time in GC×GC format. A full 
mass spectrum of “everything” which elutes from the columns is retained and can be used 
for retro-search for e.g. new designer steroids and new drugs in the future. It is also now 
of interest to apply the method more generally to all drugs of relevance to sports drug 
testing.   
 
The orthogonal separation of impurities in ecstasy samples combined with enhanced 
signal due to the modulation process, plus full mass spectra of the matrix has been shown 
advantageous over current ecstasy profiling methods. A large number of components 
have been revealed in profiles when components have been separated on the best 
(preferred) column set (BPX5 / BP20), many of them can be used as potential markers for 
synthesis route identification or sample differentiation. Piperonyl methanol, a low 
abundance, a polar and coeluting component with other background components (which 
share some diagnostic ions), has been shown to be one of the most discriminative 
components in ecstasy profiling. Proper identification and integration of low abundance 
components which show tailing in classical GC can be very difficult. 24 ecstasy tablets 
have been correctly classified in 8 groups according to their post-tabletting characteristics. 
This approach can now be validated for a much wider range of ecstasy samples, covering 
as wide a sample set as possible, of different synthetic route, and other relevant factors, to 
appreciate the power of the GC×GC method for profiling. 
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The full mass spectral data of targets, non-targets and matrix components detected in illicit 
drugs permit many more compounds to be tested and used as markers. Although heroin 
samples originated from SEA region usually exhibit poor impurity profiles, around 1000 
volatile components have been detected in heroin samples from Australia (which 
presumably come from the same region) by using GC×GC-TOFMS. Some of them could be 
very unique for a particular group of samples or geographic origin if strong relationships 
are established.  
 
PCA followed by Log pre-treatment for cocaine and N + SQR pre-treatment of the raw 
data for heroin samples has shown best discrimination between non-linked samples and 
good grouping of linked samples. While discrimination between heroin samples from 
different countries and presumably from different production regions is trivial even with 
the current 1D GC profiling methods, the differentiation between samples within regions 
is greatly facilitated by the large number of peaks detected and selected for profiling 
purpose when GC×GC is employed. 
 
By virtue of the improved separation and enhanced sensitivity of GC×GC a high number 
of components have been detected in the profiles, which in turn requires further research 
on establishing links between their presence and their origin in drugs to be undertaken. 
Once a strong link is established, they can be used as new markers for particular 
geographic origin of plant materials used as precursor for drug production, for specific 
route of production of synthetic drugs, or for establishing routes of trafficking. Another 
advantage is that the same method conditions can be used for profiling of both heroin and 
cocaine volatiles. In currently employed methods, the conditions for heroin and cocaine 
profiling are different.  
 
This study is not the first to investigate the application of GC×GC to drugs or to sterols in 
general, but it is differentiated by the novel methods, proposals, and investigations that 
have been instituted. The study using WADA key anabolic agents sought to apply 
established  WADA criteria to the GC×GC results, and in doing so bring some measure of 
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knowledge to the ‘harmonisation’ of this area where GC×GC could be a critical new 
testing tool. This is done through demonstration of equivalency of the data so obtained.  
 
Profiling should be the most logical use of the GC×GC method, and its inherent 2D data 
presentation format. That this resembles a two-dimensional picture of the sample, where 
the brush now paints a picture of the unique chemical properties of compounds within the 
axes, offers considerable molecular knowledge to a sample’s composition. This distinctive 
pattern can be likened to a fingerprint, to compare samples across a related sample set. 
Whilst strategies have been proposed for sample-to-sample comparison, it is not clear that 
the ‘simplicity’ or robustness of fingerprint comparison has been established yet. The 
activity in GC×GC will continue to advance the technique. Different – and new – MS 
methods, different column geometries, alternative modulation methods… The field will 
continue to provide the GC community with further advanced methods into the 
foreseeable future, and forensic and law enforcement community will benefit as well.  It is 
hoped that this thesis will be recognised as playing its part in the total literature and 
science of comprehensive two-dimensional gas chromatography.    
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